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Abstract 
This thesis investigates ionotropic and metabotropic signalling mechanisms in 
developing neurons from human embryonic stem cell and primary sources. Focus is 
placed on the measurement of functional activity using primarily whole-cell patch-
clamp and Ca2+ imaging techniques 
These signalling mechanisms were investigated in undifferentiated human 
embryonic stem cells, hESC-derived neurons, fetal primary human neurons and 
neonatal primary mouse neurons. The results of this research are separated into 
three chapters. Preliminary work carried out on iPSC-derived neurons is also 
included as an indication of future direction 
Chapter 3: P2 Receptors in hESCs 
Purinergic signalling was shown to be active in undifferentiated hESC populations. 
Specifically, the activity of P2Y1 receptors was confirmed pharmacologically. This is a 
novel observation and indicates a mechanism for physiologically relevant signalling 
molecules to modify [Ca2+]i  
Chapter 4: Functional Characterisation of hESC-Derived and Primary Neurons 
Functional characteristics associated with neuronal development were measured in 
human embryonic stem cells during terminal neuronal differentiation in a 
chemically-defined medium. The presence and activity of voltage-gated Na+, K+ and 
Ca2+ channels were recorded, alongside data on neuronal excitability (Vm, iAP 
induction and threshold and spontaneous electrical activity). These data were also 
recorded in fetal hWGE- and neonatal mWGE-derived neurons for comparison. 
hESC-derived neurons were shown to be functionally more similar to fetal hWGE-
neurons suggesting an immature neuronal phenotype 
Chapter 5: GABAergic Signalling in hESC-Derived and Primary Neurons 
GABAergic signalling in hESC-, mWGE- and hWGE-derived neuronal populations was 
investigated. Focus was placed on hWGE-derived neurons and the developmental 
state of GABAergic responses. In fetal hWGE-derived neurons, a percentage of cells 
displayed an ‘inhibitory’ response to GABAAR activation. This is a novel observation 
with implications in human neuronal development. In vitro modulation of 
GABAergic signalling was also shown, providing potential tools for future research 
into this phenomenon 
Chapter 6: Future Developments and General Discussion 
iPSC-derived neuronal populations were shown to display basic neuronal functional 
properties. This work will form the basis of future studies on these cells 
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Chapter 1.  Introduction 
Regenerative medicine is the practice of producing healthy cells or tissue for the 
replacement or repair of damaged tissue in the host. Stem cells have been widely 
publicised as a potential source of cells for tissue transplantation. Similarly, the 
ability to grow and differentiate cells in vitro provides the potential for producing 
developmental and disease models which mimic in vivo phenotypes. Such models 
may provide valuable information about developmental processes and may also 
offer a platform for high throughput drug screening and testing. Ionotropic and 
metabotropic signalling within stem-cell populations remains relatively uncontrolled 
in vitro yet offers the potential for improved differentiation. The following thesis 
focuses on ionotropic and metabotropic signalling within stem cell and progenitor 
populations, specifically with respect to neuronal development.  
1.1. Tissue Transplantation 
Tissue transplantation has long been used as a method to alleviate or eliminate the 
symptoms of disease. It is commonplace for patients with kidney, heart, liver or skin 
defects to undergo transplantation surgery to replace defective with healthy tissue 
although progress with neuronal transplantation has been limited (Starzl, 2000). In 
the early 20th century, the first successful corneal transplantation was carried out by 
Dr Eduard Zirm (Zirm, 1906), whilst whole-organ transplants have been used 
successfully since the 1950s to replace organs which have become defective 
(Murray et al., 1956). There are several types of transplantation, defined by the 
source of donor tissue: autograft - where donor and recipient are the same 
individual (e.g. skin grafts, tendon replacement); allograft – where the donor is a 
non-identical individual species-matched to the recipient; isograft – where donor 
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and recipient are genetically identical individuals (e.g. identical twins), and; 
xenograft – where the donor is of a different species to the recipient (e.g. the use of 
porcine valves in heart transplantation). Organ donation, in these many forms, is 
often a complicated procedure both physically and ethically. It is also, with the 
exceptions of autografts and isografts, subject to rejection of donor tissue by the 
host immune system. This problem, due to histoincompatibility between the donor 
and recipient human leukocyte antigen system (HLA), is one of the major obstacles 
to successful tissue transplantation (Kahan, 2009).  
 The use of immunosuppressants, such as cyclosporine-A, has been shown to reduce 
the destruction of donated tissue by the recipient’s immune system. However, the 
suppression of the immune system dramatically increases the risk of infection and 
malignancy within the patient (Starzl, 2000). Together with the difficulties in finding 
donors with matching HLAs, rejection of transplants makes the process of tissue 
transplantation a difficult and lengthy challenge which, at best, is still far from 
perfect as a treatment for the original disorder or disease (Kahan, 2009). 
 Since autografts employ donor tissue originating from the recipient, they are not 
subject to rejection and, consequently, carry less risk than the more commonly 
employed allografts. The obvious downside to autografts is the availability of tissue. 
Being unable to provide tissue for direct replacement of organs restricts this type of 
donation to the movement of tissue from one area in order to repair other areas, as 
in skin grafts or muscle and tendon repair (Starzl, 2000; Marrale et al., 2007). To 
combat the problems of both tissue availability and compatibility, the use of stem 
cells as a source of donor tissue is widely considered as a potentially realistic 
prospect. With recent advances in the production, maintenance, differentiation and 
Chapter 1. Introduction 
 
3 
 
manipulation of stem cells, it is becoming more apparent that, with further research 
and development of techniques, it may be possible to produce tissue for donation 
that has been specifically engineered for the intended purpose (Dominguez-Bendala 
et al., 2002).  
 Although there is exciting potential for stem cells to provide tissue for 
transplantation, current knowledge and techniques are as yet underdeveloped. 
Embryonic stem cells (ESCs) are now widely cultured in many laboratories and 
multiple established cell lines are now available. Furthermore, there are established 
protocols for the differentiation of these cells into various important tissue types, 
and clinical trials involving the transplantation of stem cells into human patients, 
although uncommon, are in progress (Bongso & Fong, 2009; Cristante et al., 2009; 
Menasche, 2009). However, there is still a requirement for more information about 
the biological characteristics and functional properties of these cells. Studying their 
integration into patient organ systems, observing similarities between 
differentiation in vitro and in vivo of various cell types and assessing the 
effectiveness of differentiated cells at performing functions necessary for their use 
is important in order to realise fully their clinical potential (Blum & Benvenisty, 
2008).  
It is possible that treatment of neurological disorders through the introduction of 
tissue may potentially alter the patient’s personality and psychological 
characteristics. Even if exogenous neuronal tissue was effectively integrated into 
the existing network, it may not necessarily improve cognitive function. Not enough 
is known about neuronal networks and the complicated system of integration of 
newly generated neurons in vivo let alone that of exogenous tissue introduced 
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through surgery. In some cases of neuronal degradation, there is preliminary 
evidence that suggests transplantation of new tissue may lessen the disease-
associated psychological and motor effects observed in many patients. This area is 
still in its infancy and a greater understanding of the integration and of both the 
beneficial and detrimental effects of neuronal grafting will be of tremendous value 
to this area (Lindvall & Kokaia, 2006). 
1.2. Stem Cells as Disease Models 
In addition to their use in transplant therapy, it has been suggested that stem cells 
may be useful in producing in vitro models of disease. This would allow improved 
study of diseases and how they affect cell populations in systems more accessible to 
various investigative techniques, such as whole cell patch clamp. Once established, 
these models may provide important information that could otherwise be 
unobtainable, or ethically unreasonable, using animal or patient studies, 
respectively. They may also be useful for high-throughput drug discovery and drug 
toxicity testing that employ large libraries of drugs to be screened for advantageous 
or negative effects on specific stem cell-derived cell types. Using these models to 
test the efficacy of candidate drugs before clinical trials may reduce the ethical 
complications in setting up such trials (Scheffler et al., 2006). 
1.3. Neuronal Transplantation 
The transplantation of neuronal tissue has been studied since the late 1800s when 
W. G. Thompson transplanted cortical tissue from feline and canine brains into 
canine host brains (Markakis & Redmond, 2005). The low level of transplant 
success, and the minimal requirements for a transplant to be considered successful, 
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was a clear indication of the necessity for improvement and further research. At this 
early stage, a successful transplant had only to show signs that the tissue had 
survived a short period of time within the host system. Integration and interaction 
were not required. As the implications of neural transplantation became more 
focused on the potential clinical advantages, rather than mere scientific curiosity, 
research into this area became more commonplace. 
The focus of recent research into neural transplantation has largely centred on the 
treatment, or improvement to pathology, of patients with neurodegenerative 
conditions effecting specific cell types or brain regions including Huntington’s 
disease (Hauser et al., 1999; Bachoud-Levi et al., 2001; Gaura et al., 2004), 
Parkinson’s disease (Perlow et al., 1979; Bjorklund et al., 1980; Dunnett et al., 1981) 
and stroke damage (Savitz et al., 2004) in particular (Markakis & Redmond, 2005). 
Research into spinal injury has also received considerable attention (McDonald & 
Becker, 2003), but, whilst showing many similarities, is considered to be a different 
area of research and will not be considered further herein. 
Neuronal grafting, as it is referred to in this thesis, consists of injecting suspensions 
of neuronal progenitor cells into the relevant region of the host brain. 
1.3.1. Fetal Neural Tissue Transplantation 
Early studies have shown that immature postnatal tissue provides a greater success 
rate than mature tissue for survival of transplanted tissue in rodent models 
(Markakis & Redmond, 2005). This idea was further refined to show that prenatal 
tissue conferred a considerable improvement of graft survival in rodent models (Le 
Gros Clark, 1940).  
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As with many areas of research, the use of animal models as research tools has 
been the focus of the majority of efforts. Animal models provide a means to 
understand and research the process of tissue transplantation without endangering 
further the health of people with neurological disorders using procedures that are 
not yet fully optimised. Following the success for fetal grafts in animal models of 
Parkinson’s disease, where functional improvements were first observed (Bjorklund 
& Stenevi, 1979; Perlow et al., 1979), research into grafting as a therapy for 
Huntington’s disease also began with the use of animal models. Originally, it was 
shown that fetal rat tissue grafted into quinolinic acid excitotoxicity-lesioned rodent 
striatum (a model for the degeneration seen in Huntington’s disease), could survive 
in the host brain up to 16 weeks and that choline acetyltransferase and glutamic 
acid decarboxylase levels, normally decreased in the diseased state, were restored 
in the graft-treated striata of rats compared to the control (sham-operated) rats. 
Not only were physical properties restored to the striatum, but functional 
properties were also improved; striatal-lesioned rats recieveing grafts had reduced 
locomotor-hyperactivity symptoms post-graft (Deckel et al., 1983; Isacson et al., 
1984). The combined improvement of physical and functional properties led to the 
study of behavioural improvements, and it was observed that the performance of 
graft-treated, lesioned rodents at delayed alternation in the T-maze was improved 
when compared to a sham-operated, lesioned rodent control. Nocturnal 
hyperactivity, seen in lesioned rodents, was also reduced when graft-treated 
(Deckel et al., 1986; Isacson et al., 1986). The apparent success in rodent models led 
to the introduction of clinical trials in humans, although these are still relatively low 
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in number and restricted in their depth (Piccini et al., 1999; Lindvall & Bjorklund, 
2004; Trounson et al., 2011). 
 Success rates of clinical trials of fetal tissue transplantation have been variable 
(Markakis & Redmond, 2005). Freed and colleagues compared grafted and sham-
operated patients, without immunosuppressive treatment, and observed no 
significant improvement in the grafted patients’ pathology or neurological function 
over a 12 month period post-transplantation (Freed et al., 2001). Conversely, 
Lindvall and Bjorkland pooled results from four separate studies (Hagell et al., 1999; 
Hauser et al., 1999; Brundin et al., 2000; Freed et al., 2001) and concluded that 
modest improvements to motor control were observed in graft-treated patients. 
Results for fetal mesencephalon-derived cells in Parkinsonian primate graft trials 
showed significant functional benefits in the host and were reported to have high 
survival of transplant tissue (Bakay & King, 1986; Redmond et al., 1986). It has been 
suggested that the high variation seen in clinical outcomes may reflect that seen in 
the pre-clinical treatment of the fetal tissue used, the disease state of patient 
cohorts and the exact methods of treatment making conclusive comparisons 
difficult to justify. The lack of consistency between trials means that the true value 
of grafting as a treatment for neurodegenerative diseases is currently difficult to 
assess (Lindvall & Bjorklund, 2004). 
The discovery, and subsequent culture, of proliferative populations of multi-potent 
cells from fetal and adult mammalian brain that are capable of self-renewal and 
differentiation into any of the three major CNS lineages, neurons, astrocytes and 
oligodendrocytes, provides two clinically relevant options (Reynolds & Weiss, 1992; 
Ma et al., 2009). Firstly, the presence of endogenous neurogenic centres may 
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enable recruitment of the patient’s own cells in vivo for the repair or replacement 
of neuronal tissue. Secondly, the ability to culture cells, under proliferative 
conditions, which are semi-fate-determined potentially provides a source of cells 
that can be produced in the scale needed for tissue transplantation and which are 
already ‘primed’ for neuronal differentiation (Uchida et al., 2000; Schwartz et al., 
2003). Such fetal NSCs are currently being used in multiple clinical trials (Aboody et 
al., 2011). 
1.3.2. ESC-Derived Neuronal Transplantation 
ESC-derived neurons and neuronal precursors have been used for transplantation in 
numerous animal models in order to establish their potential as a source of tissue 
for therapeutic use. One study showed that hESC-derived NSCs were incorporated 
into multiple regions of neonatal mouse brain. These grafts were shown to 
differentiate into neuronal and astrocytic populations (Zhang et al., 2001). Another 
study showed mESC-derived NSCs ‘survived, migrated, and differentiated into 
various types of neurons in different brain regions including cerebral cortex, 
hippocampus, and amygdala’ (Wernig et al., 2004). Further work on hESC-derived 
NSCs grafted into the lateral ventricles of neonatal rat brain showed that these 
grafts exhibited migration into grey and white matter of the host brain within weeks 
of transplantation (Reubinoff et al., 2001). H9 hESC-derived NSCs displayed 
improved differentiation potential upon transplantation into neonatal rodent 
hippocampus and injured adult rodent striatum and spinal cord (Joannides et al., 
2007b).  
Unfortunately, due to the tumourigenic potential of ESC-derived NSCs, clinical trials 
with these cells are rare. Currently, there are only 4 clinical trials on-going within 
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the USA. Geron Inc. are looking to treat subacute thoracic spinal cord injuries with 
hESC-derived oligodendrocyte progenitor cells. This trial is in Phase I and aims to 
have 10 patients enrolled between 2010 and 2012 
(http://clinicaltrials.gov/ct2/show/NCT01217008, accessed on 27th September 
2011). Advanced Cell Technologies have two Phase I/II studies, one on 12 patients 
investigating the clinical benefits of hESC-derived retinal pigment epithelial cells on 
juvenile macular degeneration. The other is looking at the same cells as treatment 
for age-related macular degeneration in another 12 patients. Finally, California 
Stem Cell are studying type 1 spinal muscular atrophy after transplantation of hESC-
derived motor neuron progenitor cells, although this study is currently on hold. The 
results of these clinical trials are not yet complete and many more trials will be 
required to show that these cells can fulfil the expectations that have been placed 
on them by so many (Ben-David & Benvenisty, 2011). 
As the research into graft-treatment improves, and as their use in a clinical 
environment becomes more of a reality, it is of greater importance that we fully 
understand the process of neural development and integration, both in vivo and in 
vitro. Such research will in itself provide the crucial information needed to improve 
the efficiency and clinical outcome of transplantation therapies.  
The improved outcome of grafted tissue derived from the region of the donor brain 
which corresponds to that which it is hoped it will replace in the host brain (i.e. 
striatum of Huntington’s Disease patients and the dopamine containing neurons of 
the ventral mesencephalon for Parkinson’s Disease) and the improvement of graft 
success seen when using fetal tissue at a developmental stage which is close to the 
time of birth of the specific neurons to be transplanted highlights the importance of 
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the production of hESC differentiation protocols aimed at replicating the 
characteristics of these fetal populations.  
The focus of this thesis is on the study of both hESC-derived neurons and of neurons 
derived-from striatal regions of fetal human and neonatal mouse. It is hoped that 
comparisons between these populations will provide insight into future directions 
for the improvement of hESC-differentiation. 
1.4. Striatal Development 
Striatal development begins, as does all neuronal development, with neural 
induction. This process is the thickening of the ectoderm of the gastrula to form the 
neural plate. The rounding and subsequent fusing of the neural plate forms the 
neural tube in a process called neurulation. Neural precursor cells, which will give 
rise to the central nervous system, line the neural tube forming the pseudostratified 
columnar epithelium. Through a process of patterning along the rostro-caudal axis, 
the neural tube is subdivided into distinct regions: the hindbrain 
(rhombencephalon); midbrain (mesencephalon); and the forebrain 
(prosencephalon), which is separated into the diencephalon and the telencephalon 
(Barker & Barasi, 1999). In the developing embryo, the telencephalon can be 
subdivided into the pallium and subpallium, the pallium developing into the 
cerebral cortex and other dorsal structures, and the subpallium giving rise to, 
among other ventral structures, the globus pallidus and the striatum (Rubenstein et 
al., 1998). This whole process takes approximately 6 weeks in humans with the 
striatum appearing at around Carnegie stage 18 (O'Rahilly & Muller, 1999). 
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 During telencephalic development, two ganglionic eminences begin to protrude 
into the ventricles. These are the medial ganglionic eminence (MGE) and the lateral 
ganglionic eminence (LGE). Together, these regions of precursor proliferation 
provide the cells for the striatum and other structures. The LGE produces the 
GABAergic MSNs and interneurons and the MGE provides the cholinergic 
interneurons and GABAergic neurons that migrate tangentially to the cortex. More 
specifically, the neuroepithelium of these eminences form the ventricular zone (VZ), 
a region of sustained proliferation and mitotic activity. Further in (away from the 
ventricle) from the VZ is the subventricular zone (SVZ), also a region of proliferation, 
which lacks the organised epithelial structure of the VZ. The neural precursors in 
these zones undergo asymmetric division, producing an identical neural precursor 
capable of further division, and a mitotically inactive neuroblast which migrates 
away from the region towards the mantle zone. This neuroblast migrates and then 
differentiates to become a mature striatal neuron (Olsson et al., 1998; Jain et al., 
2001; Hebert & Fishell, 2008). 
As has been mentioned, the main neurogenic region of the adult brain is the 
subventricular zone of the striatum (Ming & Song, 2011). As the region from which 
new neurons are generated, migrating through the rostral migratory stream to the 
olfactory bulb where they are integrated as functional components of the CNS. To 
be able to direct hESC-differentiation toward the development of neurons which 
mimic those utilised endogenously for the replenishment of neuronal tissue would 
likely provide an improvement in success rates in hESC-derived tissue 
transplantation. Furthermore, the observed specific loss of striatal medium spiny 
neurons (MSNs) in Huntington’s Disease makes the production of tissue similar in 
Chapter 1. Introduction 
 
12 
 
phenotype to striatal neurons clinically relevant. In order to refine directed 
protocols that direct the differentiation of hESCs towards specific subtypes of 
neuronal populations, it is important to understand the developmental processes 
which occur in vivo during the endogenous maturation of these cell types. 
The striatum makes up part of the basal ganglion and has been linked to motor, 
cognitive and limbic functions (Alexander et al., 1990; Parent & Hazrati, 1995). It 
consists of the ventral striatum, containing the nucleus accumbens and part of the 
olfactory tubercle, and the dorsal striatum, containing the caudate nucleus and the 
putamen. Approximately 90% of the striatum is made up of MSNs. These projection 
neurons primarily use γ-aminobutyric acid (GABA) as a functional neurotransmitter 
and project into both the direct pathway, through the globus pallidus, and the 
indirect pathway to the substantia nigra via the internal pallidum. The remaining 
10% is mostly made up of aspiny interneurons, which are either cholinergic or 
GABAergic and can be further subdivided (Jain et al., 2001). 
For striatal MSNs, the dopamine- and cAMP-regulated phosphoprotein (Darpp32) is 
the most commonly used antigen for immunohistochemical identification. Although 
there are others reported, like Ctip2 (Arlotta et al., 2008), these are not as widely 
used, or universally accepted. 
1.5. Embryonic Stem Cells 
ESCs are undifferentiated, self-renewable, pluripotent cells, isolated from the inner 
cell mass of an embryo at the blastocyst stage that can be cultured in an 
undifferentiated state indefinitely or, through the activation of differentiation 
pathways, can give rise to mature cells of various types (Dhara & Stice, 2008). 
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Human ESCs (hESCs) are widely accepted as having great potential in the treatment 
of a number of diseases and disorders involving cell loss (Thomson et al., 1998). 
These cells are capable of differentiation into any cell type in the human body. True 
totipotent stem cells are also capable of forming cells of the placenta, but the more 
widely used pluripotent embryonic stem cells (ESCs) are capable of becoming all the 
cells within the three somatic germ cell lines, mesoderm, ectoderm and endoderm. 
In recent years, there has been increased focus on the controlled differentiation of 
these cells into specific cell types with the aim of employing them in transplant 
therapies for certain degenerative diseases or other disorders requiring tissue 
replacement (O'Brien & Barry, 2009).  
1.6. Fetal Stem Cells 
Fetal stem cells are, to a degree, already fate determined, and they are often more 
suitably named fetal precursor cells. Taken from the developing fetus, these cells 
provide tissue that is pre-programmed to mature into specific cell types depending 
on the fetal location from which they were extracted. Whilst currently providing the 
gold standard of immature tissue for neuronal transplant therapy, fetal stem cells 
are limited in availability and are often seen as ethically unreasonable for large scale 
clinical use (Ogawa et al., 2009).  
1.7. Adult Stem Cells 
As with fetal stem cells, adult stem cells are fate-determined precursor cells. Until 
recently, it was not realised how many adult stem cells populations were present in 
the body. It is now accepted that these cells exist, usually in a state of quiescence, 
and that they can provide a source of renewable tissue to replace mature, non-
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dividing adult cells (Ma et al., 2009). Although adult stem cells are not seen as a 
potential cell source for therapy, their presence and activity within the body is 
encouraging as it suggests there are mechanisms in place for the integration of 
immature cells into functional adult tissue. 
1.8. Induced Pluripotent Stem Cells 
The discovery that mature, differentiated cells can be directed back to an 
undifferentiated, pluripotent ‘stem cell’ state through the expression of certain 
proteins has given further weight to the potential of stem cells to be a source of 
tissue for clinical use. To take a sample of tissue directly from a patient and use it to 
produce functional tissue for autologous transplantation therapy entirely removes 
the problems associated with ethics and immunological rejection. It is likely that 
sharing identical genetic origins would allow the tissue to be more easily and fully 
integrated than any other tissue source. This technique is still in its infancy, and the 
current procedure requires the transfection of exogenous DNA into the cells to 
induce pluripotency (Takahashi & Yamanaka, 2006). The foremost problem, as with 
any random integration of DNA, is the potential for disruption of oncogene and 
tumour suppressor gene function, resulting in cancer. Much is being done to 
establish methods of induction which negate the need for transfection, and should 
the outcome be an effective and safe method of inducing pluripotency in 
differentiated cells, this would likely be a huge advancement in the field of cell 
transplantation therapy (Chen & Liu, 2009; Normile, 2009). These induced 
pluripotent stem cells (iPSCs) have the potential to provide cell lines derived from 
patients with genetic disorders for use in disease modelling. The in vitro 
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developmental profile of these cells may also provide data relevant to the in vivo 
progression of the disease from which the donor patient suffers. 
1.9. Electrophysiology and Ion Channel Study 
The study of ion channels and electrical signalling in cells began in earnest in the 
late 1930s when Hodgkin and Huxley first measured action potentials and 
membrane potential in the squid giant axon (Hodgkin & Huxley, 1939). Using 
techniques which were at their infancy, it was determined that cells of the nervous 
system had negative resting membrane potentials and that they could, upon 
stimulation, fire an action potential, where membrane potential was seen to rise, 
reversing and reaching a peak, then falling below original baseline before re-
establishing the same baseline.  
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Figure 1.1. The First Recording of an Action Potential: Shown is an 
action potential recorded between the inside and outside of a squid 
giant axon. Below the recorded trace is a time marker displaying 500 
oscillations per s. The vertical scale indicates the potential of the 
internal electrode (mV), the sea water outside being taken as zero 
(figure directly copied from (Hodgkin & Huxley, 1945) 
Hodgkin and Huxley reported in their paper of 1945 entitled ‘Resting and action 
potentials in single nerve fibres’ that the traditional (at that time) concept, that 
action potentials arise from a transient breakdown in membrane potential, was not 
correct and that the inside of the nerve fibre becomes positive during an action 
potential due to a reversal of the membrane potential (Figure 1.1). Without 
knowing about the movement of ions across the membrane through selective 
pores, this was a near perfect explanation of what we now know happens during 
this event. It should also be mentioned that another group, Curtis and Cole, using 
different methods, observed similar results (Curtis & Cole, 1942), and in fact their 
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work provided information that allowed Hodgkin and Huxley to improve their 
model (Hodgkin & Huxley, 1945).  
 As technology developed and new methods were made available, observations on 
the nature of this electrical signalling in nerve fibres allowed the establishment of 
ion channels as a mechanism for ionic movement in and out of the fibre. Hodgkin 
and Huxley went on to propose that there was a voltage-sensitive aspect to the ion 
channel activity and that in order for this to be the case there must be a voltage 
sensitive component to the channel (Hodgkin & Huxley, 1952a). Through the 1950s 
and 1960s, the development of such techniques as dialysis (Brinley & Mullins, 
1967), internal perfusion (Baker et al., 1961; Oikawa et al., 1961) and the use of 
permeable chambers and tubing to change the internal solution of the axon 
(Chandler et al., 1965) allowed further observations to be made leading to advances 
in our knowledge of selectivity and the presence of Na+, K+ and Ca2+ channels. The 
discovery and use of certain toxins and channel blockers (such as tetrodotoxin (TTX) 
for Na+ channels and tetraethyl ammonium (TEA) for K+ channels) that could 
selectively inhibit the action of specific channels provided the proof for this theory 
(Tasaki & Hagiwara, 1957; Narahashi et al., 1964; Armstrong & Binstock, 1965). 
Although the function of these channels and their selectivity was now becoming 
more understood, the actual structure was still unknown. Work by Rojas and Luxoro 
in 1963 showed, using protease treated axons, that these channels are proteins 
embedded in the membrane (Rojas & Luxoro, 1963). Isolation of the Na+ channel 
from electric eel electrocytes (Agnew et al., 1978) provided information about the 
size and structure of this channel. Single channel recordings were first made using 
artificial bilayers into which protein channels could be placed (Bean et al., 1969a; 
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Bean et al., 1969b). This paved the way for more functional studies and increased 
efforts into the exact mechanisms at work such as the Na+ channel ‘ball and chain’ 
hypothesis (Goldman & Schauf, 1972; Armstrong & Bezanilla, 1977; Bezanilla & 
Armstrong, 1977). 
 In 1976 Erwin Neher and Bert Sakmann developed a technique using a pipette 
pressed against denervated frog muscle fibres. This allowed them to record single-
channel currents from the membrane. This work, eventually winning them the 
Nobel prize in 1991, revolutionised electrophysiology and our knowledge of nervous 
transduction. Through modifications and experimental trial, the method was 
refined, altered and presented as ‘The extracellular patch clamp: a method for 
resolving currents through individual open channels in biological membranes’ in a 
paper of the same title (Neher et al., 1978). The later development of this protocol 
to enable efficient seal formation and physical access to the cell via applied suction 
(whole-cell access) allowed for the control over ionic driving forces through the use 
of solutions with known ionic concentrations on both sides of the membrane 
(Hamill et al., 1981). 
The patch clamp method was to become the most important advancement in the 
field of electrophysiology, allowing direct recording of ion channel activity in almost 
any given cell type, and later in intact tissue (Sakmann et al., 1989). The ability to 
study channels in situ was of tremendous importance to the study of neurons and 
neurological activity.  
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1.10. Ca2+ Imaging 
Ca2+-sensitive, fluorescent dyes have been used to image Ca2+ for 50 years 
(Shimomura et al., 1962). Originally, this process was highly laborious, requiring 
relatively large volumes of solution. For measurements of intracellular Ca2+, the cell 
membrane had to be broken and the cytoplasm collected. Later developments 
allowed the use of microelectrodes or injection of aequorin, a luminescent Ca2+-
binding protein from jellyfish, through the cell membrane, a process that often left 
the cell damaged and the data unreliable. The pioneering work of Roger Tsien and 
his colleagues in the late 1970s provided membrane-soluble, efficient dyes that 
could be used for the measurement of intracellular Ca2+ in living cells far more 
simply and with a higher success rate than previously. The production of the Ca2+-
sensitive fluorescent dye Quin2 paved the way for the development of Ca2+ imaging 
as it is now. By using membrane-permeable ester derivatives of the dye, cells 
incubated in its presence would take up the dye, cleave it of its esters via 
intracellular esterases and, in doing so, both ‘activate’ the dye and render it 
membrane-impermeable, allowing recordings of intracellular Ca2+ to be made. This 
dye was not without its problems though and, as Ca2+ concentration was 
determined by the intensity change of the dye, the observed signal was also 
dependent on a number of variables other than the Ca2+ concentration. The signal 
was directly affected by the dye concentration and the thickness of the cell at the 
region being measured. The excitation wavelength of Quin2 is also only 339 nm, this 
is relatively short and as a result autofluorescence of the cell components interfered 
with the signal. One way around this problem was to load the cells with very high 
levels of the dye (greater than millimolar concentrations), however, this was found 
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to have significant deleterious effects on Ca2+ signalling itself due to Ca2+-buffering 
by the dye. Non-specific heavy metal binding also altered the Ca2+ signal strength as 
the heavy metals, especially magnesium, quenched the Quin2 without inducing 
fluorescence. A direct result of these flaws was the improvement of the dye and 
eventual synthesis of ‘a new generation of Ca2+ indicators with greatly improved 
fluorescence properties’ (Grynkiewicz et al., 1985). The article of that title is 
currently the second most cited paper in the journal of biological chemistry (Current 
as of 27th September 2011; http://www.jbc.org/reports/most-cited), indicating 
exactly how important these compounds have become for this research area. The 
development of Ca2+-sensitive dyes that respond to changes in Ca2+ by a shift in the 
wavelength rather than the intensity allows for the intracellular Ca2+ concentration 
to be determined by a ratio of the emissions when excited at both wavelengths. 
This significantly reduces any effect on the signal from Ca2+-independent factors, 
such as dye concentration, bleaching and cell thickness. The increased specificity in 
these compounds reduced the non-specific heavy metal binding and associated 
signal loss. Of these compounds, Fura 2 (or more specifically, its derivative Fura 2-
acetoxymethyl ester (AM)) has become the most widely used Ca2+-sensitive 
fluorescent dye in the field of intracellular Ca2+ imaging and is used for cytosolic free 
Ca2+ measurements in this thesis. 
1.11. Aims and Objectives 
The study of stem-cell differentiation often focuses on changes at the gene 
expression and protein level. Immunohistochemical analysis of cell cultures 
provides population data about the cell types present. The influence of signalling 
mechanisms on the control of cellular development is prominent. This thesis aims 
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to investigate multiple signalling mechanisms in clinically relevant cell types with a 
view to further understanding the importance of these pathways in neuronal 
development. It aims to draw comparisons between hESC- and primary-derived 
neurons in order to better evaluate the functional maturation of hESC-derived 
neuronal populations with regard to endogenously differentiated cells. 
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Chapter 2.  General Methods 
2.1. Tissue Culture 
All tissue culture was carried out in a laminar flow hood using standard aseptic 
techniques. Cells were maintained in culture in a humidified incubator at 5% CO2 
and 37 oC.  
2.1.1. Human Embryonic Stem Cells: 
Pre-cultured and frozen stocks of the hESC H9 line (WiCell Research Institute, 
Madison; WI, USA) between passages 60 and 90, derived in accordance with local 
and national guidelines, were used throughout as the source for hESCs. 
2.1.2. H9 Embryonic Stem Cell Feeder-Free Culture: 
2.1.2.1. Media Ingredients: 
ADF: 
Advanced DMEM:F-12 (Dulbecco's Modified Eagle Medium⁄Ham’s F-12) was 
supplemented with lipid concentrate, transferrin (300 µl in 500 ml medium, 12.5 
mg/ml stock, Sigma), insulin (700 μl in 500 ml medium, 10 mg/ml stock, Sigma) β-
mercaptoethanol (100 µM, Sigma), penicillin/streptomycin (pen/strep) and L-
glutamine (All from Invitrogen, CA, USA unless stated). 
ADF-FA: 
50 ml ADF (As above) was supplemented with fibroblast growth factor 2 (FGF2, 50 
μl in 50 ml medium, 10 µg/ml stock, Peprotech, UK) and ActivinA (50 μl in 50 ml 
medium, 10 µg/ml stock, R&D Systems, MN, USA) 
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ADF-SB: 
50 ml ADF (as above) supplemented with 50 μl SB-431542 (ActivinA inhibitor, 
Ascent Scientific Ltd, UK) 
For ADF-SB-F2(Hep): 
50 ml ADF-SB supplemented with 12.5 μl FGF2 and 5 μl heparin (5 µg/ml stock, 
Sigma)  
ADF-10F2(Hep)-10E: 
50 ml ADF supplemented with 25 μl FGF2, 5 μl heparin, 50 μl epidermal growth 
factor (EGF, 10μg/ml stock, Millipore, MA, USA) 
SFDM II:  
48.5 ml mixture of DMEM and Advanced DMEM:F12 (1:3 ratio) supplemented with 
2% B27 (+ retinoic acid), 1% pen/strep and 500 nM (additional) retinoic acid (all 
Invitrogen). 
For SFDM II + BDNF: 
SFDM II (as above) supplemented with 50 μl BDNF (10μg/ml stock, Peprotech) 
2.1.2.2. Pre-Coating Plates: 
2 ml fetal calf serum (Invitrogen) was pipetted onto 6 cm Nunclon plates and 
incubated at 37 oC for 24 h before use. 
2.1.2.3. Thawing: 
Cells were removed from frozen storage and allowed to thaw before a small 
amount of 37 oC ADF-FA was added and the suspension transferred to a 15 ml 
Chapter 2. General Methods 
 
24 
 
Falcon tube. This was spun at 500 g for 2 min, the supernatant was removed and 
the pellet was resuspended in 5 ml ADF-FA. This was then transferred to Nunclon 6 
cm plate (pre-coated in FCS (Invitrogen) and washed twice with PBS). 
2.1.2.4. Maintaining: 
Medium was removed daily and replaced with 3 ml ADF-FA until colonies were large 
and ready for splitting. 
2.1.2.5. Splitting: 
Medium was removed and 2 ml collagenase IV (Invitrogen)/media mix (1 mg/ml) 
was added. This was incubated at 37 oC for 40 min-1.5 h (depending on the age of 
the collagenase mix). Once the colonies were loosened from the plate surface, a 
further 2 ml ADF-FA was added and the suspension was transferred to a 15 ml 
Falcon tube. This was spun at 500 g for 2 min, the supernatant was removed and 
the pellet resuspended in 1 ml ADF-FA, a 200 μl pipette was used to break up the 
pellet and the colonies by repeat pipetting. 4 ml ADF-FA was then added to the tube 
and this was transferred to a 6 cm Nunclon plate (pre-coated in FCS and washed 
twice with phosphate-buffered saline (PBS, Invitrogen) before use). 
2.1.2.6. Freezing: 
Freezing medium (10% DMSO (Sigma) in FCS) was made to 1 ml per 6 cm plate and 
a corresponding number of 1 ml Cryotubes (Nunclon) were pre-labelled. 
Collagenase was added as per splitting. When colonies lifted off the plate by 
themselves they were transferred into a 15 ml Falcon tube as intact colonies and 
centrifuged at 500 g for 2 min. The supernatant was removed and the pellet 
resuspended in the freezing media. 1 ml of the suspension was quickly transferred 
Chapter 2. General Methods 
 
25 
 
into each Cryotube and placed into a slow-freezing isopropanol chamber. This was 
placed at -80 oC, left overnight and transferred into liquid nitrogen storage for 
future use. 
2.1.3. H9 Neurosphere Protocol: 
For initial differentiation down a neuronal lineage, hESCs were grown as 
neurospheres for 32 days as described below. 
2.1.3.1. Day 0-8: 
hESCs were collagenase-treated as in a normal split for hESCs, the suspension was 
spun at 500 g for 2 min in a 15 ml Falcon tube and the supernatant was removed. 
The pellet was resuspended in 200 µl ADF (without Fgf2) which was pipetted into 
the centre of a Sterilin dish. The colonies were allowed to settle so that some 
medium could be removed to improve chopping efficiency. As much as possible of 
the 200 μl media was removed without removing the cells. The tissue chopper 
(McIlwain, UK) was then used to chop the colonies into equal fragments using 
setting 1.5, chopping was repeated in a 90o angle to the first run to ensure 
fragments were equally sized. Warm ADF-SB plus the ROCK inhibitor Y-27632 
(Ascent Scientific Ltd, UK) was then added to the cells using amounts as follows: 
1 x 6 cm H9 ESCs into 7.5 ml ADF-SB + ROCK Inhibitor (10 µM) 
These cells were then transferred to a fresh Sterilin plate. 
2.1.3.2. Feeding:  
Neurospheres, suspended in medium in a Sterilin plate, were transferred to a 15 ml 
Falcon tube. This was spun at 150 g for 3 min. The supernatant was removed and 
the pellet resuspended in the appropriate amount of medium for the desired 
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dilution (after making spheres, the amount of medium was often reduced at first 
feed then, as the population increased, the amount was increased). Feeding was 
carried out every 2 days. 
2.1.3.3. Day 8-30: 
Cells were fed (as above) with ADF-SB-F2(Hep) 
2.1.3.4. Day 30+: 
Cells were fed with ADF-10F2(Hep)-10E 
2.1.4. H9 Plate Downs/Terminal Neuronal Differentiation: 
For terminal differentiation of neural precursors to mature neurons, and for 
electrophysiology and Ca2+ imaging, day 32 neurospheres were plated onto 13 mm 
glass coverslips pre-coated in poly-l-lysine (PLL, Sigma) and laminin at a density of 
1.5 x 103 per slip as described below. 
2.1.4.1. Preparing Poly-l-Lysine (PLL)-Laminin Slips: 
Coverslips (13 mm diameter VWR, PA, USA) were autoclaved on filter paper. 
Coverslips were placed into 24-well Nunclon plates using sterile forceps (flamed). 
PLL (2 μg/ml) was added and incubated overnight at 4 oC. The PLL was removed, the 
coverslips were washed with water and left to dry at room temperature over-day in 
the tissue culture hood. These plates could then be stored until required. 
The day before setting up the differentiation experiment, 80 μl of laminin (10 
μg/ml) was pipetted to the centre of each coverslip as single droplets. Water was 
added to the area between wells to prevent excessive drying out. These plates were 
incubated overnight in the tissue incubator at 37 oC. When the cells for plating 
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down were ready, the laminin droplet was removed and the culture media with the 
cells was added without allowing the remaining laminin layer to dry out.  
2.1.4.2. For Single-Cell Plate Downs: 
Neurospheres for dissociation were spun down at 150g for 3 min. These were 
resuspended in 1 ml Accutase and incubated at 37 oC for 5 min. 1 ml more Accutase 
was added and clumps were broken apart by repeat pipetting before incubating for 
a further 5 min. The resulting single cell suspension was spun down at 500 g for 2 
min. The pellet was resuspended in SFDM II+BDNF and counted. Cells were diluted 
and plated according to the dilution required e.g. 1,500 cells per well. Dilutions 
were made to allow for the correct number of cells to be in between 80 and 150 μl. 
The correct amount was then added to each cover slip and incubated for at least 3 
hours before the plate was flooded with 1 ml of SFDMII+BDNF. 
Plated down cells were fed every 3 days by replacing half the media each time. Cells 
were grown for up to 7 weeks post-plate down (PPD). 
2.1.5. H9 Embryonic Stem Cell mefi-Culture: 
H9 hESCs cultured on irradiated mouse embryonic fibroblasts (mefi) were provided 
by Shona Joy (Cardiff University). The information provided here is for the purpose 
of clarity. 
2.1.5.1. H9 Media 
412.5 ml Knockout DMEM was supplemented with 75 ml serum replacement, non-
essential amino acids, L-glutamine, 2.5 ml pen/strep, 3.5 μl β-mercaptoethanol and 
4 ng/ml FGF2. 
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H9 hESC colonies were grown on low density mefi cultures on gelatin coated tissue 
culture plates. When these colonies were ready for harvesting they were 
collagenase-treated, as described in section 2.1.2.5. Complete colonies were 
suspended in H9 media and pipetted in a droplet onto FBS coated glass coverslips 
maintaining a medium colony density. 
2.1.6. Human Fetal Neurons 
The fetal tissue used throughout this thesis was collected and prepared by either 
Claire Kelly or Sophie Precious (Cardiff University). Once the cells were plated they 
were passed on for functional characterisation. The information provided here is 
included for the purpose of clarity. 
Human fetal tissue was obtained following termination of pregnancies in maternal 
donors. All tissue was collected and used following the guidelines of the 
Polkinghorne and Department of Health reports and with Bro Taf Local Research 
Ethics Committee approval. In all cases, full, informed consent was provided by the 
maternal donor following consent for termination of pregnancy. Consent was 
obtained as part of the MRC-sponsored, South Wales initiative for transplantation 
(SWIFT) program. 
Fetal tissue was obtained from fetuses ranging in age from 6 to 12 weeks post-
conception 
Surgical Termination of Pregnancy (STOP) and Medical Termination of Pregnancy 
(MTOP) tissues were collected as described previously (Kelly et al., 2011). 
Following extraction and identification, fetal parts were transferred to a 50 ml 
Falcon tube containing hibernation media (Hibernate E, Invitrogen). The WGE was 
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dissected and the tissue either processed immediately or stored in hibernation 
media overnight at 4 oC. 
WGE fragments were incubated in TrypLE express (Invitrogen) for 20 min at 37 oC 
for dissociation. DNAase (Sigma, 0.01%) was added and the tissue incubated for a 
further 5 min at 37°C. 
The tissue was then spun down at 150 g for 3 min, washed twice with DMEM/F-12 
and then spun down at 150 g for 3 min. The pellet was resuspended in 200 µl 
DMEM/F12 and triturated to produce a single cell suspension (Kelly et al., 2011). 
This suspension was used to plate neurons using the same method applied to hESC-
derived neurons described in section 2.1.4.  
2.1.7. Postnatal Mouse Neurons 
Postnatal day 1 mice were sacrificed by decapitation and their brains were surgically 
removed for processing. Whole brains were transferred to a dish containing ice cold 
Hank’s buffered saline solution (HBSS, Invitrogen). The WGE was located, removed 
and chopped into small pieces surgically. These pieces were placed in HBSS in a 15 
ml Falcon tube and allowed to settle to the bottom. The HBSS was removed from 
the tube leaving only the WGE fragments. 1.5 ml trypsin (0.5% in PBS without Ca2+ 
or Mg2+) was added to the Falcon tube and incubated for 10 min at 37 oC. 500 µl 
DNAase (Sigma, 0.04%) was added to the trypsin/mWGE mixture and incubated for 
a further 5 min at 37 oC. 
The mWGE tissue was then spun down at 150 g for 3 min, washed twice with 
DMEM/F-12 and then spun down at 150 g for 3 min. The pellet was resuspended in 
200 µl DMEM/F12 and triturated to produce a single cell suspension. 
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This suspension was used to plate mWGE-derived neurons using the same method 
applied to hESC-derived neurons described in section 2.1.4.  
2.2. Functional Characterisation 
All whole-cell patch-clamp and Ca2+ imaging work was carried out at room 
temperature (23 ± 1 oC). Cells were prepared on glass coverslips as described in the 
relevant method sections. 
2.2.1. Physiological Solutions 
The same physiological extracellular solution (ECS) was used in both whole-cell 
patch-clamp and Ca2+ imaging. The intracellular solution was only used in patch-
clamp studies. 
2.2.1.1. Extracellular Solution (ECS): 
pH made to 7.4 with NaOH   
Ingredient Final Concentration 
NaCl 135 mM 
KCl 5 mM 
HEPES 5 mM 
Glucose 10 mM 
MgCl2 1.2 mM 
CaCl2 1.25 mM 
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2.2.1.2. Intracellular Solution (ICS): 
pH made to 7.2 with KOH  
2.2.1.3. K+ Channel Blocker and Na+ Replacement Solutions 
Tetraethyl ammonium-Cl (TEA, Sigma) was used for blocking K+ channels. 20 mM 
TEA was dissolved in standard ECS on the day of use. 
For block of Na+ channel activity standard ECS with equimolar replacement of NaCl 
with NMDG-Cl (NMDG, Sigma) was made. 
Note: When using NMDG-Cl as an equimolar NaCl replacement in external solution 
pH is very high requiring HCl to bring to pH 7.4 in place of NaOH 
2.2.1.4. Liquid Junction Potential 
The liquid junction potential using the standard extracellular and intracellular 
solutions was calculated to be 2.2 mV. Where appropriate, this value was 
subtracted from the recorded data offline. For the majority of experiments this 
value was not deemed large enough to significantly alter the data, in these cases 
the junction potential was ignored.  
Ingredient Final Concentration 
KCl  117 mM 
NaCl 10 mM 
HEPES 11 mM 
EGTA 11 mM 
MgCl2 2 mM 
CaCl2 1 mM 
Na2. ATP 2 mM 
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2.2.2. Whole-Cell Patch-Clamp 
2.2.2.1. Electrodes 
Silver/silver Cl- (Ag/AgCl) electrodes for patch-clamp were produced by electrolysis 
of NaCl with a 9 V battery using pure silver wire (0.25 mm diameter, Clark 
Electromedical Instruments, UK) as the cathode. These electrodes were Cl--coated 
as required. An Ag/AgCl pellet (Clark Electromedical Instruments) connected to the 
patch-clamp headstage was used as the bath (reference) electrode. 
2.2.2.2. Patch Pipettes 
Thin-walled, filamented, borosilicate glass tubes (World-Precision Instruments, UK) 
were pulled using a two-stage pipette puller (PP-830, Narishige, Japan) to give patch 
pipettes with a measured tip resistance of 3-6 MΩ when filled with the internal 
pipette solution. These pipettes were used to establish whole-cell configuration of 
the patch clamp technique. 
2.2.2.3. Whole-Cell Patch-Clamp Technique 
Plated down cells grown on glass coverslips were transferred into a perfusion 
chamber mounted on the stage of an Olympus CK40 inverted microscope equipped 
with phase-contrast optics mounted inside a Faraday cage on an anti-vibration air 
table (Wentworth Laboratories Ltd., Oxford, UK). Continuous perfusion of the cells 
with ECS was maintained by a gravity-fed system using a 50 ml disposable syringe as 
a reservoir connected to the bath with gas-impermeable tubing (Cole-Parmer, UK). 
Continuous perfusion was maintained at a rate of approximately 2-4 ml per min. A 
gravity-fed rapid solution changer (RSC, RSC-200, Bio-Logic, France) was used to 
apply various solutions directly to the cells when required allowing for solution 
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changes as fast as 20 ms. The RSC enabled 9 different solutions using either 50 or 10 
ml disposable syringe reservoirs connected to separate, parallel glass tubes (Bio-
Logic) with capillary tubing (Cole-Parmer, UK). Flow rates of between 0.5 and 1.5 ml 
per minute were maintained depending on reservoir height. Switching of solutions 
was enabled via electromagnetic stopper valves and a step motor to move the 
appropriate glass tube in line with the patch-clamped cell. The RSC system enables 
full automation of solution application protocols enabling greater reproducibility 
with repeated experiments. Waste solution was removed via vacuum suction 
through a flame-pulled glass tube connected to a waste Buchner flask with Tygon 
tubing. 
Patch-clamp pipettes were partially filled with ICS, pushed through a 0.22 µm pore 
filter (Gelman Sciences, UK) using carbon-fibre flexible needles (MicroFil, WPI). 
Filled pipettes were mounted on a CV 201AU headstage attached to an Axopatch 
700A Amplifier (Axon Instruments; Forster City, CA, USA) and DigiData 1320 A/D 
interface. 
The patch-pipette tip was then lowered towards the cell to be patched using the 
macromanipulation controls of a manipulator (Burleigh, Canada). A slight positive 
pressure was applied through the headstage mount via tubing attached to a syringe 
allowing control of the patch-pipette pressure. This positive pressure prevented the 
accumulation of particles from the bath onto the pipette tip preventing efficient 
seal formation. Upon insertion into the bath solution, a seal test was applied using 
the pClamp software. This 10 mV step for 10 ms, applied at 50 Hz, allowed for 
measure of the resistance between the pipette and reference electrodes. At this 
stage any pipette voltage offset was zeroed using the Multiclamp Commander 
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software. When the pipette tip was within the micromanipulation limits of the cell 
to be patched the micromanipulation controls were used to bring the cell into 
contact with the cell membrane. 
Upon contact of the patch-pipette tip with the cell membrane there was an 
observable reduction in the amplitude of current flowing through the set-up 
indicating the increased resistance due to the membrane covering the tip. At this 
stage, the positive pressure in the patch-pipette was removed and a slight negative 
pressure was applied. This negative pressure, coupled with slight adjustment of the 
micromanipulator to gain better contact with the cell, was used to form a tight seal 
on the cell membrane. A holding potential of -60 mV was then applied across the 
system to prevent depolarisation upon whole-cell access. The negative pressure, 
pipette positioning and holding potential aided formation of a seal which was 
greater than 1 GΩ in resistance. Only cells in which a GΩ or greater resistance was 
achieved were taken on to the whole-cell configuration. Upon GΩ formation, any 
residual capacitance currents (pipette capacitance) were compensated using the 
fast and slow-capacitance compensation in the Multiclamp Commander software. 
Whole-cell was achieved by the gentle increase of negative pressure in the patch-
pipette until noticeable capacitance transients appeared in the seal test current 
trace. These transients, indicative of the membrane capacitance, were 
automatically or manually compensated and measured using the whole-cell 
compensation feature in the Multiclamp Commander software. Series resistance 
was measured and only cells displaying a series resistance lower than 10 MΩ were 
used for further study. The negative pressure applied to gain whole-cell access was 
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often removed upon successful whole-cell formation, however, in some cases this 
was left on to prevent loss of the cell. 
Voltage- or current-clamp were used to apply voltage or current protocols, 
generated using Axon Laboratory’s pClamp 9 software, to the patched cell. These 
were recorded on-line for further analysis using the pClamp software. Offline data 
review and analysis was performed using Axon Laboratory’s Clampfit 9, Microsoft 
Office Excel and Prism4. 
2.2.2.4. Voltage Clamp Protocols: 
Voltage step p-n: Cells were held at -70 mV and sequentially stepped, for 200 ms, to 
voltages between -120 mV and +60 mV in 10 mV increments taking 19 separate 
sweeps to complete. Data were recorded with an online p-n subtraction protocol 
where, for each sweep, four steps preceding the recording were carried out which 
were equal in size of step to one quarter of the step for that sweep. The measured 
increase in current for each of these steps were summed and subtracted from the 
current during the main voltage step for that sweep. This enabled the subtraction of 
the linear (leak) component of the voltage-induced current. 
Modifications to the voltage-step protocol for measurement of GABA reversal 
potentials involved changes to the starting and ending voltages, the number of 
sweeps and the length of the voltage step. These changes are indicated in the text 
where appropriate.  
2.2.2.5. Current Clamp Protocols: 
Gap free: Cells were held in current clamp with zero current injection for recording 
of resting membrane potentials (Vm) and observation of any spontaneous action 
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potentials. Recordings were made using the ‘Gap free’ protocol immediately after 
whole-cell access to reduce the effect of the pipette ICS dialysing with the actual 
cytosolic solution and thus influencing the resting membrane potential in anyway. 
Recordings were made for 90 s for a mean calculation of Vm and to allow for 
spontaneous action potentials to be recorded. 
Current steps: Variable current injection was used to hold the membrane potential 
close to -80 mV. A sequential injection of current for 100 ms from 0 pA to 180 pA in 
10 pA increments taking 19 sweeps was used in an attempt to elicit an action-
potential like response upon the membrane potential reaching and passing the 
action potential threshold value. 
2.2.2.6. Whole-Cell Patch-Clamp Data Analysis 
Data obtained using the ‘voltage step p-n’ protocol under voltage clamp conditions 
was analysed in Clampfit 8/9. Briefly, the minimum peak current between 1 and 20 
ms of the voltage step for each sweep was taken as the inward current and the 
mean current value between 180 and 195 ms of the voltage step for each sweep 
was recorded as the outward current. In all cases currents were normalised to cell 
size by dividing the current over the cell capacitance to give the current density 
(pA/pF). 
Data from the ‘current step’ protocol were analysed in Clampfit 8/9 and exported to 
Excel for further processing. A segment of the trace including the action potential 
threshold from the first sweep which induced an action potential response that 
exceeded 0 mV was exported to Excel where dV/dt was calculated and plotted 
against Vm. 
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The average Vm during a 90 s ‘Gap Free’ recording in current clamp was taken as the 
resting membrane potential. In cells displaying spontaneous activity, an estimation 
of the baseline was made from the trace. 
2.2.3. Ca2+ Imaging 
The ratiometric Ca2+ sensitive dye Fura-2-AM (Molecular Probes, Eugene, OR, USA) 
was used for Ca2+ imaging experiments. This dye was purchased as a dry powder in 
50 µg aliquots. Before use, these aliquots were dissolved in 50 µl DMSO (Sigma) by 
vortex. They were then incubated at 37 oC for 1 h to ensure the dye was fully 
dissolved. 1 µl of the 1 mg/ml Fura-2-AM stock was added to 250 µl of normal cell 
growth media and mixed. Cells on glass coverslips were then added to the well and 
incubated for 30 min at 37 oC and 5% CO2 in a humidified tissue culture incubator. 
Both stocks and media containing the dye were kept, where possible, out of direct 
light to prevent photo-bleaching of the dye. This incubation allowed for Fura-2-AM 
to be taken up by the cells, cleaved and turned into the active dye Fura-2. 
Fura-2-loaded cells were placed in a specialised perfusion chamber, designed to 
allow direct access of the microscope oil-immersion lens with the bottom of the 
coverslip, mounted upon an Olympus IX71 equipped with a Cairn monochromator-
based fluorescence system (Cairn Instruments, Faversham, UK) and were 
continuously superfused with ECS. Fura-2 was alternately excited using fluorescence 
light emitted from the monochromator at 340 and 380 nm. Images at 510 nm were 
acquired at 0.33 or 0.2Hz by a slow-scan CCD camera (Kinetic Imaging Ltd, 
Nottingham, UK). Solutions, agonists and antagonists were locally applied to the 
cells using the gravity-driven rapid solution changer (see section 2.2.2.3. ). 
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2.2.3.1. Ca2+ Imaging Data Analysis 
Raw data, in the form of emission intensities at 510 nm, during alternate excitation 
at 340 or 380 nm, were recorded and stored using the Andor IQ 1.3 software 
package (Andor Technology, Belfast, UK). 
Following background subtraction, emission ratios (340/380) were calculated off-
line using Microsoft Office Excel (Microsoft, Redmond, Washington, US).  
Where indicated, data were normalised to the first 10 frames to allow further 
analysis and for comparisons.  
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Chapter 3.  P2 Receptors in hESCs 
3.1. Introduction 
3.1.1. Purinergic Signalling 
Purinergic signalling is the physiological utilisation of both purine and pyrimidines 
for the process of extracellular signalling. Purines, and their derivatives - such as 
adenosine, ATP and ADP - and pyrimidines, and their derivatives - e.g. UTP and UDP 
- released from healthy cells, via diffusion, exocytosis and transport, and from dying 
or damaged cells, are employed for extracellular signalling via purinergic receptors 
located on the plasma membrane (Burnstock, 2006). This system provides a 
mechanism for extracellular signalling that has not only been employed by nearly all 
tissue types in mammals, but has been implicated in a huge number of other 
organisms from virtually all major phyla (Burnstock & Verkhratsky, 2009). There are 
three classes of purinergic receptor, P1, P2X and P2Y. The P1 family of receptors are 
sensitive to adenosine, whereas P2X and P2Y are nucleotide-sensitive receptors. 
Both P1 and P2Y receptors are metabotropic, seven-transmembrane G-protein 
coupled receptors, P1 receptors modulating cAMP production, P2Y receptors 
working through either cAMP or inositol triphosphate (IP3) to release Ca
2+ from 
intracellular stores. P2X receptors are ionotropic nucleotide receptors which, upon 
binding of the relevant ligand, open to allow cations to pass through the cell 
membrane(Burnstock & Williams, 2000). 
3.1.2. P1 Receptors 
Currently, four subtypes of the adenosine receptors making up the P1 receptor class 
have been confirmed. These subtypes, A1, A2A, A2B and A3, are all G-protein coupled 
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receptors and are encoded by separate genes. The subtypes A1, A2A and A3 show 
high affinity for adenosine whereas A2B shows low affinity for this nucleoside. A1 
and A3 act via Gi and Go, A2A and A2B act via Gs (with A2B also acting via Gq). Through 
these G-proteins, these receptors modulate a number of cellular signalling 
molecules including adenylyl cyclase, PLC and protein kinase C (PKC) leading to 
downstream effects on gene expression and protein activity (Ralevic & Burnstock, 
1998; Klinger et al., 2002). 
3.1.3. P2X Receptors 
The ligand-gated non-selective cation channels of the P2X family are formed when 
three subunits form a stretched trimer (North, 2002). So far, seven of these 
mammalian subunits have been identified and classified P2X1-7. The seven subunits 
show 30-50% homology at the protein level. Each subunit consists of intracellular N- 
and C- termini, two transmembrane regions (TM1 and 2) and a large extracellular 
loop containing a hydrophobic region (H5) and an ATP binding site. There is 
evidence for the presence of both homo- and hetero-trimer formation between 
these subunits. The family of functional P2X receptors displays great variability with 
regards to pharmacological characteristics and physiological functions (Ralevic & 
Burnstock, 1998; Bianchi et al., 1999). 
3.1.4. P2Y Receptors 
Of the metabotropic, G-protein-coupled P2Y receptors there are eight known 
subunits. P2Y1,2,4,6,11,12,13 and P2Y14 make up a complex family showing a large 
amount of pharmacological and physiological variation. Of these subtypes, only 
P2Y1,2,4,6 and P2Y11 have been found in human tissues. The primary agonists of 
heterologously expressed human P2Y-receptors are ADP (P2Y1), UTP/ATP (P2Y2), 
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UTP (P2Y4), UDP (P2Y6) and ATP (P2Y11). These subtypes characteristically display an 
extracellular N-terminus, an intracellular C-terminus and seven transmembrane 
regions. Each P2Y receptor is coupled to a single heterotrimeric G-protein. This is 
primarily Gq (also referred to as Gq/11). However, P2Y11 can also bind Gs and P2Y12 
binds primarily to Gi. Activation of these receptors by their associated ligand elicits 
activation of phospholipase C (PLC), resulting in an increase in inositol trisphosphate 
(IP3) formation and the subsequent mobilisation of intracellular Ca
2+. This Ca2+ 
mobilisation can lead to direct and indirect stimulation of various signalling 
molecules such as PKC, phospholipase A2 (PLA2) and Ca
2+-activated K+ channels. 
P2Y11 has also been linked with stimulation of adenylate cyclase, resulting in 
increased cyclic adenosine monophosphate (cAMP) production. Through such 
mechanisms, activation of these receptors influences a number of intracellular 
pathways and expression cascades, the increase of PKC, for example, provides a 
mechanism for modulation of intracellular proteins through phosphorylation 
(Ralevic & Burnstock, 1998; von Kugelgen & Wetter, 2000; Marinissen & Gutkind, 
2001). 
3.1.5. Extracellular Release of Purines and Pyrimidines 
Until relatively recently, it was assumed that ATP release from cells occurred only as 
a result of cellular damage and the subsequent loss of membrane stability. 
However, it is now understood that cells may release ATP as a response to other 
factors such as hypoxia, physical stress, inﬂammation and cellular exposure to 
certain agonists (Bodin & Burnstock, 2001). In its role as a neurotransmitter, ATP 
has been shown to be co-packaged in vesicles and co-released at the presynaptic 
membrane with other classical transmitters (Pankratov et al., 2006). Vesicular 
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release of ATP has also been demonstrated in other, non-excitable cells types. 
However, since the presence of ATP permeable ion channels has also been 
suggested, it may be that both methods are present and provide distinct 
physiological roles (Burnstock, 2006). 
The presence of multiple nucleotidases and hydrolysing enzymes shortens the half-
life of extracellular ATP considerably within the body. These enzymes produce the 
ATP derivatives ADP, AMP and adenosine. These may function as agonists for 
multiple purinergic receptors with different affinities, and it is likely that the specific 
dynamic of local ATP release and degradation is physiologically relevant to the 
functional output of the signalling event that is required (Dubyak & el-Moatassim, 
1993; Shukla et al., 2005; Yegutkin, 2008). More recently, confirmation of UTP and 
UDP release by healthy or damaged tissue has been observed. These experiments 
have shown UTP that release from mechanically stimulated murine airway epithelial 
cells directly stimulates Ca2+ waves in this tissue (Homolya et al., 2000). Similarly, 
circulating UTP concentrations in humans during acute myocardial infarction were 
also shown to have risen (Lazarowski & Boucher, 2001). 
3.1.6. Physiological and Developmental Roles of Purinergic Signalling 
Purinergic signalling has been shown to play a role in a huge number of 
physiological processes. Early work on the effect of these compounds on biological 
systems focussed largely on modulation of cardiovascular parameters, including 
lowering of blood pressure, vasodilatation and hypotension (Drury & Szent-Gyorgyi, 
1929). Effects on platelet aggregation, mast cell function, intestinal contraction, 
immune response and pain sensing were later observed (Born, 1962). Further 
investigation revealed a role for purinergic signalling in neurotransmission and 
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neuromodulation (Burnstock & Kennedy, 1986). Purinergic signalling is not 
restricted to fast-acting effects on tissues and organs, a number of roles in slow-
acting alterations to cellular physiology have also become apparent. Effects of 
purinergic signalling on cell cycle progression, proliferation, apoptosis, migration 
and differentiation have all been proposed and observed in various cell populations 
(Ralevic & Burnstock, 1998; D'Ambrosi et al., 2001; Burnstock, 2002; Greig et al., 
2003).  
In human fetal astrocyte cultures from 1st trimester brainstem and diencephalon, 
both ATP and ATPγS (a hydrolysis-resistant ATP analogue) were shown to increase 
DNA synthesis, as measured by [3H]thymidine incorporation (Neary et al., 1998). In 
the same cells, ATP-induced increases in the mitogen-activated protein kinase 
(MAPK) known as extracellular signal-related protein kinase (ERK) were also 
observed. This increase was reduced by inhibition of P2 signalling with suramin, but 
was unaffected by P1 inhibition with 8-(p-sulfophenyl)-theophylline suggesting that 
P2 receptors were, at least partially, responsible for the response. ERK is linked with 
modulation of cellular proliferation and differentiation in various tissues. Activated 
MAPK has been shown to translocate to the nucleus where it can activate 
transcription factors, potentially modifying the expression of genes involved in cell 
growth (Seger & Krebs, 1995). In adult rat dorsal root ganglionic neurons in vitro, 
P2Y2 signalling has been linked, via ERK signalling, to neuronal survival through its 
anti-apoptotic effects. Conversely, P2Y1 activation in human prostatic carcinoma 
(PC-3) cells was induces apoptosis, as measured by caspase-3 activity, lactate 
dehydrogenase (LDH) release, and annexin-V staining, all of which are linked to 
apoptotic events (Wei et al., 2011). 
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In cultured human umbilical vein endothelial cells, P2Y1 has been shown to 
stimulate migration, as measured in in vitro wound repair assays, an effect inhibited 
by MRS2179, a P2Y1 receptor antagonist (Shen & DiCorleto, 2008). Furthermore, 
neural stem cells, prepared from 8- to 12-week-old C57BL/6N wild-type mice 
display increased migration in the presence of ATP, ADPβS and UTP. Again, this 
result was linked to a purinergic signalling-regulated increase in ERK activity (Grimm 
et al., 2010). 
Although it is now understood that purinergic signalling plays an important part in a 
large number of biological processes. It is apparent that more information is needed 
to elucidate their complete function and to understand more fully the extent of 
their activity. This knowledge, along with an increase in the use of microarray 
studies providing large-scale genetic expression data, has led to research into the 
presence and effect of purinergic signalling within stem cell populations.  
3.1.7. P2 Receptors in Undifferentiated Human Embryonic Stem Cells 
In 2004, Wang et al. presented evidence for the expression of P2 receptors within 
human stem cell populations (Wang et al., 2004). Although this work was carried 
out on CD34+ stem and progenitor cells from bone marrow, it provided the basis for 
further investigation into the expression and function of P2 receptors in stem cells. 
Within the CD34+ line, both P2Y1 and P2Y2 mRNA were abundant. Furthermore, 
P2X1, P2X4 and, to a lesser degree P2X7, were also shown to be expressed. As a 
number of these receptors have been linked to cellular functions such as 
proliferation (Neary et al., 2001; Ryu et al., 2003), migration (Scemes et al., 2003), 
differentiation (D'Ambrosi et al., 2001) and apoptosis (Burnstock & Williams, 2000; 
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Greig et al., 2003), it was hypothesised that purinergic signalling may influence stem 
cell differentiation (Verfaillie, 2002; Wang et al., 2004). 
Another group observed that adult neural stem cells from C57BL/6N mice 
subventricular zone express functional P2 receptors, which, upon activation, elevate 
intracellular cytosolic free Ca2+ concentration ([Ca2+]i) and increase proliferation in 
these cells (Mishra et al., 2006). In this study, P2Y1 and P2Y2 were shown to be 
responsible for purinergic-signalling dependent modulation of cellular proliferation. 
P2Y1 knockout neural stem cells showed 53% reduction in cell number when 
compared to wild-type. Similarly, 5 µM MRS 2179, a selective P2Y1 antagonist, 
reduced the cell number by 27% compared to the control. The addition of ADPβS 
and UTP resulted in increased cell counts. It was concluded that P2Y1 had the 
dominant effect on proliferation and that this action may be applicable to the study 
of human embryonic stem cell differentiation and development (Mishra et al., 
2006). 
P2Y1 was also suggested as the key mediator of proliferation and also of 
differentiation. In this study, murine P19 embryonal carcinoma cells were used to 
study the effects of purinergic signalling on progenitor cell proliferation and 
neuronal differentiation. It was shown that during the process of neuronal 
differentiation in these cells several P2X and P2Y receptors were differentially 
expressed, most notably P2Y1, although P2Y2 and P2X4 expression was also shown to 
change (Resende et al., 2008). 
A recent review compiles a list of further experimental evidence which suggests 
that purinergic signalling is involved in a number of processes in multiple cell types. 
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However, there is still a lack of knowledge and evidence for the role of these 
receptors in embryonic development (Burnstock & Ulrich, 2011). In order to realise 
the potential benefit, with regards to both disease modelling and therapeutic 
outcomes, that modulation of these receptors in stem cells offers, it is necessary to 
elucidate further their expression, function and the consequences of their 
activation. 
Currently, there is no information available on the functional activity of P2 
receptors within human embryonic stem cell lines. The information available has 
been gathered from mesenchymal, hematopoietic, mouse stem and progenitor cell 
lines. It was therefore decided to investigate the functional activity of P2 receptors 
within undifferentiated H9 hESCs.  
3.1.8. Aims of Chapter 
In order to better understand the degree of purinergic signalling within hESC 
populations, and to apply knowledge gained from research into other stem-cell 
sources, purinergic signalling in undifferentiated hESCs was investigated. Particular 
attention was be paid to Ca2+ mobilisation as a direct effect of purinergic receptor 
activation as this has been shown to directly affect cellular properties. 
Pharmacological evaluation of subtypes of purinergic receptors and their 
mechanisms of action was carried out. 
3.2. Non-Standard Methods 
The Ca2+ imaging technique used in this chapter is discussed fully in section 2.2.3. of 
Chapter 2: General Methods. Details of the individual agonist/antagonist application 
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protocols are discussed in the results text and highlighted in the corresponding 
figures.  
3.2.1. Extracellular Solutions: 
Extracellular solution: as described in section 2.2.1.1.  
50 mM KCl ECS: as per standard ECS, but with 50 mM KCl and 90 mM NaCl 
Ca2+ Free ECS: as per standard ECS, but with no added CaCl2 and 1 mM EGTA 
supplement 
3.2.2. Reagents 
Adenosine 5′-triphosphate disodium salt (ATP): Sigma, stocks of 100 mM dissolved 
in standard ECS, stored at -20 oC 
Adenosine 5′-diphosphate monopotassium salt (ADP): Sigma, Stocks of 100 mM 
dissolved in standard ECS, stored at -20 oC 
Uridine 5′-triphosphate tris salt (UTP): Sigma, stocks of 100 mM dissolved in 
standard ECS, stored at -20 oC 
Uridine 5′-diphosphate disodium salt (UDP): Sigma, stocks of 100 mM dissolved in 
standard ECS, stored at -20 oC 
α,β-methyleneadenosine 5'-triphosphate trisodium salt (αβme-ATP): Sigma, stocks 
of 100 mM dissolved in standard ECS,stored at -20 oC 
2′(3′)-O-(4-Benzoylbenzoyl)adenosine 5′-triphosphate triethylammonium salt (Bz-
ATP): Sigma, stocks of 10 mM dissolved in standard ECS, stored at -20 oC 
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[[(1R,2R,3S,4R,5S)-4-[6-Amino-2-(methylthio)-9H-purin-9-yl]-2,3-
dihydroxybicyclo[3.1.0]hex-1-yl]methyl] diphosphoric acid mono ester trisodium 
salt (MRS2365): Tocris, supplied pre-dissolved at a concentration of 10mM in H2O, 
stored at -20 oC 
Adenosine: Sigma, stocks of 100 mM in dissolved in ECS, stored at -20 oC 
8,8'-[Carbonylbis[imino-3,1-phenylenecarbonylimino(4-methyl-3,1-
phenylene)carbonylimino]]bis-1,3,5-naphthalenetrisulfonic acid hexasodium salt 
(Suramin): Tocris, stocks of 50 mM in H2O, stored at -20 
oC 
Pyridoxalphosphate-6-azophenyl-2',4'-disulfonic acid tetrasodium salt (PPADS): 
Tocris, stocks of 50 mM dissolved in H2O, stored at -20 
oC 
2-Aminoethoxydiphenylborane (2-APB): Tocris, stocks of 100 mM dissolved in 
DMSO, stored at -20 oC 
1-[6-[((17β)-3-Methoxyestra-1,3,5[10]-trien-17-yl)amino]hexyl]-1H-pyrrole-2,5-
dione (U-73122): Sigma, stocks of 5mM in DMSO 
3.2.3. hESC Culture 
For the experiments in this chapter, the H9 line of hESCs was cultured on MEFi until 
larger, healthy colonies were available for experiments as described in section 2.1.5. 
These cells were provided for me by another member of our lab (Shona Joy) and 
were not plated by myself. The method is included here for the purpose of 
reference. 
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When ready for Ca2+ imaging, H9 colonies were lifted through collagenase 
treatment (as described in section 2.1.5. These cells were then plated onto glass 
coverslips (13 mm diameter VWR cat. no 631-0149) pre-coated with Matrigel.  
hESC colonies on glass coverslips were incubated overnight at 37 oC at 5% CO2/95% 
air in a humidified tissue culture incubator to allow firm attachment to the Matrigel. 
Ca2+ imaging experiments were carried out within 36 h of plating. 
Only those colonies which appeared healthy and undifferentiated (large, compact 
colonies with no ‘spiking’ of peripheral cells and a clearly defined colony edge with a 
morphology characteristic of hESCs) were used for further experiments. 
3.2.4. Data Analyses 
Ca2+ imaging data were analysed as described in section 2.2.3.1.  
Statistical analyses were carried out using Prism4 software as described in the 
relevant text. 
3.3. Results 
In order to assess the functional characteristics of P2 receptors in the H9 hESC cell 
line, it is important to measure the functional output of these receptors. 
Measurement of P2X receptor function can be carried out using both standard 
whole cell patch-clamp (to measure ionic currents) and Ca2+ imaging (to measure 
Ca2+ influx). P2Y receptor function, as Gq/11-coupled receptors, can be measured by 
observing IP3-dependent Ca
2+ release from intracellular stores in response to 
agonists. 
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Unlike murine stem cells, it is not currently possible to maintain undifferentiated 
hESCs in culture as single cells for prolonged periods. Due to the formation of gap-
junctions between stem cells in culture, and the subsequent issues associated with 
patch-clamping large numbers of electrically coupled cells, little work has been 
carried out on hESC electrophysiology. For this reason, the focus of the following 
chapter is on the characterisation of P2 receptor physiology in the H9 line of hESCs 
using standard Ca2+ imaging methods to measure [Ca2+]i.  
3.3.1. Extracellular Application of ATP Induces Intracellular Ca2+ Rise in hESCs 
Fura-2 loaded H9 cells were imaged using the standard Ca2+ imaging method (See 
section 2.2.3. ) 100 µM ATP was applied externally and the fluorescence measured 
(Figure 3.1). In all cells, [Ca2+]i increased transiently in response to ATP. Three 
distinct Ca2+ responses were observed and labelled ‘A’, ‘B’ and ‘C’ accordingly. ‘A’ 
type responses were fast activating, reaching a peak and inactivation within the 160 
s application of ATP. ‘B’ types were fast activating, reaching a peak and partially 
inactivating to a plateau which subsequently declined to baseline within the 160 s 
application of ATP. Type ‘C’ transients were fast activating, reaching a peak and 
partially inactivating to a plateau which was maintained throughout the 160 s 
application of ATP. 
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Figure 3.1. Extracellular ATP induces transient intracellular Ca2+ 
increases: The extracellular application of 100 µM ATP for 160 s (black 
bars) resulted in an increase of intracellular free Ca2+, as reported by an 
increase in the Fura-2 fluorescence ratio (340/380). Three 
distinguishable Ca2+ transients were observed and named type ‘A’, ‘B’ 
and ‘C’. 
In all cells (n = 79), the first application of ATP elicited a greater response than 
subsequent applications. This desensitisation of the ATP response is shown in Figure 
3.2. It is apparent that those cells labelled as type ‘A’ show a greater level of 
desensitisation than those labelled ‘B’, which, in turn desensitise more readily than 
those labelled ‘C’.  
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Figure 3.2. Desensitisation of ATP induced Ca2+ transients: Sequential 
applications of 100 µM ATP for 160 s (black bars) resulted in a 
desensitisation of intracellular free Ca2+ transients as reported by an 
increase in the Fura-2 fluorescence ratio (340/380). The responses from 
the raw traces (Examples: Left) were normalised to the initial ATP 
response and plotted for each response ‘type’ (Bars: Right). Type ‘A’, 
n=34. Type ‘B’, n = 32. Type ‘C’, n = 13 (Error bars represent standard 
error of the mean (SEM)). 
In order to establish a concentration response curve for the transient Ca2+ response 
to P2 receptor activation, incrementally increasing concentrations of ATP were 
applied to the cells and the fluorescence ratio measured (Figure 3.3). The responses 
were averaged, normalised to the peak response in an attempt to calculate EC50. 
Due to the high level of desensitisation which was observed in the response to the 
higher concentrations of ATP applications it was impossible to record accurately an 
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EC50. However, it is clear that the half maximal activation is between 3 and 30 µM, a 
range consistent with previously reported values for P2 receptors.  
 
Figure 3.3. Concentration response curve for ATP: The Fura-2 ratio 
increase observed during transient Ca2+ rise in response to various 
concentrations of ATP was measured (top graph, averages). A sigmoidal 
concentration response curve was fitted to the data (bottom graph). 
Error bars represent SEM (not visible in concentration response curve as 
behind markers), n = 116. 
3.3.2. ATP Induced Ca2+ Transients in hESCs are Dependent on P2 Receptor 
Activation 
To determine if the response to ATP was a result of P2 receptor stimulation, the 
specific P2 antagonists suramin and pyridoxal-phosphate-6-azophenyl-2′,4′-
disulfonate (PPADS) were pre- and co-applied with ATP and the effect on the Ca2+ 
transients observed (Figure 3.4). These antagonists completely and reversibly 
removed any observable Ca2+ transients suggesting that P2 receptors are 
responsible for the rises seen in the absence of the blockers. 
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Figure 3.4. ATP-induced Ca2+ transients are P2 receptor dependent: 
Suramin (100 µM) and PPADS (50 µM) fully blocked the effect of ATP 
(100 µM, 15 s applications). The top example trace indicates the 
experimental protocol (black bars indicate application times). The 
bottom graph provides average responses normalised to the initial ATP 
response (Error bars represent SEM, n = 78). 
3.3.3. ATP-Induced Ca2+ Transients in hESCs Involve Release of Ca2+ from 
Intracellular Stores 
In order to establish whether the Ca2+ transients resulted from an influx of Ca2+ 
from the extracellular solution or from release from the Ca2+ store, Ca2+ was 
removed from the extracellular solution and ATP applied to the cells (Figure 3.5). 3 
applications of ATP in the normal extracellular solution were followed by five 
applications in a “zero” Ca2+ solution. After a waiting period in normal extracellular 
solution (in case the cells should undergo store-operated Ca2+ entry), a further three 
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ATP applications were applied. As before, all of the cells responded to ATP with a 
transient rise in intracellular Ca2+. When the extracellular Ca2+ was removed, the 
cells initially responded to the ATP with a Ca2+ transient similar in size to that of the 
initial ATP responses. The height of the next ATP response was reduced greatly and 
subsequent ATP responses were further diminished until no observable response 
occurred. Upon replacing the extracellular Ca2+, no store-operated capacitive Ca2+ 
entry was observed in any cells. Further ATP applications (once more in the 
presence of extracellular Ca2+) elicited transient Ca2+ responses from all cells. 
  
Chapter 3. P2 Receptors in hESCs 
 
56 
 
 
Figure 3.5. ATP induced Ca2+ transients are independent of 
extracellular Ca2+: Ca2+ transients persist, but sequentially reduce in Ca2+ 
free solution. Multiple ATP applications in 1.25 mM Ca2+ (control) and 
Ca2+-free solutions were applied as indicated (Black bars, top graph, 
example trace). The averages of each response normalised to the initial 
ATP response are shown (bottom graph, Error bars represent SEM, n = 
56) 
The capacity for the cells to respond to ATP applications with a rise in intracellular 
Ca2+ in the absence of extracellular Ca2+ suggests the release of Ca2+ from 
intracellular stores. This suggests that a G-protein coupled receptor (P2Y) has been 
activated. This does not show that the responses observed in the presence of 
extracellular Ca2+ are not also the result of P2X, only that P2Y is more than likely 
present in these cells. That the transient response depletes over multiple 
applications is indicative of Ca2+ store depletion. Such an event, in cells with the 
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appropriate intracellular mechanisms, would normally lead to capacitive Ca2+ entry 
(CCE). This was not observed in any of the cells suggesting this mechanism is either 
not in place in these cells or inactive in the experimental situation. The apparent 
absence of CCE in these cells is of interest and may reflect an absence of the 
necessary coupling mechanisms required for CCE, such as STIM1 or ORAI (Várnai et 
al., 2009). 
To determine the signalling pathway responsible for the Ca2+ transients observed 
upon application of ATP, blockers of the common pathway for P2Y G-protein 
coupled Ca2+ release were employed. 2-aminoethoxydiphenylborane (2-APB), a 
potent blocker of the IP3 receptors(Maruyama et al., 1997), and 1-[6-[[(17β)-3-
methoxyestra-1,3,5(10)-trien-17-yl]amino]hexyl]-1H-pyrrole-2,5-dione (U-73122), a 
blocker of PLC signalling (Bleasdale et al., 1990), were pre- and co-applied to hESCs 
loaded with Fura-2. As in the previous experiments, 15 s applications of 100 µM ATP 
were repeated in the presence and absence of each antagonist. The resulting effect 
on intracellular Ca2+ was observed (Figure 3.6). In all cells (n = 35), a Ca2+ transient 
was observable even in the absence of extracellular Ca2+. In all cells, this transient 
response was abolished by the application of either 2-APB or U-73122. This suggests 
that the pathway common to P2Y receptor signalling, where ligand binding leads to 
G-protein coupled activation of PLC and subsequent hydrolysis of PIP2 to IP3, 
resulting in a release of Ca2+ from intracellular stores. The observed block of Ca2+ 
transients upon block of this pathway suggests that these transients are dependent 
upon this signalling cascade. 
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Figure 3.6. ATP induced Ca2+ transients are dependent on PLC and IP3 
signalling: hESCs, loaded with Fura-2 were perfused in control, Ca2+ free, 
2-APB (100 µM) or U73122 (10 µM) as indicated (black bars). ATP (100 
µM) applications were made in the indicated solutions and the Ca2+ 
transients observed. The top trace shows an example trace and the 
bottom graph gives the average responses, normalised to the control 
ATP response, of all cells (n = 35). Error bars indicate SEM. 
3.3.4. Ca2+ Transients in hESCs are Induced by Multiple P2 Receptor Agonists 
In order to investigate further the subtypes of P2 receptors in these cells, a variety 
of P2 agonists were applied to the cells and the Ca2+ response measured (Figure 
3.7). A panel of agonists were chosen to best highlight the subtypes of P2 receptors 
present in the stem cell population. These were chosen from the information 
available from the British Journal of pharmacology’s Guide to Receptors and 
Channels (Alexander et al., 2009), and from other work on purinergic signalling in 
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the literature. ATP, αβme-ATP, UTP, ADP, UDP and BzATP were all applied and the 
effect on intracellular [Ca2+]i concentrations observed. 
 
Figure 3.7. Ca2+ transients in response to various P2 agonists: Example 
traces from the application of multiple P2 receptor agonists. ATP, αβme-
ATP, UTP, ADP, UDP (all 100 µM) and BzATP (10 µM) were applied to H9 
hESC loaded with Fura-2 according to the protocol indicated (black dots, 
15 s applications). Ca2+ transient responses were recorded from each 
cell individually. Examples show a trace from two cells, one responding 
(Bottom trace) and one not responding (top trace) to BzATP (n = 174). 
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As previously shown, all cells responded to 100 µM ATP. Similarly, all cells 
responded to 100 µM ADP. Approximately 38% (66/174) of cells responded to 
BzATP (Figure 3.8). None of the cells responded to αβme-ATP, UTP or UDP. 
 
Figure 3.8. Percentage of cells responding to various P2 agonists: The 
percentage of cells responding to 100 µM ATP, 100 µM ADP and 10 µM 
BzATP are shown, n = 174. 
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As all cells responded to both ATP and ADP (at 100 µM), to establish the order of 
potency of the two agonists multiple applications were made in turn and the Ca2+ 
transients observed (Figure 3.9). It is clear that these cells respond more readily to 
ADP than to ATP at this concentration (Each ADP response is significantly larger 
than adjacent ATP responses when analysed using a one-tailed, paired t-test, P < 
0.001, indicated as ∗∗∗  on the graph).  
 
Figure 3.9. Ca2+ transients are larger in response to ADP than ATP: The 
average fluorescence ratio (380/340 nm) increases resulting from P2 
receptor activation by either 100 µM ATP or 100 µM ADP is shown 
(Bottom graph, significance indicated; *** = P < 0.001, t-test, Error bars 
represent SEM, n = 77). An example trace from a single cell is included 
(top graph). 
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3.3.5. P2Y1 Receptors are Functionally Active in hESCs 
The observation that ADP responses in these cells are greater than those of ATP, 
along with the evidence to suggest that P2Y receptors are present and data showing 
that these receptors do not respond to UTP or UDP, indicates that P2Y1 may be 
present. In order to investigate this idea more completely, the P2Y1 specific agonist, 
MRS2365, was applied in experimental conditions identical to those already 
employed establish the ATP response. Figure 3.10 shows an example trace of a cell 
responding to MRS2365 with a Ca2+ transient similar to those observed in the 
presence of ATP. 77 % (30/39) of the cells observed responded with a Ca2+ transient 
indicating P2Y1 activation. 
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Figure 3.10. P2Y1 specific agonist, MRS2365, induces Ca
2+ transients in 
hESCs: MRS2365 (100 nM) was applied extracellularly to hESCs loaded 
with Fura-2. The resulting transient Ca2+ increase was measured. 77 % 
(30/39) of cells observed showed Ca2+ transients in response to this 
agonist. An example trace is shown with the application time indicated 
(black bar). 
 
3.3.6. hESCs do not Respond to P1 Receptor Agonists with an Observable Change 
in Intracellular Ca2+ 
The P1 receptor agonist, adenosine (100 µM), was applied to cells loaded with Fura-
2. An application of adenosine for 60 s was repeated in triplicate on 67 cells. No 
effect on the Fura-2 ratio (340/380 nm) was ever observed in any of the cells. 
3.4. Conclusions 
Purinergic signalling in organisms provides a mechanism for extracellular purines 
and pyrimidines to influence cellular processes via purinergic receptor activation. By 
measuring intracellular Ca2+ alterations in response to extracellular applications of 
ATP and other purinergic receptor agonists, purinergic signalling has been shown to 
be functionally active within undifferentiated H9 hESC cultures in vitro. 
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Furthermore, functionally active P2Y1 has been observed within these cells 
indicating a mechanism present which could allow influence by purinergic receptor 
agonists on hESC development.  
Showing that extracellular application of ATP induces a transient rise in [Ca2+]i 
suggests that purinergic signalling is possible within hESC populations. A rise in Ca2+ 
provides a mechanism by which protein activity and gene expression which can be 
acutely modulated to influence a wide variety of cellular functions. As highlighted in 
the introduction to this chapter, previous work in purinergic signalling has provided 
evidence for effects on cell cycle progression, growth, apoptosis, proliferation, 
migration and differentiation in several cell types. Influences on these processes 
would likely have major consequences for stem cell pluripotency and 
differentiation.  
It was observed that three ‘phenotypes’ of response to extracellular ATP application 
were present (Figure 3.1). This suggests heterogeneity within the hESC population 
indicative of variability in receptor subtypes, expression levels or mechanisms of 
signalling. Whether this is due to separate and distinct populations of cells within 
the hESC culture or variation within the population due to such factors as cell cycle 
phase requires further investigation and could provide greater insight into the 
cellular composition of hESC cultures. 
That the ATP induced Ca2+ rise was dependent upon extracellular Ca2+ during 
repeated applications is consistent with G protein-coupled receptor dependent 
release of Ca2+i from intracellular stores, i.e. in the absence of [Ca
2+]i, the stores 
cannot be replenished before the next application of agonist. The predicted EC50 
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within the region of 3-30 µM is not dissimilar to published possible physiological 
extracellular concentrations of between 5 and 50 µM during ATP release events 
(Dubyak & el-Moatassim, 1993; Soslau & Youngprapakorn, 1997; Sørensen & Novak, 
2001). This suggests that control over the purinergic pathway present in these cells 
is possible during physiological purine release. Whether a high (µM) phasic release 
event is required for transient activation, or a low (nM) tonic presence of the 
agonist could elicit a longer term effect will require further investigation. In human 
blood samples, nanomolar ATP has been shown to stimulate platelet aggregation, 
whereas micromolar ATP was shown to inhibit significantly aggregation (Soslau & 
Youngprapakorn, 1997). This work suggests a mechanism is present for a 
physiologically relevant, dual mode of action for purinergic signalling. Such a 
mechanism may be present within stem cell populations. This is an important 
consideration when planning future experiments as comparison of full activation 
(µM) and full block (i.e. with an antagonist, or genetic knock-down) may mask a 
possible physiological role of these agonists at the nM level.  
Co-application of suramin (100 µM) and PPADS (50 µM) was shown to block 
completely the transient rise in Ca2+ observed during extracellular application of 
ATP (Figure 3.4). This suggests that the rise in Ca2+ was the result of purinergic 
receptor activation. In order to establish whether this transient rise in Ca2+ was due, 
in part, to P2Y receptor activation, ATP was applied to the cells in the absence of 
extracellular Ca2+ (Figure 3.5). This prevented the influx of Ca2+ through P2X 
receptor activation and allowed measurement of the P2Y activity as release of Ca2+ 
from intracellular stores. That the transient Ca2+ increase was not abolished by the 
absence of extracellular Ca2+ suggests that P2Y receptors are present and active in 
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these cells. It does not suggest that P2X are not present, and it is important to 
consider that they may also be expressed in these cells.  
To confirm that P2Y receptors were active and responsible for the rise in Ca2+ 
observed upon ATP applications, antagonists of the signalling pathways used in 
receptor activation induced intracellular Ca2+ release were pre- and co-applied with 
ATP in these cells (Figure 3.6). 2-APB, a potent blocker of IP3 induced Ca
2+ store 
release, prevented a rise in intracellular Ca2+. It is important to note that this 
antagonist also inhibits store-operated Ca2+ influx so will prevent the replenishment 
of exhausted Ca2+ stores (Bootman et al., 2002). For this reason, and to reduce 
artefact of store reduction and receptor desensitisation, a replenishment time of 
135 s post ATP application, in the control extracellular solution (1.25 mM Ca2+) was 
included in the protocol. With no other Ca2+ store release event before co-
application of ATP with 2-APB, the effect of inhibition of store-operated Ca2+ influx 
would be minimised. A second antagonist, U 73122, a blocker of PLC, prevents the 
PLC mediated rise in IP3 and hence blocks the same pathway as 2-APB via an 
alternative mechanism (Bleasdale et al., 1990). In these cells U 73122 prevented an 
observable rise in Ca2+ upon application of ATP suggesting that this mechanism was 
in use during the ATP-mediated rise. The effect of both of these antagonists, along 
with the independence of the ATP-mediate Ca2+ regarding extracellular Ca2+ 
strongly suggests the activity of ATP-induced release of Ca2+ from intracellular 
stores, thereby indicating P2Y activity in these cells. 
To investigate further the subtypes of purinergic receptors present in these cells, 
the following agonists were chosen based on published data; ATP, αβme-ATP, UTP, 
ADP, UDP (all 100 µM) and BzATP (10 µM) (Alexander et al., 2009). The Ca2+ 
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transients seen in response to these agonists was observed and recorded As 
observed in the previous experiments, 100% of cells responded to ATP suggesting 
that purinergic signalling was active in all cells (Figure 3.7 and Figure 3.8). Similarly, 
100% of cells responded to ADP. None of the other agonists elicited an alteration in 
[Ca2+]i, with the exception of BzATP, which resulted in a Ca
2+ transients in 
approximately 38% of cells. Bz-ATP is commonly associated with P2X7 as it has a 10-
fold greater potency than ATP for this receptor (Surprenant et al., 1996). However, 
it has also been linked with activation of P2X1, P2X2 and P2Y1 ((Evans et al., 1995; 
King et al., 1996; King et al., 1997). Whilst it may not be apparent which of the 
purinergic receptor subtypes is responsible for the rise in intracellular Ca2+ during 
extracellular Bz-ATP application, it is apparent that, due to the selective nature of 
the responses, with only 38% of cells responding, there are two functional 
populations with respect to responses to Bz-ATP. Further work is needed to 
elucidate the cause of this divide, whether it is the presence of alternative receptors 
(such as P2X7) or modulation in the expression or post expression processing of 
receptors expressed in all cells. It may be that the observed difference in response 
is due to cell cycle phase. The cells in neuronal populations are in a proliferative 
state, therefore there are cells present in all stages of the cell cycle at any given 
time. Cell cycle phase-dependent gene expression may result in the appearance of 
certain receptors in some cells and not others (Jaksch et al., 2008). 
It is known that P2Y1 responds to ADP with higher affinity than ATP (Alexander et 
al., 2009). Repeated, alternating applications of equimolar (100 µM) ATP and ADP 
(Figure 3.9) indicate that ADP displays a higher potency for increasing intracellular 
Ca2+ than ATP. Further to this, a high proportion of the cells exhibited sensitivity to a 
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highly selective P2Y1 agonist MRS2365. 30 out of 39 cells showed a transient rise in 
intracellular Ca2+ upon extracellular application of 100 nM MRS2365 (Figure 3.10). 
hESCs respond to purinergic stimulation with a transient rise in intracellular Ca2+ 
that is independent of extracellular Ca2+, dependent on the PLC and IP3 signalling 
pathway, greater in response to ADP than ATP and also occurs, in the majority of 
cells, in response to a potent and selective agonist of P2Y1. This suggests that it is 
highly likely that these cells express functional P2Y1 receptors. This evidence does 
not serve to suggest that other purinergic receptors are not present and highlights 
that these undifferentiated stem cell cultures are heterogeneous in their responses 
to purinergic stimulation.  
The apparent presence and function of at least one purinergic receptor (P2Y1) in 
undifferentiated H9 hESCs is indicative that purinergic signalling may not only be 
endogenously modulating early cellular development, but also that there may be 
the potential to modify purinergic signalling in hESCs and possibly other stem cell 
populations (i.e. iPSCs). The recently found evidence linking purinergic signalling to 
key developmental events such as proliferation, survival, migration and 
differentiation (Burnstock & Ulrich, 2011) provides the further possibility that 
controlling purinergic signalling in these cells could be beneficial for both disease 
modelling and the production of large-scale, consistent stem cell cultures for 
therapeutic uses.  
An interesting link between P2Y1,2,4 and P2Y6 and Rho Kinase activation has been 
published (Sauzeau et al., 2000). Rho-kinase upregulation promotes apoptosis and 
the inhibition of this upregulation is already in common use during stem cell 
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passage to promote cell survival (Koyanagi et al., 2008): coincidentally, a time 
associated with high cell damage and ATP release. That there is a direct link 
between P2Y1 activation and this pathway may provide a starting point for future 
investigation into the beneficial effects of controlling purinergic signalling in 
undifferentiated stem cell cultures.  
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Chapter 4.  Functional Characterisation of hESC-Derived and Primary 
Neurons 
4.1. Introduction 
Mature neurons are terminally differentiated, preventing them from producing new 
neurons through cell division (De Filippis et al., 2007; Galli et al., 2008; Goffredo et 
al., 2008; Hellstraom et al., 2009). In the majority of stem-cell studies, neurons are 
typically characterised by their expression of certain markers, such as β-tubulin III, 
NeuN and Map2. However, this type of characterisation does not fully reflect their 
cell physiology. 
4.1.1. Neuronal Physiology 
The key function of neurons is to rapidly convey electrical signals over relatively 
long distances. In order to do this, a number of ion channels and transporters are 
necessary. These provide the required cellular machinery to produce the electrical 
signal, and the means to transmit it. Whilst there are a great many ion channels and 
transporters, only those which are commonly associated with neuronal activity will 
be discussed here. 
In neurons, the voltage-gated, inwardly rectifying channels and two-pore domain K+ 
channels (K2P) are the main neuronal K
+ ion channels. The voltage-gated K+ channels 
are a diverse group of channels which selectively allow the movement of K+ across 
the cell membrane when Vm reaches their activation threshold. Upon 
depolarisation, and reaching this threshold, a conformational change in a voltage 
sensor (the S4 voltage sensor) results in a further conformational change in the ion 
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channel allowing K+ to move down its electrochemical gradient. Inward rectifier K+ 
channels function to re-establish the resting membrane potential after an excitatory 
event. Hyperpolarisation, observed after an action potential spike, removes a 
magnesium ion from a specific binding site within the channel. This magnesium ion 
acts as a channel blocker and its removal allows the influx of K+ through the channel 
and thus re-establishment of the resting membrane potential (Nichols & Lopatin, 
1997; Doyle et al., 1998; Gouaux & MacKinnon, 2005). K2P channels are 
constitutively open providing leak pathways for K+ ions. The activity of these 
channels stabilises membrane potentials at values approaching EK depending on 
their prevalence and activity (Goldstein et al., 2005). These channels serve to 
modulated neuronal excitability through their control of Vm (Plant et al., 2005). 
The voltage-gated Na+ channels initiate and propagate action potentials within 
neurons. As with the voltage-gated K+ channels, a certain membrane potential will 
activate these channels, opening a pore for the influx of Na+. Increases of Vm which 
exceed the threshold of these channels results in fast activation. This activation is 
followed by fast-inactivation and results in the transient current observed during 
voltage-gated Na+ channel activity. The presence and activity of voltage-gated Na+ 
channels contributes to excitability within neuronal populations (Kallen et al., 1993; 
Sato et al., 2001). 
Voltage-gated Ca2+ channels are involved in most aspects of neuronal development 
and function. The influx of Ca2+ through these channels controls the integration of 
synaptic input, synaptic transmission, repetitive synaptic firing as well as 
modulation of gene expression (Catterall, 2011). 
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As the most abundant anion in organisms, regulation of Cl- is vital to cellular 
function. In neurons it is also key to the establishment and maintenance of the 
resting membrane potential and excitability. There are many varieties and subtypes 
of Cl- channels with a number of functions and mechanisms of activation. Cl- 
channel gating can be regulated by membrane potential, cell swelling, ligand 
binding, ATP hydrolysis, phosphorylation and by other ions, such as Ca2+ (Jentsch et 
al., 2002). In neurons, the ClC-2 channels and the γ-aminobutyric acid (GABA) 
channels are highly important functionally. ClC-2 has been implicated in the 
maintenance of [Cl-]i, whilst GABA is the main inhibitory neurotransmitter in the 
brain. Through the opening of this ligand-gated Cl- channel upon binding with GABA, 
and the resulting Cl- efflux from mature neurons, the resting membrane potential 
hyperpolarises, pushing it further from the action potential threshold and, 
therefore, inhibiting excitatory activity within the cell (Gold & Martin, 1984; Wisden 
& Seeburg, 1992). As the MSNs of the striatum are GABAergic and as GABA appears 
to play a role in neuronal development, this neurotransmitter is considered in more 
detail later in the thesis. 
There are also a number of ligand-gated ionotropic and metabotropic channels 
which are associated with neuronal function.  
Of the ligand-gated ionotropic receptors, there are the classically excitatory, cation-
selective (such as nicotinic acetylcholine, 5-HT3, ionotropic glutamate and P2X), and 
classically inhibitory, anion-selective (such as GABAA and glycine) receptors. These 
receptors are associated with modulation of fast synaptic transmission in neurons, 
however, more it is now understood that they mediate a number of physiological 
functions in non-excitatory cells (Alexander et al., 2009). 
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The ligand-gated metabotropic receptors act via coupled G-proteins to modulate 
many cellular functions. There are numerous G-protein coupled receptors. These 
include the adenosine, P2Y and GABAB receptors which are discussed within this 
thesis. Many of these receptors are targets for drugs in currently in development or 
testing (Marinissen & Gutkind, 2001; Alexander et al., 2009). 
4.1.2. Neuronal Differentiation and Ion Channel Development 
There is an uneven bias within the research area of neuronal differentiation 
towards classical cell biology aspects of differentiation, such as the effect of 
neurotrophic factors and the expression of neuronal genes and proteins as markers 
of differentiation, and away from the electrophysiological aspects, such as the 
appearance of spontaneous activity on the formation of functional synapses. The 
search entry ‘embryonic stem cell neuronal differentiation gene expression’ returns 
632 papers in PubMed. The entry ‘embryonic stem cell neuronal differentiation 
electrophysiology’ returns only 47 (http://www.ncbi.nlm.nih.gov/pubmed: current 
as of 25th September 2011). Although this is not an adequate comparative tool for 
assessing research interests, it does highlight the bias. Whilst it could be argued that 
the expression of certain markers is vital for the production of specific neuronal 
subtypes for clinical purposes, it could also be suggested that it is the functional 
activity, alongside environmental cues, that most likely determine the fate of a 
differentiating neuron in vitro.  
 It has been shown that embryonic stem cells (ESCs), differentiating in vitro down a 
neuronal lineage, develop electrochemical characteristics that are neuronal in 
nature, such as fast activating and inactivating action potentials (Song et al., 2002). 
The appearance of voltage-gated Na+, K+ and Ca2+ channels, alongside the 
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development of neuronal action potential-like responses to threshold activation in 
current-clamp have been reported (Strubing et al., 1995; Cho et al., 2002; Bibel et 
al., 2004; Biella et al., 2007; Joannides et al., 2007c). However, standardised 
protocols, for both functional studies and differentiation treatments, are not used. 
Whilst this is important from the standpoint of developing new techniques and 
investigating their effects on differentiation, it prevents the direct comparisons of 
data sets from multiple papers and the comparison of various cell lines that have 
received different environmental stimuli. 
Electrical activity within neuronal populations is not only the end-point of 
differentiation and maturation. It is now understood that electrical signalling plays 
an important part in neuronal progenitor proliferation, migration, ion channel 
expression, neurotransmitter specification, axon path-finding, dendritic outgrowth 
and terminal differentiation (Spitzer, 2006). The importance of transient rises in 
[Ca2+]i during neural induction (Webb et al., 2005) and the involvement of electrical 
activity in synapse formation and neuronal survival (Mennerick & Zorumski, 2000; 
Zito & Svoboda, 2002) suggest that electrical signalling is not only present during, 
but is also a requirement of, proper neuronal development. 
GABAAR activation in neuronal progenitors of the mouse SVZ results in 
depolarisation and subsequent Ca2+ influx (Wang et al., 2003). This mechanism, 
alongside multiple similar endogenous mechanisms, provides a method for non-
synaptic spontaneous activity. Glutamate receptors are activated by vesicular 
release of their appropriate ligands (NMDA, kainate and AMPA) in pre-neuronal 
populations (Blanton et al., 1990; Flint et al., 1999). The release of such 
neurotransmitters, and the presence of their receptors in immature neuronal 
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populations, enables the use of signalling pathways allowing the control of electrical 
signalling via the cellular environment. This signalling can, in turn, influence cellular 
properties. Most notably, alterations to [Ca2+]i during development result in 
downstream changes in gene expression and the activity of numerous proteins 
(Komuro & Rakic, 1996; Spitzer, 2006). 
Electrical signalling also provides a mechanism for cell synchronicity within large 
populations. In embryonic mouse, serotonin stimulates synchronised [Ca2+]i 
transients in cranial motor neurons (Hunt et al., 2005). Similarly, voltage-gated Na+ 
and Ca2+ channel activity in prenatal mouse cortex results in large-scale [Ca2+]i 
transients which become more synchronised during development, peaking at birth 
(Corlew et al., 2004). 
In adult neuronal precursors of the hippocampus, NMDA-mediated increases in 
[Ca2+]i repress genes which induce glial differentiation whilst stimulating NeuroD, a 
gene which promotes neuronal maturation. Similarly, the depolarising action of 
GABA on these adult neural progenitors induced an increase in NeuroD expression 
(Deisseroth, 2004).  
4.1.3. Aims of Chapter 
There is a lack of comparative data obtained in both hESC-derived and primary 
tissue sources. As has been stated, by far the most common source of tissue for 
neuronal transplantation has come from fetal brain, specifically from the 
neurogenic SVZ (Kelly et al., 2011; Trounson et al., 2011). One of the aims of the 
following chapter is to address the issue of tissue source comparison and, in doing 
so, compare functional characteristics of hESC-derived neurons during terminal 
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differentiation with fetal human WGE- and neonatal mouse WGE-derived cells in 
vitro. Focus is placed on the ontogeny of voltage-gated channel activity and 
excitability. The inclusion of data obtained from neonatal mouse WGE provides 
reference to cells which are more mature than their fetal counterparts. It is obvious 
that human tissue would be preferential for this comparative analysis. However, the 
availability of viable neonatal human neuronal tissue is low, and the ethical and 
legal ramifications of its use meant that, for this work, mouse WGE was substituted. 
4.2. Non-Standard Methods 
4.2.1. Neurosphere Plating Efficiency Protocol 
Neurospheres, grown as described in section 2.1.3. of Chapter 2: General Methods, 
were dissociated using one of three techniques. 
4.2.1.1. Mechanical Dissociation 
Neurospheres were transferred from the Sterilin plate into a 15 ml Falcon tube. 
These were spun down at 150 g for 2 min. The media was removed and 2 ml fresh 
neurosphere media added. The neurospheres were then triturated by repeated 
pipetting using a 1000 µl pipette tip until the majority of the visible neurospheres 
were dissociated. Large clusters of cells were allowed to sink to the bottom of the 
Falcon tube before the supernatant, containing single cells and small cell clusters, 
was transferred to another 15 ml Falcon tube and spun down at 500 g for 2 min. 
This supernatant was discarded and the pellet was resuspended in the plate-down 
medium (SFDMII, see section 2.1.2.1. ) and used for plate-downs as described in 
section 2.1.4.  
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4.2.1.2. Chemical Dissociation 
Chemical dissociation was carried out using a method derived from that described 
by Sen and colleagues (Sen et al., 2004). The medium (PPRF-M4) described in that 
publication was designed for mouse cells and was based on DMEM:F12 in 1:1 ratio. 
As the cells in this experiment were only exposed to this medium for min and were 
then replated in the standard medium, it was decided that the supplements 
described in the original paper were not necessary; thus basal medium of 
DMEM:F12 in a 1:1 ratio and relevant pH was used. All pH values were measured 
using a pH meter (pH 210, HANNA Instruments) before medium was filtered 
through a 0.2 µm syringe filter (Minisart, Sartorius Stedim Biotech, Cat. No. 17844Q) 
for sterilisation. 
Neurospheres were harvested essentially as described with mechanical dissociation 
with the exception that, after the first spin down, the spheres were resuspended in 
200 µl DMEM:F12 in a 1:1 ratio. 200 µl of alkaline medium (DMEM:F12 in a 1:1 
ratio, made to pH 11.6 with NaOH) was added to the sphere suspension and mixed. 
After 120 s, the solution was very lightly triturated with a 1000 µl pipette (with the 
tip widened by removing the end with sterile scissors). The suspension was left for a 
further 5 min, then gently mixed as before. A further 200 µl of acidic medium 
(DMEM:F12 in a 1:1 ratio, made to pH 1.7 with HCl) was added and the suspension 
was gently triturated until the neurospheres had visibly dissociated. The suspension 
was then spun down at 500 g for 2 min and the supernatant discarded. The 
remaining pellet was resuspended in terminal differentiation medium (SFDMII) and 
plated as described in section 2.1.4.  
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4.2.1.3. Enzymatic Dissociation 
Enzymatic dissociation is described in section 2.1.4.  
4.2.1.4. Rock Inhibitor Addition 
For each of the dissociation conditions 8 wells were plated, 4 with, and 4 without 
Rock inhibitor Y-27632 (10 µM). 
4.2.1.5. Viable Cell Counts 
Cell viability was measured by a Trypan Blue exclusion assay. 
24 h after the cells from the dissociation experiments were plated down, cells were 
dissociated again using 0.5% trypsin in PBS (Ca2+ and Mg2+ free). The medium was 
removed from the wells to a 15 ml Falcon tube (Media from each well were 
transferred to separate Falcon tubes), 500 µl of the trypsin PBS mix was then added 
to each well and incubated at 37 oC for 5 min. As the cells has only been plated for 
24 h and were previously in single cell suspensions, trypsin did not take long to 
remove cells from the coverslips.  
The trypsin/PBS/cell suspension was transferred into the Falcon tube containing the 
original medium from each well. A further 500 µl of PBS was added to each well and 
transferred to the appropriate Falcon tube. 
Each Falcon tube now contained the living and dead cells from one well. These 
tubes were spun down at 500 g for 5 min. The supernatants were discarded and the 
pellets resuspended in 200 µl PBS. 200 µl 0.4 % Trypan Blue was added to this 
solution to give a 400 µl cell suspension in 0.2 % Trypan Blue. This suspension was 
incubated for 3 min to allow uptake of the stain by dead cells. 
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10 µl of each sample was added to a haemocytometer and the total number of cells 
with or without the blue stain counted in 4 separate regions. From this number, a 
percentage cell survival was calculated for each well. In order to prevent cell death 
during this procedure, the whole process was staggered with regards to the wells so 
that counting could occur within 5 min of Trypan Blue addition. 
4.2.2. Immunohistochemical Analysis of β-III-Tubulin Expression 
4.2.2.1. Paraformaldehyde 
Stocks of 20% w/w paraformaldehyde (PFA) in PBS (Ca2+ and Mg2+ free, Gibco, Cat 
No. 14200-059) were prepared in advance and stored until use. PFA was dissolved 
in PBS through addition of NaOH until the powder went into solution. HCl was used 
to bring the solution pH back to 7.8 before PFA stocks were aliquoted at 500 µl and 
stored at -20 oC. 
4.2.2.2. Blocking Mix 
For 15 ml blocking mix, 750 µl FCS and 7.5 µl Triton X-100 (0.05% after dilution) 
were added to 14.25 ml PBS. 
4.2.2.3. Immunostaining 
Immunohistochemistry (IHVC) was performed using the monoclonal antibody anti-
β-III-tubulin (Sigma) produced in rabbit and an anti-rabbit secondary antibody 
raised in goat (Sigma, Cat No. R9380). 
Cells plated on glass coverslips, as described in section 2.1.4. were fixed for 
immunohistochemical staining in 0.5 ml 4 % PFA in PBS (Ca2+ and Mg2+ free). 
Coverslips were washed 3 times in 0.5 ml PBS before being incubated in 4% PFA for 
10 min at room temperature. The PFA/PBS mixture was removed and the coverslips 
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were then incubated in 0.5 ml fresh PBS (no PFA) for 5 min. This wash step was 
repeated 3 times. 
The PBS was removed and 0.5ml blocking mix added to the well. This was incubated 
at room temperature for 1 h. The blocking medium was removed and 0.5 ml of the 
primary antibody (anti-β-III-tubulin: 1:200 in blocking mix) was added to the well. 
The primary antibody was incubated at 4 oC overnight. 
The primary antibody was then removed and the cells washed again 3 times for 5 
min each time in PBS. 
0.5 ml of the secondary antibody (goat anti-rabbit, 1:200 in blocking mix) was then 
added to the well and incubated at room temperature for 1 h. Aluminium foil was 
used after addition of the secondary antibody to prevent degradation of the 
fluorescent signal by exposure to light. 
A further 3 washes with PBS were carried out and 0.5 ml Hoechst (Sigma, Cat. No. 
33258 1:10000 of 5 mg/ml stock in PBS) was added to the well and incubated for 10 
min. This was followed by a single 5 min wash in PBS before the glass coverslip was 
removed from the well gently, so as not to lose any cells, and was mounted on a 
glass microscope slide using Clearmount IHC mounting solution (Invitrogen, Cat. No. 
00-8010). Stained coverslips were viewed and photographed using a fluorescent 
Leitz microscope. 
4.2.3. Functional Analysis of hESC- and Primary Tissue-Derived Neurons 
The whole-cell patch clamp and Ca2+ imaging techniques used in this chapter are 
described fully in sections 2.2.1.4. and 2.2.3. of Chapter 2: General Methods, 
Chapter 4. Functional Characterisation of hESC-Derived and Primary Neurons 
 
81 
 
respectively. Individual agonist/antagonist application protocols are discussed in the 
results text and highlighted in the corresponding figures.  
4.2.3.1. Solutions 
ECS: as described in section 2.2.1.1.  
50 mM KCl ECS: as per standard ECS, but with 50 mM KCl and 90 mM NaCl 
Ca2+ Free ECS: as per standard ECS, but with no added CaCl2 and 1 mM EGTA 
supplement 
ICS: as described in section 2.2.1.2.  
4.2.3.2. hESC-Derived Neurons 
hESC-derived neurons were plated down as described in section 2.1.4. Functional 
analysis of cells began at 1 day PPD. Cells were maintained in culture for a 
maximum of 7 week The results were obtained from cells plated from multiple 
neurosphere preparations. 
4.2.3.3. Human Fetal Primary Neurons 
WGE was extracted from human fetal brain as described in section 2.1.5. hWGE-
derived neurons were used for functional characterisation after 24 h PPD and within 
2 days in vitro (DIV) 
4.2.3.4. Postnatal Mouse Primary Neurons 
WGE was extracted from neonatal mouse brain as described in section 2.1.7. 
mWGE-derived neurons were used for functional characterisation after 24 h PPD 
and within 2 days in vitro (DIV) 
Chapter 4. Functional Characterisation of hESC-Derived and Primary Neurons 
 
82 
 
4.2.4. Statistical Analysis 
Comparisons of variability across multiple data-sets were carried out using one way 
analysis of variance (ANOVA) followed by the post-hoc Tukey-Kramer multiple 
comparison test. Data-sets from hESC-derived neurons were compared first, 
followed by analysis of all data-sets. Prism4 was used for all statistical analysis. 
Tukey-Kramer was chosen for multiple comparison testing as it is associated with a 
reduced rate of type I errors (false positives) and allows all possible pairwise 
comparisons (Ludbrook, 1991). The Kramer extension of the post-hoc Tukey test 
was used to correct for variation in the size of individual data-sets.  
Data recorded regarding properties about which population distribution would be 
of interest (current amplitudes, threshold and Vm values) have been displayed as 
box-and-whisker plots in order to display a more accurate representation of the 
distribution of values that is seen using bar graphs with standard error of the mean. 
These charts were plotted in Prism4. 
4.3. Results 
4.3.1. hESC-Derived Neurosphere Plating Efficiency is Improved by Enzymatic 
Dissociation and Inhibition of ROCK by Y-27632 
The generation of neurospheres, as detailed in section 2.1.3. of Chapter 2: General 
Methods, provided neuronal precursors which could be plated as single cells and 
further differentiated into mature neurons (Joannides et al., 2007a). This process of 
dissociation and plating as single cells can be damaging to cells, resulting in a loss of 
both quality and quantity of neurons in these cultures.  
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In order to test the impact of enzymatic, compared to mechanical or chemical 
dissociation, cell suspensions were made from day 32 neurospheres using each of 
these methods (see section 4.2.1. ). Figure 4.1 shows the increased viability 
observed with dissociation using both chemical and enzymatic against mechanical. 
In both chemical and enzymatic dissociation, the addition of 10 µM ROCK inhibitor 
increased cell viability. This effect was not seen in mechanical dissociation where 
viability was already greatly reduced. The highest mean viability obtained was using 
the enzymatic dissociation in the presence of ROCK inhibitor, at 76.5% cell survival. 
This method was used for all subsequent neurosphere plate-downs. 
 
Figure 4.1. Enzymatic dissociation of neurospheres with ROCK 
inhibitor, Y-27632, increases viability of single cell cultures: 
Dissociation of neurospheres using various methods with or without 
ROCK inhibitor Y-27632 (Y). Left side, brightfield image of neurospheres 
(Scale bar: 300 µm). Right side graph indicates mean cell viabilities for 
each condition (for each condition n = 4, error bars represent SEM). 
4.3.2. hESC Neurosphere Differentiation Protocol Produces Cells With Neuronal 
Characteristics 
Previous work within our lab has shown that the differentiation procedure outlined 
in section 2.1.3. and 2.1.4. produces cells which express proteins associated with 
neuronal maturation, such as β-III tubulin and MAP2, as well as glutamate and 
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GABA receptors (Joannides et al., 2007a). In order to assess the successful 
production of neurons from hESCs, the expression of β-III tubulin was investigated 
during terminal differentiation. Figure 4.2 shows that at PPD 3 a high proportion of 
these cells express the neuronal marker β-III tubulin. The close association of cells 
and the morphological characteristic of cells crossing and overlying one another 
prevented effective cell counts being made regarding percentage of cells expressing 
β-III tubulin. However, it is noticeable that in those regions where no cell nuclei are 
apparent (as measured with Hoechst), there is also no apparent expression of β-III 
tubulin suggesting that non-neuronal differentiation was minimal during terminal 
differentiation. The images also serve to highlight the tendency of these cells after 
several weeks PPD to form 3 dimensional sphere-like structures with large, 
protruding, multi-axon extensions. This ‘clumping’ of cells results in technical 
difficulties with whole-cell patch clamp, Ca2+ imaging and immunohistochemistry. 
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Figure 4.2. hESC-derived neurons express β-III tubulin protein: Anti-β-III 
tubulin (red, middle images) was used to stain the neuronal marker β-III 
tubulin in hESC-derived neurons at PPD week 3. Hoechst nuclear stain 
(blue, left images) was used to identify the nuclei. A merged image for 
each magnification is shown (right image). Progressively increased 
magnifications are shown to highlight expression distribution and 
morphology (top to bottom). Scale bars (white) indicate 50 µm. 
It is not practical to label neuronal cells for whole cell patch clamp experiments. 
Although it is possible to transfect cells with GFP-tagged markers for neuronal 
expression and then selectively patch-clamp only those cells, the procedure of 
transfection, coupled with unknown effects of overexpression of GFP in these cells 
means this option was not utilised for the study of functional development in these 
cells. In place of a direct marker of neurons, selection of cells for attempted patch-
clamp was made using morphological features. Only cells with a small (8-12 µm) 
soma, with long, branching axonal extensions (indicated in Figure 4.3) were chosen 
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and these were the most common cell type present. Other cell types present in 
smaller numbers and exhibited morphological features consistent with epithelial 
and glial cells. These were avoided for patch clamp and Ca2+ imaging experiments.  
 
Figure 4.3. hESC-derived neurons display neuronal morphological 
features: Image of hESC-derived neurons at PPD week 1 with patch 
clamp pipette approaching a cell for whole-cell patch clamp. Image 
highlights the typical morphology of hESC-derived neurons and the 
preferred distribution for whole-cell patch clamp. Image recorded on an 
LG U990 compact cameraphone. 
4.3.3. Functional Characterisation of hESC-Derived Neurons 
Standard whole-cell patch-clamp and Ca2+ imaging techniques were employed to 
measure the functional development of hESC-derived neurons during the terminal 
differentiation stage PPD. Measurements of K+, Na+ and Ca2+ channel activities were 
made throughout the terminal differentiation at weeks 1, 2, 3 and 4+. Weeks 4, 5 
and 6 were incorporated into the category of week 4+ as the progressive ‘clumping’ 
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of cells during the terminal differentiation phase resulted in low success rates of 
patch-clamp attempts. The ability of cells to fire spontaneous and induced action 
potentials was also recorded, along with the resting membrane potential. These 
characteristics were compared with measurements taken from hWGE- and mWGE-
derived neurons. For the experiments in this chapter, hWGE-derived neurons (from 
fetuses all aged between 6 and 12 weeks post-conception) and mWGE-derived 
neurons (from postnatal day 1 mice) were all used within 2 DIV. 
4.3.3.1. Cell Capacitance 
Cell capacitance gives a measure of the cell membrane surface area. This was 
measured during whole-cell capacitance correction upon successful whole-cell 
access. The mean capacitance values for hESC-derived neurons show little variation 
during the terminal differentiation protocol (Figure 4.4). Mean values of 11.08, 
12.05, 7.13 and 11.57 pF were recorded for weeks 1, 2, 3 and 4+, respectively. For 
fetal hWGE-derived neurons and neonatal mWGE-derived neurons, the mean 
capacitance values were 9.92 and 7.50 pF, respectively. Separate one way ANOVA 
tests were carried out on the data from only the hESC-derived neurons, and then 
from all data sets. In both cases ANOVA indicated no significant variation across the 
data sets.  
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Figure 4.4. Cell capacitance development in hESC-derived neurons 
compared with primary neurons: The recorded capacitance (pF) for 
each cell during terminal differentiation of hESC-derived neurons was 
recorded. Box plots of the data are show here alongside those of data 
obtained from hWGE- and mWGE-derived neurons. ANOVA and post-
hoc Tukey-Kramer tests were applied. ANOVA results indicated (n.s. 
indicates non-significance). 
4.3.3.2. Voltage-Gated Ion Channel Development 
Measurement of voltage-gated channel activity was carried out using the voltage-
step protocol in the standard whole-cell patch clamp configuration outlined in 
section 2.2.1.4. K+ currents were recorded in the presence and absence of 
extracellular Na+ and were confirmed using 20 mM TEA block. Na+ currents were 
recorded in the presence and absence of 20 mM TEA to reduce the effect of 
outward K+ channel activity and were confirmed by their removal in the absence of 
extracellular Na+ (NMDG-Cl equimolar replacement of NaCl in the ECS). 
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Figure 4.5 to Figure 4.10 show example traces indicative of those observed in the 
majority of cells from the stage/cell type indicated. 
 In all cell stages/types, K+ currents, when activated, rose quickly and reached a 
stable plateau which was maintained for the duration of the voltage step. The I-V 
plot, showing the mean current at the plateau phase against the voltage, shows that 
there is little or no outward current at voltages more negative than -50 mV. The 
voltage-dependent mean outward plateau begins to be activated as the voltages 
become more positive peaking and often plateauing at approximately 40 mV. 
Voltage-activated K+ currents were recorded in all cell types and at all cell stages.  
In contrast, voltage-activated Na+ currents were not measured in all cells. Figure 4.5 
shows example traces recorded from a hESC-derived neuron at 1 week PPD and the 
current-voltage (I-V) plot generated from that recording. The example trace, 
indicative of those observed in the majority of cells at week 1, shows that there is 
no voltage-activated inward current in these cells. Cells measured later in the 
differentiation protocol displayed voltage-gated Na+ channel activity. Figure 4.6 
shows an example of a week 2 hESC-derived neuron displaying voltage-activated 
Na+ currents. The shape of the current in these traces is indicative of those recorded 
in all neurons displaying voltage-activated Na+ currents. Upon voltage-activation, 
there was a large inward current which was fast-activating and fast-inactivating. The 
I-V for this current, plotting the peak negative current density against the voltage, 
shows that little or no current is present at voltages more negative than -40 mV. 
More positive voltages elicit a larger current as the threshold voltage for the 
voltage-gated Na+ channels is reached. The peak negative current is between 
approximately -30 to -20 mV and begins to reduce in subsequent sweeps. 
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Figure 4.5. Voltage-activated currents in week 1 hESC-derived neurons: 
Example traces showing the currents elicited by a voltage-step protocol 
are shown (A, B and C). A. Voltage-activated currents in control (ECS) 
solution. B. Voltage-activated currents in the presence of 20 mM TEA-Cl. 
C. Voltage-activated currents during the replacement of extracellular 
Na+ with NMDG. D. The current density-voltage curves for the mean 
outward plateau (open circles) and minimum inward peak (filled circles). 
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Figure 4.6 Voltage-activated currents in week 2 hESC-derived neurons: 
Example traces showing the currents elicited by a voltage-step protocol 
are shown (A, B and C). A. Voltage-activated currents in control (ECS) 
solution. B. Voltage-activated currents in the presence of 20 mM TEA-Cl. 
C. Voltage-activated currents during the replacement of extracellular 
Na+ with NMDG. D. The current density-voltage curves for the mean 
outward plateau (open circles) and minimum inward peak (filled circles). 
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Figure 4.7 Voltage-activated currents in week 3 hESC-derived neurons: 
Example traces showing the currents elicited by a voltage-step protocol 
are shown (A, B and C). A. Voltage-activated currents in control (ECS) 
solution. B. Voltage-activated currents in the presence of 20 mM TEA-Cl. 
C. Voltage-activated currents during the replacement of extracellular 
Na+ with NMDG. D. The current density-voltage curves for the mean 
outward plateau (open circles) and minimum inward peak (filled circles). 
Chapter 4. Functional Characterisation of hESC-Derived and Primary Neurons 
 
93 
 
 
Figure 4.8 Voltage-activated currents in week 4+ hESC-derived 
neurons: Example traces showing the currents elicited by a voltage-step 
protocol are shown (A, B and C). A. Voltage-activated currents in control 
(ECS) solution. B. Voltage-activated currents in the presence of 20 mM 
TEA-Cl. C. Voltage-activated currents during the replacement of 
extracellular Na+ with NMDG. D. The current density-voltage curves for 
the mean outward plateau (open circles) and minimum inward peak 
(filled circles). 
Chapter 4. Functional Characterisation of hESC-Derived and Primary Neurons 
 
94 
 
 
Figure 4.9 Voltage-activated currents in hWGE-derived neurons: 
Example traces showing the currents elicited by a voltage-step protocol 
are shown (A, B and C). A. Voltage-activated currents in control (ECS) 
solution. B. Voltage-activated currents in the presence of 20 mM TEA-Cl. 
C. Voltage-activated currents during the replacement of extracellular 
Na+ with NMDG. D. The current density-voltage curves for the mean 
outward plateau (open circles) and minimum inward peak (filled circles). 
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Figure 4.10 Voltage-activated currents in mWGE-derived neurons: 
Example traces showing the currents elicited by a voltage-step protocol 
are shown (A, B and C). A. Voltage-activated currents in control (ECS) 
solution. B. Voltage-activated currents in the presence of 20 mM TEA-Cl. 
C. Voltage-activated currents during the replacement of extracellular 
Na+ with NMDG. D. The current density-voltage curves for the mean 
outward plateau (open circles) and minimum inward peak (filled circles). 
 
4.3.3.3. K+ Current Amplitude Development 
The amplitude of K+ currents was recorded over the terminal differentiation phase 
and compared with K+ current amplitudes recorded from hWGE and mWGE-derived 
neurons. Figure 4.11 shows the observed mean, upper and lower quartiles and 
range of K+ current amplitudes recorded in these cells. During the terminal 
differentiation phase the values rise from week 1 to week 2 and then remain 
relatively stable throughout. A large amount of variation is seen at all stages. The 
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measured mean amplitudes for both hWGE- and mWGE-derived neurons are lower 
than those of the hESC-derived neurons past week 1. mWGE-derived neurons show 
a substantially lower mean value suggesting that these cells have a lower expression 
of K+ channels. Ranges of approximately 100 pA/pF for mean values of 47.90, 75.89, 
76.64 and 60.84 pA/pF were recorded for PPD weeks 1, 2, 3 and 4+, respectively. 
Separate one way ANOVA tests were carried out on the data, firstly from only the 
hESC-derived neurons, and then from all data sets. In both cases ANOVA indicated 
significant variation across the data sets (ANOVA: hESC-derived neurons: P < 0.01, 
all data sets: P < 0.001). A post-hoc Tukey-Kramer multiple comparison test 
confirmed that there was significant difference between several pairs of the data 
sets.  
The mean amplitude for voltage-gated K+ currents was significantly smaller in hESC-
derived neurons of 1 week PPD than in those of 2 weeks PPD (Tukey-Kramer: week 
1 vs. week 2: P < 0.01). Similarly there was a significant difference between week 1 
and week 3 K+ amplitudes (Tukey-Kramer: week 1 vs. week 3: P < 0.01). No 
significant difference was observed between the remaining data-sets within the 
hESC-derived neurons, however, significant differences were observed between 
week 2 vs. hWGE-derived neurons (Tukey-Kramer: week 2 vs. hWGE: P < 0.01), 
week 3 vs. hWGE-derievd neurons (Tukey-Kramer: week 3 vs. hWGE: P < 0.01) and 
between week 3 vs. mWGE-derived neurons (Tukey-Kramer: week 3 vs. mWGE: P < 
0.01). 
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Figure 4.11. K+ current amplitude in hESC-derived neurons compared 
to primary neurons: Average K+ current amplitudes (pA/pF) for each 
week PPD and for hWGE and mWGE are shown (Boxes represent upper 
and lower quartiles, vertical bars represent range, numbers indicated 
above bars). ANOVA and post-hoc Tukey-Kramer tests were applied as 
indicated (horizontal bars, ∗∗ = P < 0.01, ∗∗∗ = P < 0.001). Non-
significant Tukey-Kramer results are not-shown.  
4.3.3.4. Na+ Current Amplitude Development 
As with the ontogeny of K+ currents in hESC, the ontogeny of Na+ current 
amplitudes was also measured in the same cells during the same period. Figure 4.12 
shows the observed mean, upper and lower quartiles and range of Na+ current 
amplitudes recorded in hESC-, hWGE- and mWGE-derived neurons. In hESC-derived 
neurons, Na+ current amplitude does not significantly change during the terminal 
differentiation phase. The variation and mean values observed in these cells are 
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similar in value to those observed in hWGE-derived cells. mWGE-derived neurons 
show a much greater Na+ amplitude than both hESC- and hWGE-derive neurons. 
As before, separate one way ANOVA tests were carried out on the data, firstly from 
only the hESC-derived neurons, and then from all data sets. ANOVA indicated 
significant variation across all of the data sets but not across only the hESC-derived 
neurons (ANOVA: hESC-derived neurons: n.s., all data sets: P < 0.001). A post-hoc 
Tukey-Kramer multiple comparison test confirmed that there was significant 
difference between several pairs of the data sets. The mean values for each 
stage/cell type were -30.27, -41.04, -28.57, -20.76, -25.42 and -123.3 pA/pF PPD 
week 1, 2, 3, 4, hWGE- and mWGE-derived neurons, respectively. 
The mean amplitude for voltage-gated Na+ currents was significantly smaller for 
each of the hESC-derived neuronal stages and the hWGE-derive neuronal data 
compared with the mWGE-derived neuronal data (Tukey-Kramer: P < 0.001 for 
mWGE vs. all other data sets). 
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Figure 4.12 Na+ current amplitudes in hESC-derived neurons compared 
to primary neurons: Average Na+ current amplitude (pA/pF) for each 
week PPD and for hWGE and mWGE are shown (Boxes represent upper 
and lower quartiles, vertical bars represent the range, numbers 
indicated below bars). ANOVA and post-hoc Tukey-Kramer tests were 
applied as indicated (∗∗ = P < 0.01, ∗∗∗ = P < 0.001). Non-significant 
Tukey-Kramer results are not-shown. Significant differences between 
pairs are indicated by horizontal bars, where these comparisons are 
equal they have been grouped for visual clarity. 
4.3.3.5. Percentage of Cells Displaying Na+ Channel Activity 
Unlike voltage-gated K+ channel activity, voltage-gated Na+ channel activity was not 
observed ubiquitously. As these channels serve to act as markers of excitatory 
membranes, the percentage of cells displaying their activity was recorded in hESC-
neurons during the terminal differentiation phase and in hWGE- and mWGE-derived 
neurons (Figure 4.13). It is evident that the number of cells displaying voltage-gated 
Na+ channel activity in hESC-derived neurons increases dramatically from week 1 to 
week 2. There was a substantial rise from approximately 27% (8/30) to 90% (25/28). 
The high percentage of cells displaying voltage-gated Na+ channel activity was 
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sustained for the remainder of the terminal differentiation phase. Approximately 
52% of hWGE-derived neurons and 100% of mWGE-derived neurons displayed 
voltage-gated Na+ channel activity. 
 
Figure 4.13. Percentage of cells with voltage-gated Na+ channels in 
hESC-derived neurons compared with primary neurons: The 
percentage of cells displaying voltage-gated Na+ channel activity using 
the voltage-step protocol are shown for hESC-derived neurons for each 
week PPD and for hWGE and mWGE (numbers are given above each 
bar). 
4.3.3.6. Percentage of Cells Displaying Ca2+ Channel Activity 
Measuring Ca2+ channel activity in neurons is often carried out using intracellular 
replacement of K+ (with Cs+), to block outward K+ currents, and extracellular Ca2+ 
replacement (with Ba2+), which amplify Ca2+ channel current recordings. This 
experimental set-up requires separate experiments to be performed for the analysis 
of Ca2+ channel activity. As several parameters were already being recorded for 
each cell during the terminal differentiation protocol it would have been difficult to 
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carry out Ca2+ current analysis on the same cell preparations using 
electrophysiology. Therefore, it was decided to employ the less laborious method of 
Ca2+ imaging to measure Ca2+ channel activity. This method also provides selectivity 
for Ca2+ current activity and therefore allows the use of standard solutions without 
antagonists or ionic replacements to reduce the effects of other channel activity. 
Figure 4.14 shows an example recording from a Ca2+ imaging experiment where a 
PPD week 3 hESC-derived neuron, loaded with 6 µM Fura-2, was exposed to 
extracellular application of 50 mM K+. The observed rise in the ratio of fluorescence 
emission at 540 nm when excited alternately at both 380 nm and 340 nm is 
indicative of influx of Ca2+ through voltage-gated Ca2+ channels upon membrane 
depolarisation induced by the increased extracellular K+ concentration. 
 
Figure 4.14. Measurement of voltage-gated Ca2+ channels in hESC-
derived neurons: Fura-2 was used to measure cytosolic free Ca2+ 
changes in a week 3 PPD cell. Extracellular application of 50 mM K+ 
(indicated by the black bar) was used to depolarise the membrane and 
bring the membrane potential above the activation threshold for 
voltage-gated Ca2+ channels. 
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As with voltage-gated Na+ channel activity, voltage-gated Ca2+ channel activity was 
not observed in all cells. The percentage of cells displaying Ca2+ channel activity was 
recorded in hESC-neurons during the terminal differentiation phase and in hWGE- 
and mWGE-derived neurons (Figure 4.15). The percentage of cells displaying 
voltage-gated Ca2+ channel activity in hESC-derived neurons rose considerably from 
PPD week 1 to week 2. At week 1, approximately 15% (5/33) of these cells display 
voltage-gated Ca2+ channel activity. By week 2, this percentage had risen to around 
91% (20/22). This high percentage was maintained throughout the remainder of the 
terminal differentiation phase. Approximately 60% (26/43) of hWGE-derived and 
87% (89/102) of mWGE-derived neurons showed voltage-gated Ca2+ channel 
activity. 
 
Figure 4.15. Percentage of cells with voltage-gated Ca2+ channels in 
hESC-derived neurons compared with primary neurons: The 
percentage of cells displaying a rise in the Fura-2 (380/340 nM) ratio 
upon extracellular application of 50 mM K+ are shown for hESC-derived 
neurons for each week PPD and for hWGE and mWGE (numbers are 
given above each bar). 
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4.3.3.7. Measurement of Induced-Action Potentials 
Voltage-gated K+ channels and, more specifically, Na+ and Ca2+ channels are 
associated with excitability within cellular membranes. This excitability takes the 
form of action potentials. In order to assess the neuronal properties of hESC-, 
hWGE- and mWGE-derived neurons the ability to fire action potentials was 
investigated. Figure 4.16 shows an example recording from a PPD week 3 hESC-
derived neuron during a current-step protocol designed to induce an action 
potential-like response. A single sweep is also shown which highlights the 
characteristic shape of an iAP during current-step stimulation.  
 
Figure 4.16. Induced action potentials in hESC-derived neurons: An 
example from a PPD week 3 cell. The top trace shows the current-step 
protocol used to elicit an action potential in this cell. The bottom trace 
shows the first sweep which induced an action potential. 
Exemplar iAPs for each of the terminal differentiation weeks and for the hWGE- and 
mWGE-derived neurons are shown in Figure 4.17. 
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Figure 4.17. Induced action potentials in hESC-, hWGE- and mWGE-
derived neurons: An example iAP is shown from one cell from each 
week of the terminal differentiation protocol and for the hWGE- and 
mWGE-derived neurons.  
4.3.3.8. Percentage of Cells Displaying Induced-Action Potentials 
The percentage of hESC-, hWGE- and mWGE-derived neurons which displayed iAPs 
upon current step stimulation was recorded (Figure 4.18). As with both Na+ and Ca2+ 
channel ontogenesis, the percentage of hESC-derived neurons which display iAPs 
was relatively low at 35% (7/20) at 1 week PPD. The percentage then rose sharply 
by week 2, reaching approximately 89% (25/28). This high percentage was 
maintained throughout the remainder of the terminal differentiation phase. The 
percentage of hWGE-derived neurons with iAPs was approximately 41% (12/29), 
and in mWGE-derived neurons was 100% (5/5). 
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Figure 4.18. Percentage of cells with inducible action potentials in 
hESC-derived neurons compared to primary neurons: The percentage 
of cells displaying iAPs using the current-step protocol are shown for 
hESC-derived neurons for each week PPD and for hWGE and mWGE 
(number of observations are given above each bar). 
4.3.3.9. Action Potential Threshold Development 
When an action potential is induced, the membrane potential must exceed the 
action potential threshold value. This value, along with a measure of the resting 
membrane potential of the cell, provides an indication of the cell’s readiness to fire 
an action potential and the amplitude of stimulus required. The action potential 
threshold for iAPs was measured in hESC-, hWGE- and mWGE-derived neurons. 
Figure 4.19 shows an example iAP recorded in a PPD week 3 hESC-derived neuron. It 
also shows a plot of the derivative of the original plot. This derivative plots the rate 
of change in membrane potential with respect to time (dV/dt) against the voltage 
(mV). This plot highlights regions where large changes in the membrane potential 
occur (such as during threshold activation). Using this method, it is possible to 
measure more accurately the threshold values. 
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Figure 4.19. Measurement of iAP threshold values: For each cell, the 
iAP threshold was measured. iAP thresholds were visualised by plotting 
the derivative (dV/dt) of the original against the membrane voltage 
(mV). The threshold value was taken as the membrane voltage at which 
the plot begins to rise sharply (indicated by the arrows). iAP threshold 
plots are shown for one cell from each week of the terminal 
differentiation protocol.  
Figure 4.20 displays the measured iAP threshold values for hESC-, hWGE- and 
mWGE-derived neurons. The threshold values are very similar for all PPD weeks 
during the terminal differentiation phase for the hESC-derived neurons. Most 
strikingly, the iAP threshold value for mWGE is significantly more negative than that 
recorded for the other cell types. The mean values recorded were -32.52, -33.58, -
31.20 and -34.33 mV for post plate-down weeks 1, 2, 3 and 4+, respectively. The 
Chapter 4. Functional Characterisation of hESC-Derived and Primary Neurons 
 
107 
 
mean iAP thresholds for fetal hWGE- and post-natal mWGE-derived neurons were -
27.32 and -52.50 mV, respectively. 
As before, separate one way ANOVA tests were carried out on the data, firstly from 
only the hESC-derived neurons, and then from all data sets. ANOVA indicated 
significant variation across all of the data sets but not across only the hESC-derived 
neurons (ANOVA: hESC-derived neurons: n.s., all data sets: P < 0.001). A post-hoc 
Tukey-Kramer multiple comparison test confirmed that there was significant 
difference between several pairs of the data sets.  
The mean iAP threshold was significantly less negative for each of the hESC-derived 
neuronal stages and the hWGE-derive neuronal data compared with the mWGE-
derived neuronal data (Tukey-Kramer: P < 0.001 for mWGE vs. all other data sets). 
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Figure 4.20. iAP threshold values in hESC-derived neurons compared 
with primary neurons: The average iAP threshold values for each week 
PPD and for hWGE and mWGE are shown (Boxes represent upper and 
lower quartiles, vertical bars represent the range, number of 
observations indicated below bars). ANOVA and post-hoc Tukey-Kramer 
tests were applied as indicated (∗∗ = P < 0.01, ∗∗∗ = P < 0.001). Non-
significant Tukey-Kramer results are not-shown. Significant differences 
between pairs are indicated by horizontal bars, where these 
comparisons are equal they have been grouped for visual clarity. 
4.3.3.10. Resting Membrane Potential Development 
Vm was recorded for hESC-, hWGE- and mWGE-derived neurons. Figure 4.21 shows 
the Vm values for each cell type and for the stages of terminal differentiation for 
hESC-derived neurons. As was observed for the threshold values, the mean Vm for 
all weeks PPD in hESC-derived neurons are similar at approximately -30 mV. hWGE-
derived neurons displayed a mean Vm which was a similar value to the hESC-derived 
cells. The mean Vm of mWGE-derived neurons was significantly more negative than 
all other cell types. 
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Separate one way ANOVA tests were carried out on the data, firstly from only the 
hESC-derived neurons, and then from all data sets. ANOVA indicated significant 
variation across all of the data sets but not across only the hESC-derived neurons 
(ANOVA: hESC-derived neurons: n.s., all data sets: P < 0.001). A post-hoc Tukey-
Kramer multiple comparison test confirmed that there was significant difference 
between several pairs of the data sets. The mean Vm was significantly less negative 
for each of the hESC-derived neuronal stages and the hWGE-derive neuronal data 
compared with the mWGE-derived neuronal data (Tukey-Kramer: P < 0.001 for 
mWGE vs. all other data sets).  
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Figure 4.21. Resting membrane potential in hESC-derived neurons 
compared with primary neurons: The average Vm for each week PPD 
and for hWGE and mWGE are shown (boxes represent upper and lower 
quartiles, vertical bars represent the range, number of observations 
indicated below bars). ANOVA and post-hoc Tukey-Kramer tests were 
applied as indicated (∗∗∗ = P < 0.001). Non-significant Tukey-Kramer 
results are not-shown. Significant differences between pairs are 
indicated by horizontal bars, where these comparisons are equal they 
have been grouped for visual clarity. 
4.3.3.11. Measurement of Spontaneous Activity 
Spontaneous action potentials (sAPs) were not recorded in any of the hESC-derived 
neurons at any stage of the terminal differentiation (74 cells examined). In both 
hWGE and mWGE, multiple cells displayed spontaneous electrical activity in the 
form of sAPs. Figure 4.22 shows an exemplar trace from an hWGE-derived neuron. 
Spontaneous activity was only observed in 2 of the 8 hWGE-derived neurons 
examined. 
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Figure 4.22. Spontaneous action potentials in hWGE neurons: 
Spontaneous action potentials recorded in zero current (I=0) using the 
Gap free protocol in neurons from hWGE. No stimulus was applied to 
elicit action potentials. Top trace: Section of trace showing multiple 
spontaneous events. Bottom trace: a single spontaneous action 
potential showing the characteristic shape of these events. 
Figure 4.23 shows a recorded trace from an mWGE-derived neuron. Spontaneous 
activity was observed in all of the 5 mWGE-derived neurons examined. 
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Figure 4.23. Spontaneous action potentials in mWGE neurons: 
Spontaneous action potentials recorded in zero current (I=0) using the 
Gap free protocol in neurons from mWGE. No stimulus was applied to 
elicit action potentials. Top trace: Section of trace showing multiple 
spontaneous events. Bottom trace: a single spontaneous action 
potential showing the characteristic shape of these events. 
4.4. Conclusions 
To say that stem cells have differentiated into neurons requires that the cells 
display, at the very least, basic neuronal functions in vitro. That these cells express 
neuronal markers and display neuronal morphology is not enough to consider them 
as mature or functionally active neurons. It is well documented that neuronal 
excitability and the cross-communication between neuronal cells and populations is 
necessary to both development and maintenance of neuronal function in vivo 
(Spitzer, 2006).  
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With the aim of investigating the development of functional characteristics in hESC-
derived neuronal populations, several aspects were considered. It was necessary to 
treat the cells in a consistent way to allow both complimentary and comparative 
analysis across labs and with other work being carried out in the same lab.  
In order to provide neurons which are amenable to whole-cell patch-clamp 
techniques it is necessary to produce single-cell cultures. Furthermore, by 
separating the cells and dissociating the neurosphere there is an increase in the 
accessibility for each cell to the medium and a reduction in cell-to-cell contact-
mediated growth inhibition (Svendsen et al., 1998). Mechanical dissociation of 
neurospheres has been shown to damage cells and provide a low level of cell 
survival for plating. It has been suggested that chemical dissociation using alkaline 
conditions can improve this viability (Sen et al., 2004). Similarly, enzymatic 
dissociation with trypsin appears to be too harsh on cells in neurospheres and 
results in high levels of cell death. As such, less vigorous enzymes such as Accutase 
are often used in neurosphere dissociation to obtain satisfactory cell viability 
(Wachs et al., 2003; Joannides et al., 2007b).  
During dissociation, Rho-kinase upregulation mediated via the Rho-associated 
protein kinase p160ROCK (ROCK) promotes anoikis, a form of apoptosis triggered by 
loss of contact with neighbouring cells and the extracellular matrix (Koyanagi et al., 
2008). The addition of Y-27632, a selective inhibitor of ROCK, to dissociated 
neurosphere preparations and other models of mechanical neuronal injury, reduces 
apoptosis and promotes cell survival (Dergham et al., 2002; Xu et al., 2008; 
Rodrigues et al., 2011). 
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The addition of the ROCK inhibitor Y-27632 provided an increase in the viability of 
plated cells (Figure 4.1) and has now become standard procedure within the lab. 
Previously the use of Accutase was already established as the standard method of 
dissociation and this procedure was also shown here to achieve increased plate-
down viability. 
With any tissue culture procedure, especially stem-cell based tissue culture work, it 
is important to consider the implications of user-dependent. As such, it was 
important that the cells produced for the experiments in this thesis were of as 
consistent quality as those used elsewhere. For this purpose, the IHC staining of 
terminally differentiated cells with anti-β-III tubulin (Figure 4.2) along with images 
showing morphological characteristics (Figure 4.3) were used as an indication that 
these cells were similar in appearance and lineage to the standard hESC-derived 
neuronal cultures. Furthermore, this provides further evidence that the 
differentiation procedure was producing viable neuronal tissue.  
The functional development of hESC-derived neurons was investigated with respect 
to key physiological properties. The measurements obtained from fetal hWGE and 
post-natal mWGE provides comparative data from two key stages of development. 
Access to regular primary fetal hWGE tissue is relatively rare but provides precious 
human cells from an early developmental stage. It is less likely, certainly within our 
lab, to be able to obtain post-natal neuronal tissue from human subjects. As a 
substitute for this, postnatal mouse (postnatal day 1) pups were used to obtain 
neurons from mWGE. These cells provided comparative data from a more mature 
stage of neuronal development.  
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The functional activities of voltage-gated K+, Na+ and Ca2+ channels were measured 
in hESC-derived neurons at PPD weeks 1, 2, 3 and 4+. The same characterisation 
process was also performed on fetal-derived hWGE (obtained from fetuses aborted 
between gestational weeks 6 and 12 within 2 DIV) and post-natal mWGE (post-natal 
day 1 within 2 DIV). These tissues were obtained in accordance with local and 
national guidelines. In all cell types, the capacitance, voltage-gated channel activity, 
Vm, ability to fire iAPs and sAPs and the iAP threshold were measured. 
Figure 4.5 to Figure 4.8 show typical recordings of voltage-gated K+ and Na+ channel 
activity in hESC-derived neurons and those recorded from hWGE- and mWGE-
derived neurons. The characteristic trace and I-V shape is similar to those seen in 
recordings from primary neurons, and cells heterologously expressing delayed 
rectifier voltage-gated K+ channels and voltage-gated Na+ channels (Zhou et al., 
1998; Castle et al., 2001; Schaarschmidt et al., 2009).  
The recorded outward voltage-activated currents were confirmed as K+ currents 
through blockade with 20 mM TEA-Cl. A high variation of K+ current amplitude was 
observed at all weeks PPD (Figure 4.11). That primary tissue-derived neurons had 
significantly lower K+ channel amplitudes than week 2 and 3 hESC-derived neurons 
suggests that hESC-derived neurons may be at a different stage developmentally 
from these primary cells. However, there was no observed significant difference 
between the K+ current amplitudes at week 4 and those recorded from hWGE- and 
mWGE-derived neurons, suggesting that, by the later stages of terminal 
differentiation, hESC-derived neurons are similar to their primary counterparts with 
respect to their K+ channel dennsity. It has been observed in embryonic mouse 
brain that developing neurons, migrating from the ventricular zone (VZ), through 
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the intermediate zone (IZ), towards the cortical plate (CP), show a reduction in 
voltage-gated K+ current amplitude during development (Picken Bahrey & Moody, 
2003b). This would suggest that the hESC-derived neurons may be at an earlier 
developmental stage than the hWGE- and mWGE-derived neurons during the 
middle stages (weeks 2 and 3) of terminal differentiation. 
Voltage-gated Na+ currents, typical of all stages of terminal differentiation in hESC-
derived neurons and in hWGE- and mWGE-derived neurons, were recorded and 
confirmed as Na+ current if they were absent upon replacement of extracellular 
NaCl with NMDG-Cl. hESC-derived neurons displayed voltage-gated Na+ currents 
that were similar in amplitude to fetal hWGE-derived neurons and smaller than 
post-natal mWGE-derived neurons (Figure 4.12). This suggests that hESC-derived 
neurons are at a developmental stage which is closer to fetal than post-natal 
neurons with respect to their Na+ channel activity. It has been shown previously 
that neurons exiting the cell cycle in the VZ, and subsequently migrating to the IZ 
show an increase in voltage-gated Na+ current amplitude (Picken Bahrey & Moody, 
2003a) suggesting that hESC- and fetal hWGE-derived neurons are developmentally 
less mature than neonatal mWGE-derived neurons regarding their Na+ channel 
activity. 
All cell types and stages exhibited voltage-gated K+ channel activity. Only a 
proportion of the cells displayed voltage-gated Na+ channel activity. As voltage-
gated Na+ channels are a requirement for the induction of an action potential, the 
percentage of cells showing voltage-gated Na+ channel provides an indication of the 
proportion of cells within a population that are excitable. In hESC-derived neurons, 
the percentage of cells expressing functional voltage-gated Na+ channels rose 
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sharply from PPD week 1 to week 2 (approx. 27% in week 1 to 89% in week 2, as 
shown in Figure 4.13). This high percentage was maintained for weeks 3 and 4+ at 
approx. 95 % and 91%, respectively. In fetal hWGE-derived neurons, approx. 52 % 
cells displayed voltage-gated Na+ channel activity compared to 100% in post-natal 
mWGE-derived cells. That the percentage of hESC-derived neurons displaying 
voltage-gated Na+ channel activity reaches a similar level to post-natal mWGE-
derived neurons and is greater during the later weeks of terminal differentiation 
than fetal hWGE-derived neurons suggest that, with respect to the number of cells 
that have the potential to fire action potentials, these cells are differentiating into a 
more homogenous population with a more mature population phenotype than the 
fetal hWGE-derived neurons. 
Voltage-gated Ca2+ channels were shown to be active in all of the cell populations 
studied. Figure 4.14 shows an example Ca2+ imaging trace from a cell exhibiting 
voltage-gated Ca2+ channel activity during membrane elicited by depolarisation 
induced by extracellular application of 50 mM KCl. The percentage of cells 
displaying such voltage-gated Ca2+ channel activity was comparable to that of 
voltage-gated Na+ channels. Initially, in the first week of terminal differentiation, a 
relatively low proportion of the hESC-derived neurons displayed voltage-gated Ca2+ 
channel activity (14.7 %). By week 2, this percentage had risen to 90.9% and this 
was maintained throughout the remaining weeks (88.2% and 86.3% for week 3 and 
4+, respectively). The percentage of cells showing voltage-gated Ca2+ channel 
activity was 60.5% in of fetal hWGE and 87.2% in post-natal mWGE. As with the Na+ 
channel results, this suggests that these hESC-derived neurons are differentiating 
towards a more mature and homogeneous population phenotype. The presence of 
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voltage-gated Ca2+ channels is important for both the formation and function of 
synapses between neighbouring neurons (Iwasaki et al., 2000) and for regulation of 
neuronal development (Bootman et al., 2001; Greer & Greenberg, 2008). 
The ability of a neuron to fire an action potential relies on the expression of voltage-
gated Na+ channels. In all cells recorded, only those with demonstrable voltage-
gated Na+ currents measured in voltage clamp were able to display iAPs in current 
clamp. However, functional expression of voltage-gated Na+ channels did not 
guarantee iAP capability. In hESC-derived neurons at 1 week PPD only 35% of cells 
were capable of iAPs. 
As with the percentage of cells displaying voltage-gated Na+ and Ca2+ channel 
activity, the pattern of iAP ability during terminal differentiation of hESC-derived 
neurons suggests a change during differentiation from a more fetal population 
phenotype to a more post-natal phenotype. 
The current-step protocol for measuring iAPs (as outlined in section 2.2.2.5. ) uses 
current injection to bring the membrane potential of the cell to approximately -80 
mV before inducing APs with a current step. This hyperpolarisation removes 
voltage-inactivation of the Na+ channels and allows an action potential to be 
induced upon current stepping. Without this, the membrane potential may be 
depolarised enough that Na+ channels are inactivated making iAPs unlikely.  
For an AP to occur across a membrane Vm must be negative enough to remove 
steady-state inhibition of voltage-gated Na+ currents. In order to assess the 
spontaneous excitability of the neuronal populations further, the iAP threshold, Vm 
and sAP generation within these populations were recorded. 
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Successful iAP generation was determined as an alteration of current-step induced 
increase of membrane potential above the standard curve seen in a non-excitatory 
cell which takes the membrane potential sharply and transiently above 0 mv, 
followed by a rapid repolarisation to a baseline potential determined by the current 
step size. It is possible to predict the iAP threshold from the recorded trace of 
membrane potential (mV) plotted against time. However, it becomes easier to 
predict the correct threshold value if the derivative (change in membrane potential 
divided by change in time from the previous value, dV/dt) is plotted against the 
membrane potential (mV) for each data point as shown in Figure 4.20 (Sekerli et al., 
2004). 
The patterns observed for both mean iAP threshold and mean Vm values in these 
cells suggest that the hESC-derived cells are not developing, with respect to their 
iAP threshold and Vm values, past a stage more similar to fetal hWGE- than post-
natal mWGE-derived neurons. The Vm values observed in both hESC- and hWGE-
derived neurons was considerably more positive than that of mature neurons 
suggesting that these cells remain in a more immature stage than the post-natal 
mWGE-derived neurons. That the iAP values are relatively less negative in the hESC- 
and hWGE-derived neurons than the mWGE-derived neurons suggests that these 
cells are fundamentally different in their electrical excitability. A reduction in action 
potential threshold during development has been proposed for some neuronal 
populations (Gao & Ziskind-Conhaim, 1998; Picken Bahrey & Moody, 2003b). 
As mentioned, the iAP protocol produced an artificial hyperpolarised ‘resting’ 
membrane potential through current injection. This was used to uncover the 
potential for AP induction. For a measure of the actual electrical activity within a 
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cellular population it is important to measure the spontaneous activity at the 
physiological Vm. For this purpose, recordings of cells in the zero current injection 
(I=0) mode of the current clamp was carried out for 90 s in order to establish the 
presence or absence of spontaneous electrical events. In all hESC-derived neurons 
at all stages of terminal differentiation there was no observable spontaneous 
activity (0/74). Spontaneous activity was observed in both hWGE- (2/8) and mWGE-
derived neurons (5/5). It is, perhaps, understandable that no spontaneous activity 
was observed in the hESC-derived neurons as the mean Vm value was so depolarised 
that it is possible there was complete steady-state inactivation of the voltage-gated 
Na+ channels in these cells, thus preventing AP induction. However, there was no 
significant difference between the Vm and iAP values of hESC- and hWGE-derived 
neurons and yet spontaneous activity was measured in some hWGE-derived 
neurons. This suggests that the relatively depolarised mean Vm and iAP threshold 
values are not entirely responsible for the apparent lack of spontaneous activity. 
This lack could be indicative of an inability of the hESC-derived neurons to form 
functional synapses, or that they are still developmentally more immature than the 
fetal hWGE-derived neurons. It could also reflect differences in the Na+ channel 
subtypes expressed in these cells, resulting in different functional characteristics. 
Several physiologically relevant functional characteristics have been observed in 
hESC-derived neurons undergoing terminal differentiation in vitro. These have been 
compared to results obtained for fetal hWGE- and post-natal mWGE-derived 
neurons providing a relatively immature and mature population of striatal cells, 
respectively. The amplitude of currents carried by voltage-gated K+ and Na+ 
channels, the percentage of cells showing voltage-gated Na+ and Ca2+, the 
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percentage of cells displaying iAPs, the iAP threshold, Vm and spontaneous activity 
within these cells was recorded. For visual purposes Figure 4.24 displays the key 
patterns of the findings. 
 
Figure 4.24. Visual representation of functional characterisation of 
hESC-, hWGE- and mWGE-derived neurons: For each of the key 
findings, the general pattern of values across the cell types/stages is 
illustrated. Actual values are not used, this image is intended as an aid 
for comparisons between cells. 
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In summary, it is apparent that the terminal differentiation of hESC-derived neurons 
is accompanied by an alteration in the functional electrical characteristics of the 
cells. Voltage-gated Na+ channel activity was apparent in a higher percentage of 
cells as they differentiate. Similarly, a higher proportion of cells displayed voltage-
gated Ca2+ channel activity from week 1 to week 2 PPD. This increase in the voltage-
gated channel activity is mirrored by an increase in the percentage of cells able to 
fire an AP upon current injection (iAPs). Conversely, it is apparent that the iAP 
threshold, Vm and absence of spontaneous activity is not altered throughout. The 
relatively depolarised Vm and iAP threshold values suggest a more immature 
phenotype, and the lack of sAPs suggest that electrical signalling is not occurring in 
these populations. That such a key component of neuronal development is missing 
in these cells is indicative of an incomplete developmental environment. 
Unfortunately it is not obvious if the apparent lack of spontaneous activity is the 
result, the cause, or independent of the relatively depolarised resting membrane 
potential values, but it is likely the two are linked.  
That the cells are increasing their potential for excitability, assayed as an increase in 
the percentage of cells displaying iAPs, mimics neuronal development in vivo and is 
promising for further development of the differentiation protocol (Gao & Ziskind-
Conhaim, 1998; Picken Bahrey & Moody, 2003b). The hESC-derived neurons 
showed a greater similarity to fetal hWGE-derived neurons than to neonatal mWGE 
derived neurons with respect to the majority of measured functional characteristics. 
Significant differences between both hESC- and hWGE-derived neurons and mWGE-
derived neurons were observed in their mean Na+ current amplitude, iAP threshold 
and Vm values. This suggests that these cells are at a developmental stage more 
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similar to fetal neurons than neonatal neurons. However, there is an apparent 
similarity between the proportion of cells displaying Na+ and Ca2+ channel activity 
and iAPs observed between hESC-derived neurons and mWGE-derived neurons 
which are not reflected in the hWGE-derived neuronal populations. It is interesting 
to note that the similarities between hESC- and hWGE-derived neurons are those 
factors which are based on measurements of channel properties (amplitudes and 
activation thresholds), whereas the similarities between hESC- and mWGE-derived 
neurons are in those characteristics which are population based (percentage of cells 
with a certain response). This may be indicative of variability in the populations of 
different cell types (neuronal and non-neuronal cells) between hESC-derived 
neurons and fetal hWGE-derived neurons. It is highly likely that the neurosphere 
and differentiation protocols produce a population of cells which is more 
homogeneously neuronal than is present in early fetal WGE. This relative 
homogeneity may be present in the more mature WGE of the postnatal mouse. 
Although these hESC-derived neuronal populations may be, like the mWGE-derived 
neurons, more homogeneous than the fetal hWGE-derived neurons they are 
apparently more immature in their neuronal development than these neonatal 
cells. 
That the neuronal population present in fetal hWGE-derived neurons is capable of 
spontaneous activity suggests it is able to be influenced by electrical activity-
induced differentiation. Similarly, the neonatal mWGE-derived neurons also display 
spontaneous activity. This mimics data observed in other studies (Spitzer, 2006) and 
highlights the importance of in vitro primary neuronal models of development as 
the gold-standard to which hESC-derived neuronal differentiation must be 
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compared. The apparent lack of spontaneous activity in the hESC-derived neurons 
suggests that activity-dependant effects on neuronal development are not currently 
involved in the differentiation of these cells. Furthermore, it suggests that the 
differentiation protocol used in this study requires further adaptation to stimulate 
differentiation which is more similar to that occurring in vivo. 
Suggested adaptations may be focused on the stimulation of neurotransmitter 
receptors, transient [Ca2+]i induction, electrical stimulation via electrodes during 
culture or modifications of the extracellular ionic concentrations to alter membrane 
properties. Studies into the effects of co-culture of neurons with embryonic mouse 
glial populations have indicated an increase in spontaneous activity in hESC-derived 
neuronal populations (Johnson et al., 2007). Similar results have now been 
replicated within our lab suggesting a link between glial conditioned media and the 
development of spontaneous activity. Further work is required to discover the 
causal factor in this increase in activity. Periods of increased extracellular K+ 
concentrations during adult rat hippocampal neuronal precursor cell culture 
increase neurogenesis and improve in vitro neuronal fate determination (Deisseroth 
et al., 2004). Similarly, mild electrical stimulation of mESCs improved neuronal 
differentiation suggesting that this is not entirely a synapse-dependent effect 
(Yamada et al., 2007). 
The utilisation of a differentiation protocol for hESCs which reduces non-human 
products and uses chemically defined ingredients provides the potential for the 
production of therapeutic grade material for transplantation. It also provides hESC-
derived populations which have been differentiated in more consistent 
environments. The control of media content offered by using serum replacements 
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and feeder-free cultures provides an alternative to the more widely used methods 
of using non-human feeder cells for stem cell cultures, and animal products such as 
FBS in their subsequent differentiation protocols. 
The production of chemically-defined protocols for producing hESC-derived neurons 
which are similar in nature to clinically relevant neuronal populations will provide a 
therapeutic tool for the potential treatment of neurodegenerative conditions. The 
work in this chapter highlights the need for a greater understanding of the 
functional characteristics of these developing neurons, both in vivo and in vitro and 
a need for greater control of electrical signalling during terminal differentiation. 
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Chapter 5.  GABAergic Signalling in hESC-Derived and Primary Neurons 
5.1. Introduction 
The use of human primary tissue in studies of development and disease modelling 
provides two distinct advantages over animal tissue and hESC-derived tissue. Firstly, 
the tissue is derived from human cells making it more clinically relevant than that 
obtained from animal sources. Secondly, primary human tissue has undergone a 
degree of differentiation within the developing fetus and, as such, is more 
developmentally appropriate than current stem-cell models. The disadvantages of 
human primary tissue are largely due to the lack of availability and the ethical issues 
associated with its use. However, tissue obtained from abortions is, although under 
strict government guidelines and patient cooperation, available in certain 
circumstances for use in basic research.  
5.1.1. GABA 
GABA is one of the major neurotransmitters in the brain. Acting through stimulation 
of its receptors, GABAARs and GABABRs, it is vital for proper brain development and 
function {}. It is worth noting that GABAC receptors are mentioned in many papers. 
However, since 2008, they have been reclassified as a subtype of GABAARs and are 
now referred to as ρ1-3 (Olsen & Sieghart, 2008).  
5.1.2. GABAA Receptors (GABAARs) 
These ligand-gated, ionotropic receptors open a Cl- selective anion pore upon 
activation through GABA binding. As pentameric transmembrane receptors, they 
consist of 5 transmembrane subunits. There are multiple subtypes of these subunits 
which can combine to form multiple heteromers. At present the accepted subtypes 
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are as follows; α 1-6, β 1-3, γ 1-3, ρ 1-3 , δ, ε, π, θ(Olsen & Sieghart, 2008). The 
degree to which these subtypes can combine is not yet fully known. If randomised 
heteromeric subunit composition was observed, there would be many thousands of 
possible permutations. However, it has been shown that this is highly unlikely and 
that there may be as few as 26 possible combinations endogenously expressed. 
Each of the combinations of subunits present specific pharmacological profiles and 
responses to agonists and antagonists. In the human brain, the (α1)2(β2)2(γ2) 
subtype is the most common (Olsen & Sieghart, 2008). 
5.1.3. GABAB Receptors (GABABRs) 
Unlike GABAARs, GABABRs are metabotropic G-protein-coupled receptors. Acting 
through a signalling cascade involving adenylyl cyclase and cAMP, these receptors 
mediate and modulate both K+ and Ca2+channels (Birnbaumer, 1990; Cooke, 1999). 
Other than some links with pain, behaviour and some possible developmental roles, 
the endogenous function of GABABRs have not been clearly established (Olsen & 
Sieghart, 2008). 
5.1.4. Role of GABA in Neuronal Development 
Whilst the function of GABA in the adult brain as an inhibitor of neuronal excitability 
is well established, more recent observations have provided evidence for a 
developmental role of this neurotransmitter. When GABA binds to GABAARs a Cl
- 
channel is opened. The electrical response to this increase in Cl- conductance is 
determined by the gradient of Cl- across the plasma membrane and Vm. If [Cl-]i is 
high enough (resulting in an ECl value less negative than Vm), then Cl
- will leave the 
cell down its electrochemical gradient, depolarising the cell and increasing its 
excitability – this is GABA acting as an excitatory neurotransmitter. Conversely, if 
Chapter 5. GABAergic Signalling in hESC-Derived and Primary Neurons 
 
128 
 
[Cl-]i is low enough (resulting in an ECl value more negative than Vm), then GABA 
binding to GABAARs will result in Cl
- influx, hyperpolarisation and a decrease in 
excitability – this is GABA behaving as an inhibitory neurotransmitter (Chavas & 
Marty, 2003). 
 The discovery that, in immature, prenatal and early postnatal rodent neurons, 
GABA is excitatory has led to an increase in research into this mechanism and its 
consequences. It was initially shown that the response was dependent on [Cl-]i 
(Owens et al., 1996) through the use of gramicidin perforated patch clamp, which 
allows electrical access to the cell without disturbing the endogenous intracellular 
Cl- concentration (Marty & Finkelstein, 1975; Horn et al., 1988). Studies went on to 
show that immature prenatal and early postnatal neurons show differential 
expression of two Cl- transporters, Na-K-2Cl co-transporter 1 (NKCC1) and K-Cl co-
transporter 2 (KCC2), when compared with mature adult neurons (Ben-Ari, 2002; 
Yamada et al., 2004). In physiological conditions, NKCC1 transports Cl- into the cell 
using the Na+ electrochemical gradient and co-transports K+ as a means to maintain 
electro-neutrality. KCC2 transports Cl- out of the cell by harnessing the K+ 
electrochemical gradient. NKCC1 is highly expressed in immature neurons and is 
down-regulated during development. KCC2 shows the opposite trend, with low or 
zero expression early on, and an increase in expression during neuronal maturation. 
The differential expression of both of these transporters during development is 
believed to control [Cl-]i and as a consequence, determines the electrical response 
to GABA application (See model in Figure 5.1 (Owens et al., 1996; Yamada et al., 
2004). If the shift of Vm towards ECl during GABAAR activation exceeds the threshold 
for voltage-gated Ca2+ channel activation then the resulting influx in [Ca2+]i can be 
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measured using standard Ca2+ imaging techniques (Figure 5.1). In this chapter, such 
an excitatory response to GABA activity was measured indirectly as a GABA-evoked, 
depolarisation-mediated activation of voltage-gated Ca2+ channels. Conversely, an 
inhibitory response to GABA is defined throughout this chapter as a lack of such 
GABA-evoked Ca2+ influx in physiological [Cl-]o in cells which did demonstrate Ca
2+ 
responses to both 50 mM KCl and GABA in non-physiological, low [Cl-]o solutions. 
 
Figure 5.1: Model of GABAergic Signalling in Developing Neurons: 
Diagram showing the resulting ionic movement upon GABA binding to 
GABAARs in cells with an immature (high [Cl
-]I) or a mature (low [Cl
-]I) 
phenotype and the associated change in Fura-2 fluorescence activation 
as a result of Ca2+ influx through voltage-gated Ca2+ channels. 
 This striking ‘double-action’ of GABA appears to have a role in a wide variety of 
developmental processes; it has so far been linked with cell proliferation (Fiszman 
et al., 1999), differentiation (Tozuka et al., 2005), integration of synapses (Ge, 
2006), migration (Behar et al., 2000) and adult neuronal function (Fritschy & 
Mohler, 1995). Furthermore, it has also been shown that this effect is not only 
apparent in immature cells of the earlier stages of development, but is also present 
Chapter 5. GABAergic Signalling in hESC-Derived and Primary Neurons 
 
130 
 
in immature precursor cells which reside in the adult nervous system (Carleton et 
al., 2003).  
 The knowledge that voltage-gated Ca2+ channels are activated through GABA-
mediated depolarisation suggests that GABA can indirectly affecti Ca2+-dependent 
gene expression. Ca2+ transients have been associated with developmental cues and 
through this action it has been suggested that GABA modulates enzyme function, 
neurite outgrowth and transmitter release (Obrietan & Vandenpol, 1995; Owens et 
al., 1996; Fiszman et al., 1999). 
5.1.4.1. Proliferation 
 The link between GABA-mediated excitation and an effect on cell proliferation has 
been shown in a variety of neuronal cell types (LoTurco et al., 1995; Fiszman et al., 
1999; Haydar et al., 2000; Nguyen et al., 2003; Represa & Ben-Ari, 2005). However, 
the observations are contradictory, and while proliferation is induced by GABA in 
some populations, in others it is inhibited (Fiszman et al., 1999; Nguyen et al., 
2003). The induction of cell proliferation is a less well understood effect of GABA 
and whether it induces proliferation in immature cells and inhibits it in more 
developed precursors has yet to be investigated. 
5.1.4.2. Migration 
The effects of GABA on neuronal migration are varied and often contradictory. 
Observations that GABA promotes motility (Behar et al., 1998), accelerates 
migration and also acts as a migration inhibitor (Varju et al., 2001) suggest that 
there are many other factors which also contribute to the GABA response. It has 
been suggested that GABA may mediate migration by altering the volume of the 
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cell, a factor often associated with cell migration (Habela et al., 2009). As GABA 
opens a Cl- channel, the resulting ionic imbalance may result in obligatory water 
movement to compensate for the change in osmolarity. Indeed a reduction in cell 
volume upon sustained opening of GABA-gated Cl- channels in glioma cells has been 
demonstrated (Habela et al., 2009). As this would only happen in cells in which ECl is 
less negative than Vm, this observation suggests only immature neuronal cells would 
be affected. It is interesting to note that volume dynamics also play a role in cell 
division and, therefore, proliferation (Represa & Ben-Ari, 2005). 
5.1.4.3. Differentiation 
 GABA induces or increases differentiation in neuronal progenitor populations. 
Blocking GABARs in those same cells reduces differentiation. This suggests GABA 
plays an important role in neuronal maturation (Tozuka et al., 2005; Parga et al., 
2007). Parga and colleagues have shown that treatment of mesencephalic precursor 
neurospheres with the GABAA antagonist bicuculline increases the number of 
dopaminergic (DA) neurons in vitro, they went on to show that this was directly due 
to increased DA neuron differentiation (Parga et al., 2007). Cancedda and 
colleagues showed that excitatory GABA activity is essential for correct 
morphological maturation in vivo by carrying out in utero transfection of KCC2 in 
fetal rat cortical neurons at a developmental stage where endogenous KCC2 is not 
normally expressed. They reported no significant difference in migration, but 
correct morphological maturation was lost. Overexpressing an inwardly rectifying K+ 
channel in a separate set of experiments, to mimic the loss of depolarisation upon 
GABA application seen with the KCC2 expression experiments, showed that this 
effect was the result of the loss of GABA-dependent depolarisation, lending further 
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weight to the theory that it is GABA excitation that results in changes to gene 
expression and function (Cancedda et al., 2007).  
5.1.4.4. Integration 
 It is becoming more apparent that neuronal activity itself induces the process of 
neurogenesis and synaptic integration, allowing the developing circuitry to self-
regulate and produce the required complex signalling pathways that are necessary 
for proper bodily function and behaviour (Kempermann & Gage, 1999; Fuchs & 
Gould, 2000; Ming et al., 2001; Doetsch & Hen, 2005). Shaoyu Ge and colleagues 
showed that newborn dentate gyrus granule cells are activated by tonic (non-
synaptic) GABA inputs, and are then integrated into functional circuits via phasic 
(synaptic) GABA and glutamate inputs in vivo. By knocking down NKCC1 translation 
using short hairpin RNA (shRNA) they were able to reduce [Cl-]i and, therefore 
generate GABA-mediated hyperpolarisation. This led to ‘marked defects in their 
synapse formation and dendritic development in vivo’ characterised by reduced 
dendritic length, branch number and complexity (Ge, 2006). 
5.1.5. Ontogeny of Excitatory/Inhibitory Responses to GABA 
The development of the GABA response is dependent on [Cl-]i, which is dependent 
on NKCC1 and KCC2 expression. Developmentally, the downregulation of NKCC1 
and complementary upregulation of KCC2, correlating with the switch from 
excitatory to inhibitory GABA responses, has been shown to occur between 3-8 days 
in vitro (DIV) in cerebellar granule cells from post-natal day rat. Glutamatergic 
responses were shown to remain similar through this period (Rego et al., 2001). The 
increase in KCC2 expression may even be triggered by activity relating to synaptic 
integration. This phenomenon can be observed across multiple species and 
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neuronal subtypes and it is now seen as a general rule that immature neurons 
respond to GABA with excitation and mature neurons by inhibition (Ben-Ari, 2002). 
Rego and colleagues reported that 100% of cerebellar granule cells taken from 
postnatal day 6 Wistar rats were excitatory upon application of GABA, this dropped 
to 0% over the next 8 DIV (Rego et al., 2001). Similarly, Ganguly and co-workers 
reported that 100% of E18 rat hippocampal neurons were excitatory upon 
application of GABA even after 3-4 DIV, a number which dropped to 0 by 18 DIV. 
They went further to show that it was the action of GABA that itself promoted this 
switch, as blockers of GABA activity delayed the change towards inhibitory 
responses. They also showed that applications of GABA modulated the expression 
levels of KCC2 (Ganguly et al., 2001). However, no information is currently available 
about the phenomenon in human neural development. 
5.1.6. GABAergic Signalling During Stem Cell Differentiation 
 This information, suggesting that GABA plays a part in all the key areas of neuronal 
development, suggest that more work is required not only to understand the 
developmental processes that are occurring within maturing neuronal networks, 
but also to provide information that may be useful in producing new developmental 
protocols for the production of differentiated mature neurons from hESCs or IPS 
cells in vitro. To be able to exploit naturally occurring developmental cues is already 
the accepted goal of many hESC differentiation protocols. The use of neurotrophic 
factors such as BDNF and GDNF in differentiation experiments is now 
commonplace. The evidence so far suggests that in vitro modification of 
endogenous GABAergic activity in developing neuronal populations produces 
measurable effects on the physical and functional characteristics of those neurons. 
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Much more work is needed to characterise these effects and harness them for 
possible clinical benefit. One particularly important observation, which underlines 
this potential benefit, is that neuronal trauma in vivo promotes down-regulation of 
KCC2 and subsequently switches GABA responses in the damaged neuronal tissue 
from inhibitory to excitatory (Rivera et al., 2005). It is hypothesised that this is to 
both induce neurogenesis in these areas and to promote synaptic integration which 
will potentially promote repair in the traumatised region (Ben-Ari, 2002; Rivera et 
al., 2005). Should the mechanism for recruitment and integration of functionally 
developed neurons to the site of damaged neuronal tissue be already in place, it 
follows that understanding and exploiting this may lead to improved tissue 
transplantation treatment of neurodegenerative conditions. 
5.1.7. Aims of Chapter 
In order to investigate GABAergic signalling within fetal neuroprogenitor 
populations, and to apply knowledge gained from research into other stem-cell 
sources, GABAergic signalling in fetal hWGE-derived neurons was investigated. 
Particular attention was be paid to Ca2+ mobilisation as an indirect effect of GABAAR 
activation as this has been shown to directly affect cellular properties. Modulation 
of GABAergic signalling was investigated in an attempt to identify potential tools for 
further research. Where possible, evidence of GABAergic signalling and modification 
of this signalling were investigated in hESC- and neonatal mWGE-derived neurons 
also. 
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5.2. Non-Standard Methods 
5.2.1. Solutions 
ECS: as described in section 2.2.1.1.  
50 mM KCl ECS: as per standard ECS, but with 50 mM KCl and 90 mM NaCl 
Low Cl- ECS: Equimolar replacement of NaCl with sodium-isothionate (Sigma) 
Mixtures of ECS and Low Cl- ECS were made as described in the relevant text. 
ICS: as described in section 2.2.1.2.  
5.2.2. Gramicidin-Perforated Patch Clamp 
Gramicidin-perforated patch clamp was performed as was whole-cell patch clamp 
(2.2.2. ), with the follow exceptions, as per previously published methodology 
(Ebihara et al., 1995). 
A modified intracellular solution containing 150 mm KCl and 10 mm Hepes buffered 
to pH 7.2 using NaOH, supplemented with gramicidin (Sigma, stock 100 mg/ml in 
ethanol, pipette solution concentration: 100 µg/ml) was sonicated (XL2020 , 
Qsonicator, CT, USA) until the precipitate (gramicidin) was no longer 
macroscopically visible. 
Upon effective GΩ seal formation, the pipette was left in place (without applied 
pressure) to allow gramicidin incorporation into the cell membrane. The access 
resistance was continually measured using the on-line seal-test (Clampex). When 
this value dropped to less than 20 MΩ (within 40 min of seal formation) and 
remained stable for a period of 5 min, experimental protocols were applied. 
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GABA applications were made during voltage-step protocols as described in the 
relevant text. 
5.2.3. Reagents 
N-Methyl-D-aspartic acid (NMDA): Sigma, stocks of 100 mM in H2O 
γ-Aminobutyric acid (GABA): Sigma, stocks of 300 mM in H2O 
α-Amino-3-hydroxy-5-methylisoxazole-4-propionic acid hydrate (AMPA): Sigma, 
stocks of 10 mM in H2O 
Kainic acid monohydrate (Kainate): Sigma, stocks of 10 mM in H2O 
L-Glutamic acid (L-Glu): Sigma, stocks of 100 mM in H2O 
Picrotoxin: Sigma, stocks of 50 mM in ethanol 
3-(Aminosulfonyl)-5-(butylamino)-4-phenoxybenzoic acid (Bumetanide): Sigma, 
stocks of 20 mM in ethanol 
1,3-Dihydro-1-[2-hydroxy-5-(trifluoromethyl)phenyl]-5-(trifluoromethyl)-2H-
benzimidazol-2-one (NS 1619): Sigma, stocks of 10 mM in ethanol 
5.3. Results 
5.3.1. MTOP-Derived Tissue is Functionally Similar to STOP-Derived Tissue 
Functional analysis of MTOP- and STOP-derived tissue was carried out to determine 
whether there were measurable differences in key physiological readouts between 
tissue sources. Ca2+ imaging was used to assess the effect, on intracellular Ca2+, of 
external application of a depolarising 50 mM K+ solution and of several known 
neuronal agonists, namely NMDA, GABA, AMPA, kainate and L-glutamic acids. 
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Figure 5.2 shows example Ca2+ imaging recordings from MTOP- (A.) and STOP-
derived neurons (B.). The mean fluorescence ratio increase as a percentage of 
baseline is shown (C.) for each agonist.  
 
Figure 5.2. MTOP-derived hWGE cells in vitro display similar functional 
characteristics as STOP-derived hWGE cells in vitro: Rises in 
intracellular Ca2+ in exemplar, individual cells derived from MTOP (A.) 
and STOP (B.) fetal hWGE tissue during brief applications of depolarizing 
50 mM K+ solutions (high K+ 1 and high K+ 2), 50 µM GABA, 50 µM 
kainate, 50 µM α-amino-3-hydroxyl-5-methyl-4-isoxazole-propionate 
(AMPA), 50 µM N-methyl-D-aspartic acid (NMDA), and 100 µM L-
glutamic acid (L-Glu) as indicated (black bars). Relative [Ca2+]i is plotted 
as relative units (R.U.) versus time to allow comparison. C. Mean rises in 
[Ca2+]i in response to each agonist and high K
+ solutions plotted as 
percentage increase in fluorescence above baseline (n = 230 MTOP, n = 
88 STOP, error bars represent SEM). Reproduced from (Kelly et al., 
2011). 
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5.3.2. hWGE-Derived Neurons Display Functional Ionotropic GABA Receptors 
Extracellular application of GABA during whole-cell patch-clamp of hWGE-derived 
neurons elicited an inward current (indicating outward Cl- movement) which was 
dependent on GABA concentration. The current elicited was composed of a fast 
activating and slow inactivating component typically taking 1-2 s to reach maximum 
amplitude before steadily declining to a plateau which was then maintained 
throughout the remaining GABA application (Figure 5.3.A.). This GABA-induced 
current was also observed in hESC-derived neurons, at week 3 PPD, and post-natal 
mWGE-derived neurons, at DIV 3. GABA-concentration dependence was observed 
in all cells. hWGE-, mWGE- and hESC-derived neurons gave EC50 values for GABA of 
19.9 ± 1.19 µM, 7.18 ± 0.55 µM and 53.37 ± 7.17 µM, with Hill coefficients of 1.7, 
1.6 and 1.3, respectively. 
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Figure 5.3. GABA-induced currents in primary and hESC-derived 
neurons are concentration dependent: Extracellular application of 
GABA at various concentrations resulted in inward currents. A. an 
example trace showing currents in a DIV 3 neuron from hWGE in 
response to indicated concentrations of GABA. B. Concentration-
response curves fitted to data obtained from hWGE-, mWGE- (DIV 1) 
and hESC-derived (post plate-down week 3) neurons (all points; n = 5, 
error bars indicate SEM). EC50 values, hWGE: 19.9 µM, mWGE: 7.18 µM, 
hESC-Neu: 53.37 µM. 
A voltage-step protocol (see section 2.2.2.4. ) coupled with extracellular GABA 
application enables the reversal potential for GABA currents (EGABA) in hWGE-
derived neurons to be measured (Figure 5.4). GABA-induced currents (after leak 
subtraction) were shown to reverse at 3.8 mV. Due to the calculated junction 
potential (section 2.2.1.4. ) for the solutions used in this experiment, this value is 
calculated to be 1.6 mV (3.8 mV - 2.2 mV). 
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Figure 5.4. GABA-induced currents in hWGE-derived neurons at various 
voltages: Extracellular application of GABA (300 µM) during variable 
voltage steps (9 steps, first step -120 mV, final step 60 mV, step-step 
change 20 mV) resulted in currents of variable amplitude. A. an example 
trace from a DIV 3 hWGE-derived neuron, voltage steps and GABA 
application times are indicated. B. plot of the average leak-subtracted 
GABA-induced current for each voltage (n = 5, error bars indicate SEM). 
Pre- and co-application of 50 µM picrotoxin reduced the mean peak GABA-induced 
current to approximately 25% of the control current (Figure 5.5). This effect was 
reversed after a wash period in the control ECS with a mean peak current of 99% of 
the initial response. 
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Figure 5.5. GABA-induced currents in hWGE-derived neurons are 
reduced by picrotoxin: Currents induced by extracellular application of 
300 µM GABA were significantly reduced when 50 µM picrotoxin was 
pre- (90 s) and co-applied. A. An example trace from a DIV 2 hWGE-
derived neuron showing the GABA induced current with or without 
picrotoxin as indicated. B. shows the average peak current as a 
percentage of that obtained in the control solution for the control, 
picrotoxin block and a 180 s wash in control solution (n = 3, error bars 
indicate SEM). 
Ca2+ imaging was used to measure transient rises in intracellular free Ca2+ in hWGE-
derived neurons during extracellular application of GABA (Figure 5.6). The effect of 
picrotoxin on GABA-induced currents was replicated using this protocol with a 
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reduction in the mean normalised fluorescence ratio increase to approximately 34% 
of the control. Again, this effect was reversed upon wash in control solution with a 
mean normalised fluorescence ratio increase of 77% of the control. 
 
Figure 5.6 GABA-induced Ca2+ transients in hWGE-derived neurons are 
reduced by picrotoxin: Transient increases in intracellular Ca2+ upon 
extracellular application of 300 µM GABA were significantly reduced 
when 50 µM picrotoxin was pre- (60 s) and co-applied. A. An example 
trace from a DIV 2 hWGE-derived neuron showing the GABA induced 
Ca2+ transient with or without picrotoxin as indicated. B. shows the 
average peak Ca2+ transient amplitude as a percentage of that obtained 
in the control solution for the control, picrotoxin block and a 60 s wash 
in control solution (n = 25, error bars indicate SEM). 
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5.3.3. hWGE-Derived Neurons Display Both Inhibitory and Excitatory Responses to 
GABA 
GABA-induced Ca2+ transients were not present in all cells at standard extracellular 
Cl- concentrations. In all cells that displayed Ca2+ transients in response to a 
depolarising application of 50 mM KCl, confirming the presence of voltage-gated 
Ca2+ channels (required for the indirect measurement of excitatory GABA 
responses), GABA induced a transient rise in intracellular Ca2+ when applied in a low 
Cl- solution. Figure 5.7 shows exemplar Ca2+ imaging recordings from separate cells 
displaying an excitatory (A.) and an inhibitory (B.) response to GABA in normal Cl- 
solution. Upon repeated extracellular application of GABA, in sequentially reduced 
extracellular Cl-, Ca2+ transients increased in ‘excitatory’ cells and appeared then 
increased in ‘inhibitory’ cells. 
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Figure 5.7. hWGE-derived neurons display either excitatory or 
inhibitory responses to GABA which are dependent on extracellular Cl- 
concentration: GABA-induced Ca2+ transients were observed in all 
hWGE-derived neurons which displayed voltage-gated Ca2+ channel 
activity in response to 50 mM K+ depolarisation. Cells either displayed 
‘excitatory’ or ‘inhibitory’ responses to 300 µM GABA in physiological Cl-
. Excitatory responses (as in A.) were increased by reducing extracellular 
Cl-. Inhibitory responses (as in B.) were changed to excitatory and then 
increased by reducing extracellular Cl-. Cl- concentrations: ECS 
(144.9mM), 1:3 (111.15 mM), 1:1 (77.4 mM), 3:1 (43.65 mM), Low Cl- 
(9.9 mM). 
The percentage of cells displaying an excitable response to extracellular GABA 
application was measured during in vitro culture of fetal hWGE-derived neurons. 
Recordings were made at three time-points after cells were plated (1-2, 6-7 and 14-
16 DIV). Post-natal day 1 (DIV 1-2) mWGE-derived neurons were used as a 
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comparison. Approximately 88.9% of mWGE DIV 2 neurons displayed excitatory 
responses to GABA. In fetal hWGE-derived neurons 66.5%, 45.1% and 21.8% of cells 
displayed excitatory responses for DIV 1-2, 6-7 and 14-16, respectively. 
 
Figure 5.8. The percentage of hWGE-derived neurons with excitatory 
responses to GABA reduces during culture in vitro: The percentage of 
voltage-dependent Ca2+ channel expressing cells displaying a transient 
increase in Ca2+ in response to an external application of 300 µM GABA 
in physiological extracellular Cl- is shown for mWGE-(black) and for 
hWGE-derived neurons which have been cultured in vitro for the 
indicated days (DIV). Percentages are based the number of observations 
as indicated above each bar. 
5.3.4. Bumetanide Switches Excitatory GABA Responses to Inhibitory 
The excitatory response to GABA is an indirect result of GABAAR activation-
mediated efflux of Cl-, subsequent depolarisation of Vm and corresponding 
activation of voltage-gate Ca2+ channels. Modulation of the intracellular Cl- 
concentration, altering the Cl- gradient and therefore movement upon GABA 
channel opening, should influence the resulting Cl- movement. If the Cl- 
concentration was reduced within the cell, the net movement of Cl- would shift 
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towards movement into the cell. Bumetanide, an antagonist of the Cl- transporter 
NKCC1 (which transports Cl- into the cell), was pre- and co-applied with GABA 
during Ca2+ imaging of fetal hWGE, post-natal mWGE- and PPD week 3 hESC-derived 
neurons (Figure 5.9).  
 
Figure 5.9. hWGE, mWGE and hESC-derived neuronal responses to 
GABA switch from excitatory to inhibitory in the presence of 
bumetanide: In cells which showed an excitatory Ca2+ response to 300 
µM GABA (left graphs), responses were switched to inhibitory by 
extracellular pre-application of 20 µM bumetanide for 5 min (middle 
graphs). This effect was reversed by washing with the control solution 
for 5 min giving excitatory responses (right graphs). Example Ca2+ 
imaging traces displaying the effect of bumetanide on GABA excitation 
in hWGE- (top), mWGE (middle) and hESC-derived (bottom) neurons are 
shown. 
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In all three cell types, bumetanide resulted in the loss of excitatory responses in the 
majority of cells which showed excitatory responses during control GABA 
applications (examples shown in Figure 5.9, % shown in Figure 5.10). 
 
Figure 5.10. Percentage of cells which ‘switch’ from excitatory to 
inhibitory GABA responses in response to bumetanide application: The 
percentage of cells from hWGE-, mWGE and hESC-derived neurons that 
display an excitatory response to 300 µM GABA before, during and after 
pre- and co-application of 20 µM bumetanide as outlined in Figure 5.9. 
The ‘switching’ of excitatory responses to inhibitory responses by bumetanide was 
investigated further using gramicidin-perforated patch-clamp. As gramicidin pores 
are impermeable to Cl-, the intracellular Cl- concentration remains unaffected by the 
ICS Cl- concentration throughout the recording (Abe et al., 1994). This allows the 
measurement of EGABA, which can be used to predict [Cl
-]i. Figure 5.11.A. shows the 
recording of EGABA using GABA applications during a voltage-step protocol in a 
Chapter 5. GABAergic Signalling in hESC-Derived and Primary Neurons 
 
148 
 
gramicidin-perforated whole-cell recording before (control), during 20 µM 
bumetanide application (bumetanide) and after a wash period in control solution 
(wash). EGABA, predicted from the plot of leak-subtracted peak GABA-induced 
currents at each voltage (B.) and is shown in C. The predicted [Cl-]i concentration, 
calculated from the Nernst equation, is shown for each condition (D.). 
 
Figure 5.11. Extracellular bumetanide negatively shifts EGABA in hWGE-
derived neurons: Results from a single cell during gramicidin perforated 
patch-clamp. A. The currents recorded during 300 µM GABA 
applications at different voltages (indicated). B. Peak current density 
plotted against voltage in control solution, during application of 20 µM 
bumetanide (5 min pre-application) and after a 5 min wash in the 
control solution. C. Predicted EGABA values (using the current-voltage 
plots in B.). D. Predicted intracellular concentrations before, during and 
after wash of bumetanide application (predicted using the Nernst 
equation). 
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5.3.5. NS1619 Switches Inhibitory GABA Responses to Excitatory 
The large-conductance Ca2+-activated K+ (BKCa) channel activator NS1619 has been 
shown to hyperpolarise Vm in cultured cells (Olesen et al., 1994). In fetal hWGE-
derived neurons at DIV 14, NS1619 was shown to ‘switch’ responses to GABA from 
inhibitory to excitatory (Figure 5.12). In all fetal hWGE-derived neurons displaying 
inhibitory responses to GABA (that were also shown to have the potential for 
excitatory responses by applying GABA in low Cl- solution), extracellular pre- and co-
application of NS1619 with GABA resulted in excitatory responses, an effect which 
was shown to be reversible after washout with the control extracellular solution, 
whereupon inhibitory responses to GABA were again observed. 
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Figure 5.12. hWGE-derived neuronal responses to GABA switch from 
inhibitory to excitatory in the presence of NS1619: In cells which 
showed an inhibitory Ca2+ response to 300 µM GABA (left graphs), 
responses were switched to excitatory by extracellular pre-application 
of 10 µM NS1619 for 85 s (as indicated). This effect was reversed by 
washing with the control solution for 375 s giving inhibitory responses 
once again. A. An example Ca2+ imaging trace displaying the effect of 
NS1619 on GABA excitation in hWGE-derived neurons is shown. B. The 
percentage of cells from hWGE-derived neurons that display an 
excitatory response to 300 µM GABA before, during and after pre- and 
co-application of 10 µM NS1619 (n = 99). 
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5.4. Discussion 
5.4.1. MTOP-Derived Tissue is Functionally Similar to STOP-Derived Tissue 
That WGE tissue derived from MTOP behaved in a functionally similar manner to 
STOP-derived tissue suggests that there is no noticeable effect on the physiological 
function of WGE neurons derived from MTOP compared to STOP. This allowed 
MTOP-derived tissue to be used in further research into human neuronal 
development.  
In Figure 5.2 responses of both MTOP- and STOP-derived tissue to various neuronal 
agonists can be seen. It is apparent from the example traces (A. and B.) that the 
responses to these agonists have a similar effect on intracellular Ca2+ in each case. 
Similarly the mean responses are very similar for both cells types. 
The greater abundance of MTOP tissue compared to STOP tissue means that this 
work, published alongside other experimental data indicating the viability of MTOP 
is comparable to that in STOP-derived tissue, will hopefully allow for an increase in 
the availability of human fetal neurons for research and clinical use (Kelly et al., 
2011).  
5.4.2. hWGE-Derived Neurons Display Functional Ionotropic GABA Receptors 
GABA currents were measured in fetal hWGE-, post-natal mWGE and hESC-derived 
neurons in vitro. GABA was shown to alter intracellular Ca2+ in a [Cl-]o-dependent 
fashion. The effect of extracellular GABA on intracellular Ca2+ concentration was 
shown to be affected by two drugs, bumetanide and NS1619. 
Recordings of currents induced by extracellular GABA application in fetal hWGE-, 
post-natal mWGE and hESC-derived neurons demonstrate that ionotropic GABA 
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receptors are present and functional in these cells (Figure 5.3). The concentration-
response curves for these currents were plotted for each cell type providing EC50 
values which are similar to those observed for GABAARs in previous findings from 
neuronal populations. The EC50 values of 19.9 µM, 7.2 µM and 53.4 µM were 
predicted for hWGE-, mWGE- and hESC-derived neurons, respectively. These 
compare with values of 20 µM in post-natal day 1-14 in rat hypothalamus (Huang & 
Dillon, 2002), 111 µM in gestational week 5-8 human dorsal root ganglion (Valeyev 
et al., 1999) and 11 µM in post-natal day 14 rat striatum (Olga A, 1998). 
Furthermore, the inward currents elicited by extracellular GABA (Figure 5.3) are 
characteristic in shape of these previously reported Cl- selective GABAARs. The 
calculated reversal potential for Cl-, using the Nernst equation and the solutions 
used in the experiment, is -2.2 mV. In fetal hWGE-derived neurons, the predicted 
reversal for GABA-induced currents (after leak subtraction) was 1.6 mV (Figure 5.4), 
providing further weight to the suggestion that these channels are GABAARs. 
The selective GABAAR antagonist, picrotoxin (PTX), was used to establish further the 
presence of these receptors in fetal hWGE-derived neurons. In whole-cell patch 
clamp, pre- and co-application of 50 µM PTX reversibly blocked mean peak GABA-
induced currents by approximately 75% (Figure 5.5). This effect on GABAARs was 
also measured indirectly as a 66% reduction in the transient intracellular Ca2+ rise 
resulting from GABA-induced Cl- efflux-mediated membrane depolarisation (Figure 
5.6). 
That, unlike GABA currents, Ca2+ transients resulting from extracellular GABA 
applications were not observed in all cells, even those shown to have voltage-gated 
Ca2+ channels, suggested that, in some cells, GABAAR-mediated Cl
- movement did 
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not result in depolarisation of the membrane potential past the activation threshold 
for voltage-gated Ca2+ channels. In order to test this idea, the extracellular 
concentration of Cl- was reduced sequentially, altering the Cl- equilibrium and 
forcing a greater depolarising shift upon GABAAR activation. This reduction in 
extracellular Cl- bought about Ca2+ transients in cells which previously showed 
inhibitory responses in the control solution, and increased Ca2+ transient sizes in 
those cells which already displayed excitatory responses to GABA. This suggests that 
within the fetal hWGE-derived neuronal population there is heterogeneity within 
the population of cells where GABA is either excitatory, or inhibitory in response to 
GABAAR stimulation. 
5.4.3. Development of GABAergic Signalling in hWGE-Derived Neurons 
As the ‘switch’ of GABA responses from excitatory to inhibitory is implicated in 
neuronal development (Ben-Ari, 2002), the presence of inhibitory cells in relatively 
immature neuronal populations was further investigated. Measurements of cells 
displaying voltage-gated Ca2+ channel activity (in response to 50 mM K+ depolarising 
stimulus) were made in response to GABA applications made in normal (144.9mM) 
and low (9.9 mM) extracellular solutions. The percentage of cells displaying 
excitatory responses was recorded at 3 PPD time points. Measurements at 1-2, 6-7 
and 14-16 DIV were compared with those from post-natal day 1 mWGE-derived 
neurons at 2 DIV. 
Previous results have shown that early (1-5 day) post-natal, and embryonic (E18) rat 
neurons display 100% excitatory GABA responses at 1-3 DIV and that these 
responses ‘switch’ during continued culture over approximately 14 days to 0% 
excitatory (Ganguly et al., 2001; Rego et al., 2001). 
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In fetal hWGE-derived neurons at 1-2 DIV only 66.46% of neurons displayed 
excitatory responses to GABA Figure 5.8. This value decreased during continued 
culture reaching 45% at DIV 6-7 and 22% by DIV 14-16. In post-natal day 1 mWGE-
derived neurons 89% were shown to have excitatory responses to GABA. 
That there is such a difference (66% vs. 89%) between human and mouse-derived 
neurons is interesting in that it highlights the potential for a variation in what is now 
considered a fundamental characteristic of neuronal development. In all cells 
displaying inhibitory responses, the presence of both GABAARs and voltage-gated 
Ca2+ channels were confirmed through repeat application of GABA in a low Cl- 
solution. This removed the potential for non-neuronal cells, or those without 
voltage-gated Ca2+ channels, from providing false negative results. It is also 
interesting to note that, unlike the results of previous studies on immature rat 
neurons, the percentage of excitatory responses was not reduced fully to 0% by DIV 
16 in fetal hWGE-derived neurons. 
5.4.4. Bumetanide Switches Excitatory GABA Responses to Inhibitory 
In order to investigate the relationship between intracellular Cl- concentrations and 
the observed excitatory or inhibitory responses to GABA, the effect of a selective 
blocker of NKCC1 (a transporter of Cl-) on excitatory responses was measured. 
NKCC1 activity has been linked to GABA excitation/inhibition in a number of studies 
(Ben-Ari, 2002; Nabekura et al., 2002; Palma et al., 2006). The use of bumetanide 
for the modification of excitatory responses to inhibitory responses represents a 
potential tool for modulation of differentiation in hESCs.  
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In fetal hWGE-, post-natal mWGE- and hESC-derived neurons displaying excitatory 
responses to extracellular GABA application, bumetanide was shown to modulate 
the GABA response, ‘switching’ the response from excitatory to inhibitory (Figure 
5.9) in the majority of cells (Figure 5.10). In fetal hWGE-derived neurons, 
bumetanide treatment resulted in loss of excitatory responses in approximately 
95% (42/44) of cells (which displayed excitatory responses in control solution). This 
effect was reversible, with excitatory responses recorded in approximately 80% 
(35/44) of cells after bumetanide washout. This pattern was repeated for post-natal 
mWGE- and hESC-derived neurons with a loss of 94% and 93% during bumetanide 
application and recovery after washout in 100% and 78% of cells, respectively. 
5.4.5. NS1619 Switches Inhibitory GABA Responses to Excitatory 
When considering aspects of excitatory/inhibitory GABA responses it is important to 
consider not only the Cl- equilibrium potential but also the Vm of the cell. If the Vm is 
less negative than the ECl then activation of GABAARs will result in a net influx of Cl
- 
and an associated inhibitory hyperpolarisation of the membrane potential. 
Similarly, Vm values more negative than ECl will result in Cl
- efflux and excitatory 
depolarisation of the membrane potential. The Ca2+-activated K+ channel (BKCa) 
activator, NS1619, has been previously shown to hyperpolarise rat cortical neurons 
isolated from E18 fetuses (Gáspár et al., 2008). In the fetal hWGE-derived neurons 
in this study, NS1619 was shown to switch inhibitory responses to extracellular 
GABA application to excitatory responses. This suggests that NS1619 could be used 
as a tool for increasing excitatory GABAergic signalling in these populations. If such 
an effect were to be observed in hESC-derived neurons, an increase in excitatory 
GABAergic signalling may result in an improved differentiation outcome. Using 
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bumetanide or NS1619 to modulate GABAergic signalling, as summarised in Figure 
5.13, needs to be investigated further both in primary fetal neurons and hESC-
derived neurons. To increase the control over cellular signalling mechanisms during 
differentiation could greatly reduce the variability observed between separate 
differentiation studies. 
 
Figure 5.13. Visual representation of ECl in GABA Signalling: ECl is based 
on the intracellular and extracellular Cl- concentrations. This value, along 
with the Vm, establishes whether GABAAR activation will result in 
hyperpolarisation (A. excitatory) or depolarisation (C. inhibitory). 
Inhibition of Cl- uptake via NKCC1 using bumetanide (B.) shifts ECl to a 
less negative value and switches excitatory responses to inhibitory. 
Activation of BKCa channels via NS1619 application (D.) shifts Vm towards 
EK
 switching inhibitory responses to excitatory. 
Currently there are no well-defined specific inhibitors of the cation- Cl- co-
transporter KCC2. Two drugs, 4,4'-Diisothiocyano-2,2'-stilbenedisulfonic acid (DIDS) 
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and R(+)-[(2-n-butyl-6,7-dichloro-2-cyclopentyl-2,3-dihydro-1-oxo-1H-inden-5-
yl)oxy] acetic acid (DIOA), are commonly used, but they lack the specificity required 
to distinguish effects on KCC2 from those of other Cl- transporters (Rivera et al., 
2005; Delpire et al., 2009). The advent and discovery of new drugs, such as the 
recently discovered N-(4-methylthiazol-2-yl)-2-(6-phenylpyridazin-3-
ylthio)acetamide (D4), which specifically inhibit this transporter will hopefully allow 
for future studies to provide a greater understanding of the role and importance of 
KCC2 activity in neuronal development, similarly these drugs may become 
important tools for the control of endogenous GABAergic signalling during neuronal 
differentiation. 
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Chapter 6.  Future Developments and General Discussion 
The data presented in this thesis provide important and novel information about 
the development of ionotropic and metabotropic signalling mechanisms present in 
hESC-derived and primary neuronal cultures in vitro. Data are presented which 
indicate that several signalling mechanisms are functionally active in these 
populations and that there are observable changes in electrical signalling during 
hESC-differentiation down a neuronal lineage. Modulation of non-synaptic signalling 
is shown in multiple cell types providing the basis for further research into the 
effect of these pathways on development. 
6.1. Functional Characterisation of an iPSC Line from a Huntington’s Disease 
Patient 
As previously discussed, the developing area of iPSC-development has provided cell 
biologists with a new tool for the study of genetic diseases during development in 
vitro. The following section outlines preliminary work carried out as part of a 
collaborative arrangement funded by the National Institute of Health (NIH) and the 
Cure Huntington’s Disease Initiative (CHDI). 
iPSC lines have been derived from both a patient suffering from Huntington’s 
Disease (HD60i.4) and their non-HD sibling (HD33i.8) by Clive Svendson at Cedars-
Sinai Medical Centre in the Univerisity of Wisconsin. Preliminary functional 
characterisation has been carried out on neurons derived from these iPSCs. 
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6.1.1. Huntington’s Disease 
Huntington’s disease (HD) is an autosomal dominant trinucleotide repeat disorder 
resulting in progressive neurodegeneration, leading to a number of characteristic 
symptoms including the selective loss of medium spiny neurons from the striatum. 
The expansion of CAG repeats in the huntingtin gene (HTT) beyond 36 conveys the 
disease state due to alterations to the protein function and formation of protein 
aggregates. In the healthy brain, the ability to control voluntary movement is 
maintained by a complex network of inhibitory and excitatory inputs. Impulses 
driving movement through the upper motor neurons are inhibited by the cells of 
the basal ganglia during times of desired inactivity. Basal ganglionic inhibition is 
increased by excitatory input from the subthalamic nucleus. External globus pallidus 
cells can inhibit this subthalamic nucleus-excitation during desired activity. These 
inhibitory globus pallidus cells are usually themselves inhibited by the medium spiny 
neurons (MSNs) which project from the striatum into the globus pallidus. In 
Huntington’s disease, approximately 95% of the observed neurodegeneration is 
attributed to loss of these MSNs, which results in reduced inhibitory control of 
involuntary movement through the pathway described above (Gelehrter, Collins et 
al. 1998; Bates and Murphy 2002). As the disease progresses degeneration of the 
cortex is also observed. The root cause of neurodegeneration in HD remains 
unknown (Landles & Bates, 2004). 
Currently there are very few effective treatments of HD. Inhibitory 
neurotransmitters are used to reduce the random movements and antidepressants 
are used to alleviate the depression highly associated with disease progression, but 
these have unwanted side effects in many patients. The potential for 
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downregulation of the mutant htt by siRNA or correction by gene therapy has been 
suggested and drugs aimed at reducing or degrading the aggregations of the mutant 
protein have been hypothesised. No successful cure has yet been produced, and 
treatment is very much aimed at reducing the impact of the disorder on the 
patient’s life rather than preventing neurodegeneration per se (Kim et al., 2008). 
6.1.2. Methods 
Clive Svendson at Cedars-Sinai Medical Centre in the Univerisity of Wisconsin 
provided neural stem cell lines derived from the patient iPSC lines, HD33i.8 and 
HD60i.4, where 33 and 60 relate to the CAG repeat number in htt for each line, 
respectively. This work was carried out externally and only the culture and terminal 
differentiation of NSC lines was carried out within Cardiff University. The following 
method sections on the generation of iPSC (section 6.1.2.1. and neural stem cell 
(6.1.2.2. lines are included for the purpose of clarity. 
6.1.2.1. Generation of iPSC Lines 
Human fibroblast lines were obtained from an HD patient with 60 CAG repeats in 
htt and the non-HD sibling of the patient with 33 CAG repeats. Pluripotency 
reprogramming was induced by lentiviral transduction of Oct4, Sox2, Klf4, cMyc, 
Nanog and Lin28 as previously described (Yu et al., 2007). Clonal colonies with iPSC 
morphology were expanded into stable iPS cell lines. 
6.1.2.2. Generation of iPS-Derived Neural Stem Cell Lines  
NSC lines were generated by collagenase treating iPS colonies and lifting them from 
feeder layers directly into Stemline media (Sigma) supplemented with 100 ng/ml 
basic fibroblast growth factor (bFGF, Chemicon), 100 ng/ml epidermal growth factor 
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(EGF, Chemicon), and 5 μg/ml heparin (Sigma) in polyhema-coated flasks to prevent 
attachment. iPS-derived NSCs were expanded as spherical aggregates and passaged 
weekly using the standard chopping technique (Svendsen et al., 1998). 
6.1.2.3. Terminal Differentiation of iPSC-Derived Neurons 
NSC lines were plated onto glass coverslips for terminal differentiation using the 
method described in section 2.1.4. Growth media (SFDMII) was supplemented with 
the notch inhibitor N-[N-(3,5-Difluorophenacetyl)-L-alanyl]-S-phenylglycine t-butyl 
ester (DAPT, 2.5 μM , Sigma) and ascorbic acid (200 μM, Sigma). 
6.1.2.4. Functional Characterisation of iPSC Lines 
Neurons derived from the two iPSC lines were functionally characterised after 2 
weeks of the terminal differentiation protocol. The preliminary electrophysiological 
characterisation was carried out as described in section 2.2.2.  
6.1.3. Results 
The preliminary functional analysis of the iPSC lines consisted of similar experiments 
to those carried out on the hESC-derived neurons in section 4.3.3. The capacitance, 
voltage-gated channel activity and action potential capabilities of these cells were 
measured. This work was carried out as a preliminary study to determine whether 
these cells were amenable to the experimental protocols used throughout the 
previous work within this thesis. The data are, therefore, not intended to provide 
conclusive evidence for an effect of the Huntingtin mutation in these cells. Further 
work, including a full characterisation at various time points throughout terminal 
differentiation, is planned as part of the on-going collaboration within HD iPSC 
disease modelling consortium funded by CHDI and the NIH. 
Chapter 6. Future Developments and General Discussion 
 
162 
 
6.1.3.1. iPSC-Derived Neurons Display Functional Neuronal Characteristics 
Capacitance was measured for each cell from the iPSC-derived neurons from both 
lines. Box and whisker plots of these data are shown in Figure 6.1. The mean 
capacitance values were 18.6 and 8.7 pF for HD33i.8 and HD60i.4, respectively. 
 
Figure 6.1. Cell capacitance in iPSC-derived neurons: The recorded 
capacitance (pF) for each cell during terminal differentiation of iPSC-
derived neurons was recorded. Box plots of the data are show here from 
the two iPSC lines.  
Voltage-gated channel activity similar to that observed in primary and hESC-derived 
neurons was observed in neurons derived from both iPSC-lines (Figure 6.2 and 
Figure 6.3). 
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Figure 6.2. Voltage-activated currents in a neuron from the HD33i.8 
line: Example traces showing the currents elicited by a voltage-step 
protocol are shown (A, B and C). A. Voltage-activated currents in control 
(ECS) solution. B. Voltage-activated currents in the presence of 20 mM 
TEA-Cl. C. Voltage-activated currents during the replacement of 
extracellular Na+ with NMDG. D. The current-voltage curves for the 
mean outward plateau (open circles) and minimum inward peak (filled 
circles). 
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Figure 6.3. Voltage-activated currents in a neuron from the HD60i.4 
line: Example traces showing the currents elicited by a voltage-step 
protocol are shown (A, B and C). A. Voltage-activated currents in control 
(ECS) solution. B. Voltage-activated currents in the presence of 20 mM 
TEA-Cl. C. Voltage-activated currents during the replacement of 
extracellular Na+ with NMDG. D. The current-voltage curves for the 
mean outward plateau (open circles) and minimum inward peak (filled 
circles). 
The K+ and Na+ current amplitudes for each iPS-line were calculated. Box-and-
whisker plots of these data are shown in Figure 6.4. and Figure 6.5, respectively. 
The mean K+ current amplitudes were 42.6 and 40.9 pA/pF and the mean Na+ 
current amplitudes were -47.0 and -49.4 pA/pF for HD33i.8 and HD60i.4, 
respectively. 
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Figure 6.4. K+ channel amplitudes in iPSC-derived neurons: Average K+ 
current amplitude (pA/pF) for the two iPSC lines are shown (Boxes 
represent upper and lower quartiles, vertical bars represent the range, 
numbers indicated above bars). 
 
Figure 6.5. Na+ channel amplitudes in iPSC-derived neurons: Average 
Na+ current amplitude (pA/pF) for the two iPSC lines are shown (Boxes 
represent upper and lower quartiles, vertical bars represent the range, 
numbers indicated below bars). 
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The percentage of cells displaying Na+ channel activity in neurons derived from the 
HD33i.8 (81%) and HD60i.4 (100%) iPSC-lines are shown in Figure 6.6. 
 
Figure 6.6. Percentage of cells with voltage-gated Na+ channels in iPSC-
derived neurons: The percentage of cells displaying voltage-gated Na+ 
channel activity using the voltage-step protocol are shown for the two 
iPSC lines (numbers are given above each bar). 
Action potential-like responses were evoked upon current stimulation in neurons 
derived from both iPSC-lines (Figure 6.7).  
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Figure 6.7 Induced action potentials in iPSC-derived neurons: An 
example iAP is shown from one cell from each iPSC-line. 
The percentage of cells displaying iAPs in neurons derived from the HD33i.8 (41.6%) 
and HD60i.4 (60%) iPSC-lines are shown in Figure 6.8. 
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Figure 6.8 Percentage of cells with inducible action potentials in iPSC-
derived neurons: The percentage of cells displaying iAPs using the 
current-step protocol are shown for both iPSC- lines (numbers are given 
above each bar). 
The iAP thresholds for each iPS-line were calculated and box-and-whisker plots of 
these data are shown in Figure 6.9. The mean iAP thresholds were -38.2 and -35.7 
mV for HD33i.8 and HD60i.4, respectively. 
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Figure 6.9 iAP threshold values in iPSC-derived: The average iAP 
threshold values for the two iPSC-lines are shown (Boxes represent 
upper and lower quartiles, vertical bars represent the range, numbers 
indicated below bars).  
Vm was calculated for each iPS-line. Box-and-whisker plots of these data are shown 
in Figure 6.9. The mean Vm values were -46.7 and -49 mV for HD33i.8 and HD60i.4, 
respectively. 
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Figure 6.10 Resting membrane potential values in iPSC-derived 
neurons: The average Vm for the iPSC-lines are shown (Boxes represent 
upper and lower quartiles, vertical bars represent the range, numbers 
indicated below bars). 
As was observed in hESC-derived neurons, none of the recorded cells from either 
HD33i.8 (n = 21) or HD60i.4 (n = 9) displayed spontaneous activity during recording 
of Vm. 
6.1.4. Conclusions 
The observation that Huntington’s Disease carrying iPSC-derived neurons display 
functional characteristics similar to those observed in both primary and hESC-
derived neurons suggests that these cells may be useful as tools for the study of this 
disease in vitro.  
The presence of voltage-gated K+ channels in all cells and Na+ channels in the 
majority of cells is similar to the data obtained from primary and hESC-derived cells 
at 2 weeks PPD. Similarly, the ability of at least some of these cells to fire an action 
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potential upon current injection indicates a neuronal phenotype and suggests these 
cells may be amenable to electrical signalling. The relatively depolarised membrane 
potentials coupled with the apparent absence of spontaneous activity suggest that, 
at the measured stage of the differentiation protocol (week 2), these cells are not 
yet being influenced by such electrical signalling and that they may need further 
maturation in order to more optimally mimic primary tissue.  
As has been mentioned, these data are preliminary findings which will form the 
basis of a larger study of the functional properties of these cells and any potential 
differences which are CAG-repeat number-dependent. However, they do indicate 
that these cells are functionally neuronal. Further characterisation, of not only their 
voltage-gated channel and action potential activity, but also their responses to 
various neurotransmitters, will provide data which can indicate an influence of the 
disease-state on neuronal function. In this regard, it has already been shown within 
our lab that neurons derived from the HD60i.4 and another iPSC line (HD180i.5/7 – 
from a patient with 180 CAG repeats) have compromised Ca2+ homeostasis during 
repeated extracellular applications of NMDA indicating an increases susceptibility to 
glutamatergic excitotoxicity, potentially leading to caspase activation and 
augmented cell death (manuscript submitted to Cell Stem Cell). 
6.2. General Discussion 
During development, cell signalling plays a crucial role in the control of apoptosis, 
proliferation, migration, fate-determination and also neuronal specific 
developmental properties such as voltage-gated ion channel expression, 
neurotransmitter specification, axon path-finding, neuronal survival and integration 
into existing neuronal circuitry. 
Chapter 6. Future Developments and General Discussion 
 
172 
 
6.2.1. Purinergic Signalling in Stem Cell Populations 
The observation that purinergic receptors are present within undifferentiated hESC 
populations suggests that not only may purinergic signalling have the capacity to 
influence hESC development, but also that the results of previously published 
studies on the effects of purinergic signalling in similar, non-embryonic stem cell 
populations may be used to predict the effect in hESCs. That ATP can induce a 
transient rise in [Ca2+]i provides a mechanism by which this signalling may be able to 
influence gene expression and protein activity (Webb et al., 2005; Greer & 
Greenberg, 2008). This raises the possibility that agonists and antagonists of 
purinergic receptors may be utilised for the control of receptor activity during 
differentiation procedures which may provide new options for targeted 
differentiation protocols.  
Purinergic signalling has also been shown to regulate neuronal progenitor 
proliferation and neuronal differentiation (Lin et al., 2007). The potential for 
recruitment of stem-cell like populations from neurogenic regions of the adult brain 
offers a therapeutic option which is independent of the introduction of exogenous 
tissue or cells. That purinergic signalling may play a part in the control of such stem-
cell populations is exciting as it suggests that regulation of such signalling, either 
through control of the relevant receptor activity using agonists and antagonists, or 
through modulation of downstream signalling cascades, could be clinically 
beneficial.  
Furthermore, the presence of purinergic signalling in stem-cell populations and the 
link between cellular stress and the release of ATP (Bodin & Burnstock, 2001) has 
both in vitro and in vivo implications. During routine cell culture, regular periods of 
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physical stress are imposed upon cell populations, especially during dissociation. 
Similarly, during surgical procedures, large sections of the patients’ tissue undergo 
severe physical trauma. The combination of these situations during neuronal 
transplantation, where NSCs cultured in the lab are routinely dissociated before 
being surgically transplanted into the adult brain (Brundin et al., 2010), highlights 
the importance of understanding this mechanism further.  
There is already evidence that purinergic signalling, specifically P2Y1-meditated 
transient increases in [Ca2+]i, effects adult NSCs (Mishra et al., 2006; Lin et al., 2007). 
In these studies, P2Y1 signalling was shown to stimulate proliferation in these cells 
and was hypothesised to modulate neurogenesis in the adult brain. Data presented 
in this thesis show that hESCs also have the capacity for ATP-mediated autocrine 
regulation. 
6.2.2.  Functional Characterisation of hESC-Derived Neurons 
By measuring functional neuronal characteristics in hESC-derived neurons and 
comparing them with foetal hWGE- and neonatal mWGE-derive neurons, it has 
been shown functionally that these hESC-derived neurons are not as mature as 
primary-derived populations. The presence, and increased prevalence, of voltage-
gated channel activity, specifically Na+ and Ca2+ channels, confirms that these cells 
are differentiating down a neuronal lineage in terms of both their gene and protein 
expression, and with respect to their excitability. The ability to fire action potentials 
is a fundamental characteristic of a neuron. That these cells display this ability is 
further evidence of their neuronal fate-determination. However, the lack of 
spontaneous activity in these cells suggests that, using the current differentiation 
protocol, these cells are not maturing to a stage where spontaneous electrical 
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signalling is influencing their development. The differences in Vm and iAP threshold 
values between these cells and the neonatal mWGE-derived neurons suggest that 
hESC-derived neurons retain an immature functional phenotype during the terminal 
differentiation protocol. However, compared to the fetal hWGE-neurons, a greater 
percentage of these cells displayed neuronal characteristics suggesting they are 
developing to a more homogeneously neuronal population. That these cells appear 
to undergo a degree of maturation towards a neuronal fate and yet fail to display 
mature neuronal properties suggests that they are maintained in a neuronal 
precursor phenotype. This has implications regarding their use as both therapeutic 
agents, and as models of disease.  
The majority of successful neuronal grafting has been carried out using either fetal-
brain-derived NSC populations (Lindvall & Bjorklund, 2004; Kelly et al., 2011; 
Trounson et al., 2011). These populations, like the fetal hWGE-neurons studied in 
this chapter, have been shown to display neuronal characteristics, but have also 
been shown to be developmentally immature compared to adult neurons (Ogawa 
et al., 2009). It is possible that the immaturity of hESC-derived neuroprogenitor 
populations may in fact improve their therapeutic potential as these cells may be at 
a developmental stage which would still permit further proliferation and 
recruitment into adult neuronal circuitry that would be otherwise less apparent in a 
more mature population. Further work regarding the functional development of 
these cells within host tissues is required. Understanding the effects of endogenous 
signalling pathways present in vivo which may modulate stem-cell-derived neuronal 
integration will hopefully enable improved graft-survival and clinical benefit in the 
future. 
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In terms of their use as disease models, that these cells display a more immature 
phenotype suggests they may not be ideal for modelling the mature neuronal 
populations of the adult brain. This area requires that populations be accurately 
represented both in terms of developmental progress and functional activity. An 
increased understanding of, and ability to regulate, in vitro differentiation will 
ultimately yield cells which are more developmentally similar to adult tissues.  
However, to suggest that under current differentiation protocols hESC-derived 
neurons are not useful for disease modelling due to their immaturity would be to 
overlook a potentially valuable resource. The study of functionally immature cells 
which show a degree of similarity to those of the developing brain offers an insight 
into clinically relevant processes. Increased knowledge of developmental processes 
will undoubtedly shed light on an area of great clinical significance. Also, by studying 
and improving upon these incomplete developmental protocols, it is likely that a 
greater understanding of neuronal maturation will be gained. 
6.2.3. GABAergic Signalling in Fetal hWGE-Derived Neurons 
The observation that GABA signalling is present and active in fetal hWGE-, neonatal 
mWGE- and hESC-derived neuronal populations provides evidence for a mechanism 
enabling functional modulation of these cells via this neurotransmitter. Currently, a 
great deal of evidence has been provided that GABAergic signalling modulates 
developmental processes in the developing rodent brain (Ge, 2006; Cancedda et al., 
2007; Parga et al., 2007). It has been shown previously that, during neuronal 
maturation, GABAergic signalling switches from excitatory (immature) to inhibitory 
(mature). The mechanism of this switch has been shown to be dependent of the 
balance between intracellular and extracellular Cl- concentrations, primarily 
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controlled by the expression of the Cl- transporters, NKCC1 and KCC2. Evidence that 
excitatory GABAergic signalling increases neural precursor proliferation, migration 
and neuronal differentiation (Ben-Ari, 2002) alongside the observation that, 
following neuronal trauma, adult neuronal populations undergo a switch back to 
inhibitory GABAergic signalling via down-regulation of KCC2, serves to highlight the 
importance of this signalling mechanism (Nabekura et al., 2002). 
The most striking and completely novel observation in this study was that fetal 
hWGE-derived neuronal populations appear to contain neurons which are already 
inhibitory in their response to GABA. The presence of cells displaying inhibitory-
responses to GABA in mouse populations has only ever been shown in post-natal 
neurons. That these may already be present during fetal neuronal development in 
humans highlights the issues associated with the use of animal models for human 
development and suggests that the mechanism of GABA regulation during human 
neuronal development must be reconsidered. 
Similarly, sustained in vitro culture of these fetal hWGE-derived neurons, whilst 
showing a reduction in excitatory GABAergic signalling, did not switch all cells 
towards an inhibitory response to GABA, as has been observed in mouse-derived 
populations previously. This may be indicative of a longer period of maturity in 
these cells, but again highlights an observable difference in an important signalling 
mechanism which may be reflected in further developmental differences. 
The modulation of GABAergic signalling in stem-cell populations has been suggested 
as a tool for the control of the downstream effects on development in these 
populations (Represa & Ben-Ari, 2005; Delpire et al., 2009). The potential benefit of 
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such control during in vitro neuronal differentiation is more than apparent. 
Similarly, the presence of excitatory GABAergic signalling in neurogenic regions of 
the adult brain further highlights the importance of understanding and potentially 
controlling this phenomenon. By efficiently modulating the excitatory/inhibitory 
nature of GABAergic signalling in neuronal populations it may be possible to 
enhance the endogenous recruitment of neurogenic populations in the brain, 
improve the functional integration of transplanted neurons into the host brain and 
optimise the differentiation of functionally mature neuronal populations for disease 
modelling. 
The similarity between purinergic and GABAergic signalling in stem-cell populations 
is notable. Both are linked heavily with apoptosis (Zhang et al., 2007), proliferation 
(Fiszman et al., 1999; Liu et al., 2005), migration (Bolteus & Bordey, 2004; Manent, 
2005) and terminal differentiation (Tozuka et al., 2005; Parga et al., 2007). Both are 
present in embryonic and prenatal neuronal populations (Cancedda et al., 2007). 
Both have been linked to control of neurogenic regions of the adult brain (Ge, 2006; 
Parga et al., 2007). In vitro modulation of either has yielded measurable effects on 
the neuronal populations studied (Yamada et al., 2004; Represa & Ben-Ari, 2005; 
Rivera et al., 2005). Whilst these areas require much more research, it is apparent 
that such work may provide tangible benefits to both in vitro and in vivo 
applications. 
6.2.4. iPSC-Derived Neurons Display Functional Neuronal Characteristics 
The observation that iPSC-derived neurons behave in a similar manner to hESC-
derived neurons in vitro suggests that any of the advances in hESC differentiation 
should be directly applicable to iPSC populations. Although both populations have 
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been shown to differentiate into functionally immature neurons, this does not 
mean they cannot be used to study the effects of the disease-state on neuronal 
development. Indeed, work on-going within our lab has uncovered an apparent 
functional phenotype in HD iPSCs which is dependent on the CAG repeat length 
responsible for the disease-state. This alone highlights the importance of further 
investigation into iPSC-derived neurons carrying known disease mutations.  
6.3. Concluding Remarks 
Ionotropic- and metabotropic-receptor mediated cell signalling during 
development, when compared with gene and protein expression, is an area which 
has been largely overlooked and is still relatively poorly understood. The absence of 
control over many of these signalling pathways during in vitro culture and 
differentiation provides a potential source of variability which could have 
tremendous effects on developmental outcome. The benefits of an increased 
knowledge and control over such pathways are apparent for both in vitro modelling 
and in vivo therapeutic strategies. The work described in this thesis provides a base 
for further study of both purinergic and GABAergic signalling within human stem-
cell populations as well as a better understanding of the comparative functional 
properties of hESC-derived, iPSC-derived and primary human neuronal populations. 
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This section annexes two papers accepted for publication and one submitted 
manuscript which contain works which I have contributed to but which have not 
been discussed at any great length in this thesis. 
